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The term ‘Medically Unexplained Symptoms’ (MUS) refers to a constellation of 
symptoms that have a low probability of disease pathology.  It is a clinical area that 
General Practitioners (GPs) have frequent contact with; managing the challenge of how 
to reduce the reported discrepancy between patient expectation of cure and the provider 
approach of symptom management. The aim of this current study is to explore how 
patients and GPs understand MUS and its management, considering how their 
understandings overlap and diverge, how any differences are negotiated and how this 
can inform future collaborative care interventions for MUS.  Six patients and four GPs 
were recruited from one practice, and an interview design was used to explore their 
experiences of managing MUS. The qualitative data were analysed using the framework 
approach, with patient and GP interview data being analysed separately, before being 
synthesised. Three conceptual themes emerged from GP and patient interviews- 
understanding of the symptom(s), the emotion response, the validating relationship, with 
one further conceptual theme present for patient interviews- deciding what gets shared in 
the consultation. The study results provide some support to existing  research that have 
suggested that patients do have a complex understanding of their MUS symptoms. 
There was also a shared belief between participant groups  that the relationship between 
patient and GP was important in the management of MUS, however a gap in 
communication between patient and GP was also highlighted. The results are 
considered in relation to existing interventions that are used to open up the shared 
dialogue between patient and GP.  The clinical implications of introducing a shared 
decision making approach to MUS consultations are discussed, alongside implications 
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CHAPTER ONE: INTRODUCTION 
This study explored how patients1 and GPs understand and manage symptoms that 
cannot be medically explained. The study used semi-structured interviews with GPs and 
patients with medically unexplained symptoms (MUS), to explore in what ways 
understanding overlapped and diverged and how any differences were negotiated within 
the patient-GP relationship. In this chapter, I will begin by providing an overview of what 
is meant by the term Medically Unexplained Symptoms, exploring how it is defined by 
the literature and how it is experienced by different stake holders – at service, patient  
and GP level. I will then move on to discuss the literature on current approaches for MUS 
management in primary care, and the extent to which consultations for MUS are viewed 
as satisfactory for patient and GP.  Finally, I will consider the different approaches used 
to support the process of decision making in healthcare and the anticipated challenges 
that may occur when using decision making tools in the management of MUS. The 
section will conclude with the research questions of this study.  
1.1 Medically Unexplained Symptoms (MUS): Terminology 
Medically Unexplained Symptoms, is the term used to describe the persistent physical 
symptoms of patients that cannot be adequately explained by physical disease or 
observable biomedical pathology (Peveler, Kilkenny & Kinmonth, 1997; MUS Positive 
Practice Guideline, 2014). It has been suggested that MUS in primary care is viewed by 
healthcare professionals as a ‘working hypotheses’ for a constellation of symptoms that 
have a low probability of  organic disease and is a disorder of function rather than 
structure (Burton, 2012; Murray et al., 2016). These symptoms can vary in how they 
cluster together and in their severity, giving rise to a variety of terms used throughout the 
MUS literature and across different clinical domains.  They include symptoms that cluster 
together to form diagnosable functional syndromes, such as fibromyalgia, chronic 
fatigue, chronic pain, as well as  symptoms that are nonspecific to a syndrome –
nonspecific MUS- and symptoms that have sufficiently high levels of clinical distress to 
                                            
1 It is recognised the term ‘patient’ may be perceived as assuming a biomedical  
perspective, however it is used to aid identification of the subjects that this study 
refers to, and the primary care context that this study and the studies reviewed are 





be recognised in the psychiatric classification system as  Somatoform disorder (ICD-10, 
2016).   
Unsurprisingly, there is disagreement in the literature on the appropriateness of 
using MUS as a generic reference term to help identify patients with such symptoms. 
One argument has been that it helps to position the problem away from the patient and 
on to the medical professionals’ lack of explanation (Peveler et al., 1997), however 
others state that this term unhelpfully suggests a dualistic message that symptoms are 
either biological or psychological (Creed, Henningsen & Finet et al., 2011). Moreover, in 
one study in which patients rated MUS related terminology,  ‘persistent physical 
symptoms’, rather than ‘functional’ or ‘Medically Unexplained Symptoms’, was the 
preferred term (Marks & Hunter, 2015). This was believed to reflect patient preference 
for wanting to move away from generic terms that do not support understanding, or have 
cross-cultural relevance (Creed et al.). This highlights not only the challenge for both 
patients and healthcare professionals in how they develop a shared understanding of the 
symptoms that are nonspecific to a diagnosable syndrome or disease, but also the 
differences between what patients view as relevant terminology in contrast to the terms 
used by researchers and health professionals.   
1.2 Medically Unexplained Symptoms (MUS): Prevalence in 
Primary care 
Both the broad spectrum of MUS and the variation in how MUS is defined and 
measured between studies complicates appraising the actual prevalence rate of  MUS in 
primary care. Where the prevalence of Somatoform disorder has been measured by 
diagnostic interview with surveyed primary care patients, the low rates reported and 
consistency found between 14 different countries (0.1-3%), suggests that severe forms 
of the MUS spectrum is relatively rare in primary care (Gureje et al., 1997). Although 
other studies that have used different measurement criteria for Somatoform disorder 
have reported higher prevalence rates of Somatoform disorder in primary care 
population (10.9- 16.1%) (Dewaal & Arnold et al., 2004; Steinbrecher et al., 2011), the 
rates suggest that the number of patients presenting to primary care that would meet 
diagnostic criteria for somatoform disorder still remains low.  In contrast, the prevalence 
of milder symptoms that do not have a medical explanation are high, with reports that 
only  26% of the common symptoms that adults present to primary care with – chest 
pain, fatigue, dizziness, headaches, swelling, back pain, shortness of breath, insomnia, 




Mangelsdorff., 1989). This suggests that whilst severe forms of MUS are rare within 
primary care, managing milder symptoms that are either medically unexplained or 
comorbid with illness are routinely seen within primary care, and become clinically 
meaningful when the symptoms persist (>3 months) and impact on patient distress and 
functional ability. Evidence suggests that compared to patients with other chronic 
conditions, patients with MUS have a lower quality of life, show greater impairment in 
functioning and worse mental health (Smith, Monson & Ray., 1986 ;Koch et al., 2007). 
This implies that although observable causes for the symptoms cannot be found, it does 
not make the patients any less justified in accessing help and support for symptoms that 
for some are experienced as disabling or more so, than chronic conditions with 
observable pathology.   
Although the impact of MUS on the patient is clear, the understanding of what 
factors increase a patients vulnerability of experiencing MUS symptoms, is less so.  
Research examining the demographic and clinical characteristics associated with 
medically unexplained symptoms, suggest that these symptoms are more likely to occur 
in females, where people are older, less educated and unemployed and where people 
are non-western in origin (Verhaak et al., 2006). However, this is in contrast with earlier 
research that found that people who were younger (16-25 years), female, reported more 
symptoms (explained and unexplained) and were employed showed a greater 
association with having MUS (Nimnuon et al., 2001). Such differences between studies 
may reflect the difference between study samples-patients who frequently attend with 
persistent MUS (Verhaak et al.) and patients who experience MUS (Nimnuon et al.). The 
implications being that the difference potentially reflects a difference in help seeking 
behaviour between older and younger patients, whereby although young patients may 
experience more MUS symptoms, it is older people who are more likely to frequently 
attend to primary care with MUS or other comorbid symptoms that may increase the 
opportunity for MUS to be identified.   In addition, there is also evidence to suggests that 
difference variables are associated with the different types of MUS that people 
experience, for example fatigue has been associated with the experience of having a 
recent serious illness of a close relative, neuroticism, depression and anxiety, whereas 
pain was associated with years of education being <12 years and 2 or more current 
general illnesses (McBeth & Tomenson et al.,2015).Only when there was concurrent 
depression or anxiety were shared factors found, which included an association found 
between childhood abuse and MUS. As such, in addition to general factors associated 
with MUS, there may also be specific factors that are associated with different 




unable to be medically explained may also exist independently from psychological 
factors of  childhood trauma, anxiety depression.  
1.3 Medically Unexplained Symptoms (MUS): Service Implications 
The cost of Medically Unexplained Symptoms (MUS) to the NHS is an estimated £3.1 
Billion (Bermingham et al., 2010), making the review of the treatment pathway for MUS a 
prioritized need (Department of Health, 2011; NHS England The Five Year Forward 
View, 2016). With 1 in 5 new consultations in primary care being with patients with MUS 
(Burton, 2003; Kroenke, 2007; Konnopka, 2012), it is a clinical area that GPs have 
frequent contact with; at times placing high demand on limited resources. There is 
increasing need for GPs to be able to manage MUS, with the view being that once 
significant pathology has been ruled out, they have a key role in reducing the overuse of 
unnecessary and costly investigations and treatment, through increasing monitoring of 
symptoms, and encouraging self-management and watchful waiting of symptoms (CSL 
Mental Health Project Team, 2010; NHG Guideline on Medically Unexplained 
Symptoms, 2013). The challenge that presents is the possible discrepancy in the 
consultation between patient expectation of cure and the provider approach of symptom 
management, and the cost implications at patient, GP and service level if this 
discrepancy is not recognised and resolved.   
1.3.1 Service Use: Frequent Attenders 
 The cost effective provision of services is an area of understandable scrutiny for 
providers and commissioners of NHS services.  Frequent attendance at primary care has 
been associated with people managing chronic conditions, with an increased prevalence 
of physical and psychological symptoms over non-frequent attenders, and a higher 
number of hospital referrals and prescriptions over a year (Heywood & Blackie et al., 
1998) and at 3 years (Smits et al., 2009). Consistent with such clinical characteristics, 
the evidence suggests that the range of reported symptoms, extent of worry about illness 
consequences, and a long timeline perspective are important cognitive representations 
of illness (illness perceptions) that have been shown to predict later service use 
(Frostholm et al., 2005). Although this highlights the importance of patient illness beliefs 
and emotions in service use,  it is unclear from the literature the extent to which  
symptoms that are explained or unexplained have a greater impact on the frequency of 




 One prospective study of patients accessing secondary health care (𝑛= 295), 
found that although the number of physical symptoms reported at the initial appointment 
showed a linear relationship to service use over 6 months, no association was found for 
whether the symptoms were explained or unexplainable, and that the number of 
symptoms was a greater predictor of service use than health anxiety (Jackson et al., 
2006). Although no relationship was found between symptom type and service use, this 
might reflect inaccuracies in clinical decisions regarding the type of symptoms- 
explainable or unexplainable; it may also be that differences between such symptom 
types are not apparent over the study’s follow up period.  For example,  a 3 year cohort 
study of people whose attendance placed them in the top 10% of primary care 
consultations, found that one in seven were still frequently attending 2 consecutive years 
later.  Referred to as ‘persistent frequent attenders’ by the study, they were found to 
consist of individuals who had more social problems, more anxiety, medically 
unexplainable symptoms, and chronic physical health conditions- particularly diabetes, 
than both non frequent attenders and frequent attenders at 1 year (Smits et al., 2009). 
Although the study recognises that the results cannot indicate to what extent frequent 
attendance in primary care is providing containment of the problem for the person, the 
study benefits from being based on a large sample size (𝑛= 28,860 patients) from a 
range of GP centres (𝑛 =5), increasing the validity and generalizability of the results.  
That being said, the two studies highlight the difficulty of not only understanding how to 
meaningfully define frequent attendance, but also the extent to which the association of 
frequent attendance with medically unexplainable symptoms can be understood as 
representing something that is specifically to do with MUS rather than the complex care 
needs that people have managing multiple co-existing symptoms. This suggests, along 
with the conclusion of one systematic review that “no generally accepted definition of 
frequent attenders” exists in the literature (Vedsted & Christensen,2005),  that further 
understanding is needed of how frequent attendance is defined in clinical practice, and to 
what extent MUS contributes to this and the reasons why.    
1.4 Medically Unexplained Symptoms (MUS): Patient Perspectives 
The literature considered so far highlights the nebulous nature of MUS, and in turn the 
difficulties in the early identification and management of such symptoms.  This next 
section moves on to explore the literature concerned with how MUS has been perceived 





1.4.1 Illness representations: How do people view their condition? 
How a patient appraises their symptoms and the resources available to manage 
them are believed to have an influence on subsequent consultation behaviour -who they 
seek support from and how they present their symptoms (Petrie et al., 2007), as well as 
the extent to which the symptoms become chronic (Brown, 2004). The Self-Regulation 
model of illness (Leventhal et al, 1984) has provided a framework for understanding how 
a person’s internal illness beliefs (the illness identity, thoughts about causes and likely 
consequences of symptoms, how long the symptoms will last) are likely to affect what 
type of action a person takes or thinks is necessary to cope with their symptoms.   
There are  some suggested theoretical explanations of MUS, which suggest  that 
unconscious psychological conflict underpins MUS and that management focus is likely 
to involve supporting people to reframe their symptoms within a psychological 
understanding (Janet, 1889; Breuer & Freud, 1893; Lipowski, 1968; Brown, 2004). 
However, evidence suggests that patients’ understanding of their symptoms are in fact 
multifaceted, comprising of consideration of both physical and psychosocial causes 
(Liden, Bjork-Bramberg & Svensson, 2015).  In a qualitative study concerned with 
exploring patient experiences of GP consultations for MUS, it was found that across all 
participants, regardless of whether or not their GP had received training to help patient’s 
consider the role of psychosocial  factors,  participants had complex and fragmented 
accounts for their symptoms, which included the interaction of psychosocial factors with 
disease causes. However, they believed that such understandings were too hard to 
convey in brief GP consultations, with concern that they would be ‘burdening’ GPs with 
talk of psychosocial issues (Peters et al., 2009).  It would seem that a barrier to what is 
discussed in the consultation, is not necessarily an unwillingness to consider 
psychosocial factors, but the difficulty in finding a way to ‘pull the multiple threads 
together’ to talk about them, as well as feeling safe enough within the consultation to do 
so. 
Similarly, research that has explored the illness representations in patients 
diagnosed with non-epileptic seizures (NES) found that patients again provided a varied 
account for their symptoms and a readiness to accept a biopsychosocial understanding 
(Green, Payne & Barnitt., 2003). That said, it was noted by the researchers that people 
found it difficult to think about how their symptoms might change over time, or that they 
may have some control over them. It was proposed that this may reflect the difficulty for 
these patients - who were being interviewed following their diagnosis of NES - to 




timeline and feelings of symptom control. This suggests that without test results being 
anchored to a clear explanation for their symptoms, one that is built within a person’s 
own illness representations, reassurance from negative test results may add very little to 
patients’ understanding of their symptoms (Petrie et al., 2006) or may even be 
discounted by their existing illness beliefs (Lucock et al., 1997; Brown, 2004).  In 
summary it would seem that finding ways to bring together the threads of understanding 
people already have about their symptoms, may help to provide a sense of control and 
empowerment over their symptoms. Understanding the factors that facilitate and inhibit a 
person sharing their existing understandings of their symptoms in the consultation, and 
to what extent understanding of symptoms can be co-constructed between ‘patient’ and 
healthcare professional, appear to be important for improvement to MUS management.  
1.4.2 The experience of MUS management in primary care 
Studies investigating patient experience of MUS management highlight the 
variability within the patient group as to what is important to them within the consultation.  
Evidence from qualitative research indicates that some patients with MUS have been 
concerned about the nature of GP explanations for their symptoms, reporting that 
explanations can either be ‘rejecting’ or too ‘colluding’ with their symptoms (Salmon, 
Peters & Stanley, 1999), whilst other studies found that patients were less concerned 
about the explanation given, but wanted a clearer understanding of the management 
plan and how they can self-manage the symptoms (Dwamena et al., 2009; Houwen et 
al., 2017).  Although the varied reports of what patients want from their consultation must 
be considered within the context of their stage of symptom management, for example 
people with persistent MUS may place greater importance on having a clear 
management plan rather than explanation, overall there appears to be a gap between 
what a patient hopes for and what they actually get from the consultation.  
Knowing what information is appropriate to discuss in consultation with their GP 
appears to be one area of difficulty, which may prevent a patient from sharing their bio-
psycho-social understanding of their symptoms. Reports from patients with MUS that 
they would not feel comfortable talking to their GP about psychological health (Peters et 
al., 2009) or that they expected that the support offered would not be helpful for that 
need (Murray et al., 2016), suggests that there is an underlying lack of trust in their 
health care provider’s ability to understand and provide reliable information for all 
aspects of their experience (Branch, 2000). Experiencing a healthcare system that 
separates physical health from mental health may add to this perception, conveying a 




giving rise to expectations about the role their GP has in managing their health (Hussain 
& Chochrane, 2004; Murray et al., 2016). Furthermore, public awareness of the effects of 
NHS and austerity may also increase scepticism about in whose interest decisions are 
being made. For example, interviews with a Canadian sample of patients who were 
accessing publicly funded services for managing MUS found that some patients held the 
perception that the suggestion of psychological intervention from a health professional 
was to infer that they should be able to fix themselves and that this was being provided 
as a way for the doctor to not prescribe or discontinue prescribing medication (Atkins et 
al., 2016).  
That said, it may also be that patients are detecting their GP’s own discomfort 
with managing MUS. One primary care study, which used videoed consultations to 
support patients (𝑛 =17) to reflect on their experience of the MUS consultation, found 
that a frequently reported theme by patients was that they felt uncomfortable with the 
approach taken by their GP, with non-verbal communication and lack of conveyed 
empathy making them feel  like they were an inconvenience. Themes of there being a 
perceived mismatch between patient and GP agendas, perceived lack of consultation 
preparation and lack of felt GP transparency about limits of understanding about the 
symptoms, highlight the importance of a person centred approach to communication, 
and what patients may want this to look like in clinical practice (Houwen et al., 2017). 
Interestingly, this study also highlighted that half of the sample that met the study criteria 
of people attending for consultation primarily for MUS, contained people who did not 
report any concerns regarding their consultation. Although the study focus was on 
people who experienced problems with their consultations only, further exploration of 
people’s accounts of what makes the experience problem free or satisfactory may also 
help to understand the nuances of MUS and the approaches needed for primary care 
management.  
1.5 Medically Unexplained Symptoms (MUS): General Practitioner 
Perspectives 
Evidence suggests that GPs have a strong desire to understand and help their patients 
(Stone, 2014). However, where symptoms do not fit a specific disease model, the 
consultation approach can become less clear and can be experienced as frustrating for 
some GPs who are  uncertain of how best to help (Steinmetz & Tabenkin, 2001; 
Wileman, May, Chew-Graham, 2002; Stone, 2014; Brownell et al., 2016).  The decision 




influenced by a fear from the treating GP that serious disease pathology will be missed 
(Murray et al, 2016), as well as concern that patients may not accept a psychosomatic 
explanation and treatment (Woivalin et al., 2004). Such concern may result in the 
psychological interventions not being put forward by health professionals, despite 
evidence and clinical guideline recommendations for psychological management of MUS 
(Kellett et al., 2016; NICE, 2006). This was evident in a study of health professionals 
experience of managing MUS (𝑛 = 12 GPs, 𝑛 = 6 speciality others), where  concern was 
shared that by introducing the option of a psychological intervention to a patient, this 
might unhelpfully convey to the patient that they think the problem is “all in your head”. 
As such, some health professionals stated they avoided suggesting psychological 
treatment as one of the options for managing MUS  (Brownell et al., 2016).  
 The influence of patient expectation on GP consultation test ordering behaviour 
has received investigation. In a cross-sectional study of GPs, it was found that 
consultations where symptoms were medically unexplained lead to twice as many 
requests for laboratory tests (Van der Weijden et al., 2003). Although this is perhaps not 
surprising if significant pathology is needing to be ruled out, the study also found that 
patient’s pre-consultation expectations for tests were positively related to test ordering 
behaviour of GPs.  This could be suggestive of difficulties occurring in managing patient 
expectations within the consultation, potentially influenced by a professional reported 
drive to ‘fix it’ (Howman et al., 2016; Brownell et al., 2016 ) or the GPs professional 
experience and confidence in managing complex consultations (Stone, 2014). However, 
acknowledged in the study is that the conclusions are limited by not collecting the GP’s 
reasons for their decision, and if it was based on their expectation of the patient, then to 
what extent was this accurately perceived by the GP and to what extent non-prescribing 
options were considered as possible treatment options in managing MUS for both the 
patient and the GP.  
1.6 Medically Unexplained Symptoms (MUS): Treatment Approaches in 
Primary Care 
With the absence of a specific disease treatment pathway for health professionals to 
follow, a particular focus for MUS interventions has been on patient-provider 
communication, with the recommendations made to commissioners to provide a stepped 
care approach whereby the intensity of the treatment is proportional to the severity of the 
symptom (CSL Mental Health Project Team, 2010; Joint Commissioning Panel for 




1.6.1 A Stepped model of care 
Watchful waiting 
 Watchful waiting has been an approach used in the management of chronic 
conditions, especially where the evidence base for curative intervention has been 
unclear (Chodak, 1994).  In MUS management, this approach appears to take the form 
of GPs providing regularly scheduled appointments to patients with MUS, whereby brief 
physical examinations are used to monitor signs of disease (Heijmans et al., 2011). This 
decision to actively monitor symptoms for progression and intervening when deemed 
clinically necessary is informed by the reported increased risk of causing iatrogenic harm 
to the patient, from unnecessary diagnostic procedures or over prescribing of 
unnecessary medication (Burton et al., 2012). The evidence of the acceptability of 
watchful waiting treatment option to patients with MUS is limited, however research from 
patients managing a chronic health condition suggest that even if patients find this to be 
an acceptable treatment option for themselves initially, the ongoing pressure to pursue 
‘active treatments’ from family, support groups, or healthcare professionals can 
contribute to a change in their decision (Chapple et al., 2002). This highlights how the 
quality of the information that patients may get about all treatment options may vary 
according to the health professional preferences and that the patient’s decision may also 
change with time and following the discussions they have with others.  The challenges of 
making an informed decision in clinical care are recognised within the NHS, and the use 
of decision aid tools are being encouraged in some areas of health as a method of 
presenting objective information in a way that supports the patient to make a decision 
based on the values they hold (see NHS Shared Decision Making, 2016; Stacey, Légaré 
& Lewis et al., 2017). 
Self-management  
Self-management as a treatment option in chronic conditions, including MUS, has 
been outlined in several government white papers (Department of Health, 1999; 2005), 
defined as being: 
‘…the ability to monitor one's condition and to effect the cognitive, 
behavioural and emotional responses necessary to maintain a 
satisfactory quality of life’   




It has been viewed as an effective way to bridge the gap between the demand on 
health services from people with chronic conditions and the limited supply of services.  It 
requires patients’ active involvement in managing their condition through processes of 
taking ownership of their illness needs, activating resources and integrating the chronic 
illness into their lives (Schukan-Green et al., 2012). However, how this is done and the 
extent of the impact that this may have on health professionals involved in providing 
such support, lacks clarity and exploration (Barlow et al., 2012).  In addition, further 
research is required to understand what forms of self-management would be appropriate 
for the varying needs of patients with MUS and what they perceive their role to be in 
increasing their quality of life with MUS.  There is some suggestion that a potential 
barrier to self-management may be the comorbidity of other conditions that the patient is 
managing and is having to prioritize (Elliott et al., 2007), as well as the effects of lowered 
mood, motivation and self-efficacy (Bair et al., 2009).  
Referring for psychological support  
Where the treatment need of the patient is unable to be managed sufficiently by 
low intensity support, GPs are advised to refer their patient on for specialist 
psychological support.  The most recent treatment development in the area of MUS has 
been the expansion of Increasing Access to Psychological Therapies to assist with 
primary care level support of long term health conditions and MUS (Department of 
Health, 2011). The treatment rationale being that mood effects MUS and that Cognitive 
Behavioural Therapy (CBT) or a therapeutic approach that blends traditional CBT with 
mindfulness, acceptance and/or  compassion (Third wave / generation approaches), can 
be used to treat anxiety and depression that underlies MUS (Kellett et al., 2016). Early 
evaluation of this service development has shown promising results in which pre-post-
depression scores, as measured by PHQ-9, showed a large effect size (0.25) and a 
similar large effect for anxiety scores (0.31)  as measured by the GAD-7 (Kellett et al.). 
However, further research is needed to assess the medical cost offset of this approach, 
for example measuring patient healthcare use in a certain time period, to get a clearer 
understanding of the impact of treating anxiety and depression on physical symptoms.  
In addition, the treatment approach may only meet the needs of some people with MUS, 
which suggests that again more research is needed to consider which patients and 
potentially forms of MUS, are most suited to an IAPT based approach.  This study also 
highlighted that there was considerably lower referral rates for patients with MUS than 
patients with other long term chronic conditions. It is unclear if this can be accounted for 




or that this was actual preference of the patient.  Further research exploring the factors 
that influence both GP and patient decision may help to identify any barriers to the 
management options for MUS and increase understanding on how best to address 
these.  
1.6.2 Enhanced management  
Enhanced management has been viewed as a way to provide treatment in an 
environment familiar to the patient, by front line staff integrating low level specialist 
support into their consultation. Defined as a structured treatment model, which uses a 
biopsychosocial understanding of symptoms and strategies to increase resilience and 
self-management (Rosendal et al, 2013), enhanced care training has been piloted 
across primary care sites (Gathogo and Benjamin, 2013).  Shown to have comparative 
outcomes to CBT, enhanced management was found to show a low to medium effect 
size in post-treatment symptom severity and at 12 months follow up (Van Dessel et al., 
2014).  CBT was found to have a higher number of dropout rates, which the authors 
suggest is possibly indicative of the acceptability of psychological treatment to the 
patient.  However, previous reviews on the effectiveness of enhanced management for 
MUS has reported that no firm conclusions can be made due to the differences seen in 
the forms of enhanced management delivered, which includes reattribution techniques 
only, CBT only, reattribution and CBT, as well as the varying intensity of the treatment 
(Rosendale et al, 2013).  Collectively it would seem that two tentative conclusions can be 
taken from this. Firstly, that frequent contact with the GP may be better than a brief 
intervention and help support patient-doctor communication (Joint Commissioning Panel 
for MUS, 2016).  Secondly, the lack of difference between two active treatments 
(enhanced management and CBT) may suggest that outcome is being affected by 
nonspecific therapy factors due to the consultation being more structured and promoting 
the patient to be an active partner in the treatment.  Having a structure for GPs to work 
from might be addressing the challenges highlighted in primary care MUS consultations, 
that patient narratives can be unfocused (Olde Hartman et al., 2013) and often 
overwhelming for the GP (Murray et al., 2016), which may heighten feelings of frustration 
for both and impact on the consultation.  
Reattribution  
 Building on the principles of person centred care, Reattribution is a structured 
intervention that has been used in primary and secondary care to support patients in 




physical symptoms they report (Dorwick, Gask & Hughes et al., 2008). Despite its uptake 
amongst practitioners and the reported increase in patient satisfaction (Morriss, Dowrick, 
& Salmon, 2007), clinical outcomes have remained unchanged (Aiarzaguena., et al. 
2007). Research exploring the potential barriers of reattribution for primary care MUS 
patients found that focusing an intervention just at GP level, did not adequately address 
the factors that affect patients’ decisions about what they discuss with their GP, for 
example how the relationship was perceived by the patient as well as any prior beliefs 
about the role of the GP (Peters et al., 2009). It would suggest that the success of this 
intervention is determined by the extent to which a GP is able to access the patient’s 
frame of reference for understanding their illness. This might be limited by a range of 
factors, such as limited consultation time and lack of diagnostic openness by the GP 
(Murray et al., 2016). 
1.7 Satisfaction with treatment decision 
There is evidence to suggest that the clinical decision on how best to manage patient 
symptoms, is more gradual, less certain and less satisfying for GPs when symptoms are 
assessed as being both somatic and psychosocial in nature (Andre et al., 2012). This is 
perhaps not surprising given the number of barriers (𝑛 =379) that have been reported in 
a systematic review of the challenges of diagnosing MUS, which include understanding 
the co-morbidity between medically explained and unexplained symptoms, considering 
the socio-legal context of symptoms (illness legitimacy of the sick role), and having 
imperfect diagnostic tools (Murray et al., 2016). It has also been suggested that the lack 
of GP satisfaction may be reflective of the professional culture that GPs, particularly 
clinicians with less experience, may hold regarding the acceptability of MUS as a real 
and important experience (Stone, 2014), or a professional culture in which MUS is 
valued but that the therapeutic skills they use with their patients are not (Salmon et al., 
2007).  Taken together, these findings imply that the uncertain consultation may require 
a greater amount of time to provide an individualised approach to understanding and 
managing the symptoms, and that the professional culture of the consulting GP may 
affect how satisfied they can be with a clinical decision of MUS and any subsequent 
management.   
The orientation of both the GP and the patient, in regards to what they expect 
their role to be within the consultation, may also affect the extent to which satisfaction is 
reported from the consultation.  Although there has been a movement from a disease 




approach taken (Laine & Davidoff, 1996), patients show variation in the amount they 
expect to be involved in the consultation, particularly in older adults (Bastiaens et al., 
2007; Butterworth & Campbell, 2014), as well as health professionals in the extent to 
which collaboration is encouraged (DiMatteo, 1998). Despite potential differences 
between GP and patient, research looking at the effect that GP – patient congruence on 
orientation preference has on patient satisfaction found that this was not based on the 
level of agreement in the consultation but on the GP’s patient centred orientation, even in 
patients who have a medically orientated approach (Krupat et al., 2000). This suggests 
that patient satisfaction is concerned with both the style and content of the consultation, 
and the extent to which the patient perceives their contribution in the consultation to be 
listened to and perceive themselves to be viewed by the GP as an equal in their 
relationship (Butterworth & Campbell, 2014). This would support the humanistic position 
that fundamental to outcome is the therapeutic relationship and showing acceptance of 
the patient and their position, and that empathy and genuineness is perceived by the 
patient (Rogers, 1959).   
1.8 Decision Making  
The literature reviewed so far, highlights the extent to which MUS challenges the idea of 
conventional medicine. Without objectifiable tests or evidence base to guide 
management, it is a clinical area with much uncertainty. As such, there is a reliance on 
there being good patient-provider communication, to not only develop a shared 
understanding of the problem but to end up with a treatment plan that is aligned with a 
patient’s preference and values, without compromising the professional obligation to 
maintain both duty of care to patient and cost-effective care for the service.  To help think 
about how these agendas are negotiated, this next section will begin by outlining the 
process involved in decision making and consider the approaches used to support 
clinical decisions made between patient and provider.   
1.8.1 The information processing model 
The diverse nature of the clinical issues presenting in primary care, requires GPs to 
make use of different decision making processes to judge the nature of a problem and 
treatment options. In addition, patients too make decisions about what part of the illness 
narrative to share in the consultation and what provided information is attended too. The 
information processing model has been used to help understand what influences the 
decisions that people make; including how people decide what to attend to in their 




motivations for a decision to be made (Johnson, 1999; Bekker, 2010).  Two forms of 
processing are said to be used either simultaneously or separately; these are heuristic 
thinking (rules of thumb, unconscious process and simple analysis) and systematic 
(analytic, conscious, detailed analysis) (Acker, 2008; Bekker, 2009). Heuristic strategies 
such as probability reasoning - the extent to which symptom presentation is perceived as 
being similar to a known understanding of disease - has been observed to help with 
quick decision making and risk assessment in health professionals (André,Borgquist, & 
Mölstad, 2003), whilst social heuristics such as the status of a doctor have been said to 
impact on how patients see the role of doctors in managing their health (Marewski & 
Gigerenzer, 2012). 
 However, such short cuts to thinking may also impede medical decision making. 
In a recent systematic review of the cognitive biases associated with medical decisions 
made by physicians, one to two thirds of case scenarios showed an association between 
cognitive bias and diagnostic inaccuracies, the most common cognitive biases 
researched in this area being-availability bias- judgements based on ease of recall rather 
than probability, anchoring effects- not updating initial premature appraisal with new 
information and overconfidence bias- acting on intuition or haunches rather than 
information (Saposnik, Redelmeier, Ruff et al., 2016). Although the studies reviewed 
were unable to clarify the nature of the relationship shared between specific cognitive 
biases and medical decision outcome, it does highlight the potential for cognitive biases 
to have an unhelpful influence on medical decision making and the need for strategies 
that can encourage the use of systematic thinking and meta cognitive awareness of the 
intuitive processes being used.  
1.8.2 Informed decision making 
Since the Health and Social Care Act 2012, a shift has been seen in how decisions are 
made in public service spending, with greater autonomy and decision making ability 
placed at local rather than government level (NHS Five Year Forward View, 2014). 
Arguably this has also been reflected in government policy, emphasising the need that 
decisions about patient care should consider not only professional experience, but also 
the wishes and wants of the people who are experts by their own experiences, as seen 
in “No decision about me without me” (DoH, 2012). As such, there has been a move 
towards developing the delivery of person centred care; exploring ways to strengthen the 




Informed decision making in routine clinical care positions the decision away from 
a paternalistic view of this being only the responsibility of the treating healthcare 
professional, and increases patient involvement (Woolf et al., 2005; Department of 
Health, 2012). This requires that the patient has access to evidenced based information, 
presented in a suitable format for them to make an informed decision about preferences 
for  treatments.  However, there is evidence to suggest that the information provided to 
patients may not encourage collaboration, with concerns raised that the facts of 
treatment and what is believed to be necessary for patients to know is being 
emphasised, rather than providing information to support the active engagement of 
patients (Bekker, Luther & Buchanan, 2010).   
This might be a particular issue in the area of MUS management, whereby there 
is limited evidence based information regarding how the symptoms are understood and 
what the appropriate management options are. Where studies have looked at GPs 
decision to offer medical management of MUS, they have found that this treatment 
decision has been associated with patients increasing the number of physical complaints 
and the consultation being longer, as opposed to the patient requesting a medical 
approach (Salmon et al., 2006; Edwards et al., 2010). However, the reasons for 
informing the chosen approach for patient and GPs were not documented in the study. 
The findings could be due to patient heuristics about how distress is appropriately 
communicated and managed in primary care, as well as GPs own beliefs that may have 
prevented them from understanding and adequately exploring the context of the patient’s 
symptoms (Van der Weijden, 2003). Additional barriers to understanding the context of 
symptoms might be created by environmental and systemic factors. It has been put 
forward that the appointment time constraints may influence what information is provided 
about available management strategies (Hansen et al., 2012), as well that the 
compensatory recognition for GPs is placed on procedures provided rather than the 
decision making process that supports the patient to get to that point in their treatment 
(Lewis & Pignone, 2009).   
1.8.3 Shared decision making 
The process of the informed decision has moved from being an informed choice that the 
patient makes on their own, to a collaborative shared decision between patient and the 
health professional. Shared decision making has been cited as a way to reduce the 
overuse of unnecessary treatment, particular where there is clinical equipoise, and helps 
to promote the rights of the patient to be involved in their health (Coulter & Collins, 




explanations that are developed in partnership with patients and considers their existing 
health beliefs increases not only reported increased patient satisfaction but also 
adherence to treatment recommendations (Martin et al., 2005).  For patients with MUS, 
this may be particularly important in decisions made about when to discontinue with 
further tests or medication,  reducing the need for patient initiated second opinions, 
which has been said to increase the risk of conflicting advice (Payne et al., 2014).   
However, Shared Decision Making (SDM) research is limited in its application to 
MUS, which possibly reflects the unique starting position of being medically uncertain 
about the cause of the symptoms and its management. One study that looked at rates of 
SDM in primary care patients with chronic conditions, did include patients with Irritable 
Bowel Syndrome (IBS), a functional disorder that is believed by many to be a form of 
MUS, and found that the greatest predictor of lower SDM scores were from patients who 
were younger and reported more general health concerns (P< 0.001), followed by those 
who had IBS (P= 0.05) (Fullwood et al., 2013).  Although the lower SDM found in certain 
patient groups might be reflecting patients who were less satisfied with their health status 
and who were attributing this to lack of SDM, the results may also suggest that there 
may be difficulties in establishing a shared conversation when the GP and patient are 
less clear on how to label the symptoms together.  Additionally, review data from the 
2005-2016 National Surveys on patient satisfaction with care and decisions, suggests 
that in addition to health needs, patient age may contribute to the extent to which people 
feel involved in their care. Younger patients (18-24 years old) with complex health needs 
felt the least positive about discussing aspects of their care with their health professional 
and reported that information provided did not support their understanding (Care Quality 
Commission, 2016). Such data is collected across multiple care providers, making it 
difficult to know to what extent this reflects patients’ experience within one sector of care. 
That said, it does highlight the importance of contextual factors that may give rise to the 
level of power and agency people perceive to hold when making decisions about their 
care, which may fluctuate over time (Hoggett, 2001) and in different social contexts 
(Glenister, 1994) .   
1.9 Challenges of shared decision making in MUS 
A systematic review of 38 studies on professionals’ views on implementing Shared 
Decision Making found that time constraints (22/38), the intervention’s inapplicability due 
to patient characteristics (18/38), and the intervention’s inapplicability due to the clinical 




clinical practice (Légaré et al., 2008).  The review mainly consisted of physicians 
reporting experiences of introducing SDM in routine practice and suggests that decisions 
about who would be suitable to use SDM were made without consultation with the 
patient. Considering the literature on GP-patient communication in MUS consultations, 
there is indication that there may be additional  barriers when  establishing a shared 
conversation for this patient group. 
1.9.1 Different frames of understanding 
Studies that have looked at GP-patient communication within the MUS consultation, 
suggest that a particular difficulty for establishing SDM may be to do with the differences 
found between the patients’ frame of understanding of their symptoms and their GPs’, as 
well as differences in treatment expectations (Salmon, 1999; Allegretti et al., 2010). In a 
study that conducted paired interviews with GPs and their patients with low chronic back 
pain, it was found that greatest divergence was seen in the explanatory models used for 
symptoms and treatment goals and expectations (Allegretti et al., 2010). Patients were 
found to adopt a biomedical model, looking for pain reduction, which was resistant to the 
GPs biopsychosocial approach and treatment goal of improving functioning.  Such 
findings are in contrast to studies outlined in section 1.3.1, whereby illness 
representations shared by individuals with MUS have been multifaceted, combing 
psychological and physiological factors (Green, Payne & Barnitt, 2003;  Liden, Bjork-
Bramberg & Svensson, 2015). One explanation for this difference may be found in the 
literature that suggests that resistance to psychological explanations of MUS may be 
more about people wanting to emphasise a point; that their symptoms are severe and 
legitimate, rather than reflecting their understanding of the cause (Horton-Salway, 2001). 
In summary, it would seem that to support a shared conversation between patient and 
GP it is important to consider what concerns are potentially being communicated by any 
interactional differences, and that the relationship needs to be one of mutual acceptance 
to enable the co-construction of a new illness narrative between GP and patient.  
1.9.2 Multiple and complex symptom presentation 
Another challenge for establishing patient preferences in their MUS management may be 
that symptom narratives are often complex and confusing for both patient and GP (Olde 
Hartman et al., 2013; Stone, 2014; Peters et al., 2009; Brownell et al., 2016). In a 
synthesis of GPs’ experiences of managing multi-morbidity in patients, it was found that 
GPs managed the reported difficulties in eliciting patient preferences by some prioritising 




used additional tests to support the decision (Sinnott & Mc Hugh et al.,2013). Similar 
findings have been found in MUS consultations, with one study finding in their review of 
videoed MUS consultations, that where patient’s presented with multiple symptoms, GPs 
were seen to explore the beliefs that patients held for one or two symptoms, but did not 
incorporate these beliefs into the reassurance that was then provided (Olde Hartman et 
al., 2013). It would seem that there is a struggle to know how to meaningfully incorporate 
the patient view with that of the professional, resulting in one view point getting prioritised 
over the other. Furthermore, where there is increasing uncertainty, the need for both 
patient and GP to be in control of the consultation may be heightened, which may 
increase the likelihood that symptoms are then made sense of separately. 
1.10 Study rationale  
Whilst research on GP-patient communication suggests that GPs and patients 
hold different frames of understanding MUS, how these differences are negotiated and 
management options decided on is relatively under researched.  Predominately, the 
focus has been at the population and behavioural level of patient and GP experiences. 
For example, quantifying speech focus within the consultation as a proximate for what is 
important for the patient and how this is responded to by the GP (Olde Hartman et al., 
2013), or patients’ pre-consultation expectations and GPs’ test ordering behaviour (Van 
der Weijden et al., 2003).  Although this provides indication of the complexity of the 
patient presentation and challenge of the MUS consultation, they are unable to explore 
the process of managing medical uncertainty between the patient and the GP and how 
differences in understanding and management expectations are negotiated.  
Where qualitative research has been completed, the focus has been on exploring 
patients or GPs individual experiences of MUS management (Salmon, Peters & Stanley, 
1999; Dwamena et al., 2009; Nunes et al., 2013; Stone, 2014; Houwen et al., 2017), 
providing a rich detailed account of the general challenges that present individually to 
participants from a MUS population group and GP population, but which again do not 
capture the process of how this is managed between GP and patient.  To my knowledge, 
only one qualitative study has compared and contrasted patient and practitioner 
experiences to explore this aspect. This study used Interpretative Phenomenological 
Analysis (IPA) to explore the experiences of MUS management in 18 patients and 18 
practitioners recruited from two urban provinces in Canada. The study highlighted the 
shared frustration and concern between patient and professionals, with the researchers 




with the patient-professional relationship by increasing empathy and fostering greater 
collaboration (Atkins et al., 2013). However, replication of the study would be needed in 
the UK to verify the transferability of such results to UK primary care and MUS 
management, as well as further exploration with patients and GPs as to what they think 
has helped or would be helpful in facilitating a shared understanding in the patient-GP 
relationship.  As such, this study aims to explore how patients and GPs in the UK 
understand and manage MUS.  
1.11 Research Questions 
The aim of this current study is to explore how patients and GPs understand MUS and its 
management. The following research questions will be addressed:  
 How are medically unexplained symptoms understood and managed by patients 
and GPs? 
 What way does their understandings overlap and diverge? 
 How are differences in understandings negotiated?  
 How can this inform shared decision making interventions to manage medically 




CHAPTER TWO: PROTOCOL DEVELOPMENT 
This chapter provides information on how the study protocol was developed, based on 
the site visit made to the General practice that had expressed an interest in supporting 
the study, the feedback received from patient and GP study consults and the process of 
NHS ethics committee review. Details of how these aspects informed the final study 
protocol will be outlined, along with details of the study design, recruitment framework 
and sample, and proposed method of data generation and analysis. In order to explore 
the lived experiences of patients and GPs managing and treating MUS, a qualitative, 
semi structured interview was selected as the approach to use in line with the aims of the 
study, as it explores the unique meanings that people attach to their experience (Willig, 
2013), as well as highlighting the social processes involved, and where there is the 
potential for change in the social context (Chamberlain & Murray, 2008. p396). 
2.1. Service Context  
Recruitment was planned from one GP practice in South Yorkshire who had declared an 
interest in participating. This practice was reported to have a high proportion of patients 
who were non-English speakers and have come to the UK from other countries, as well 
being situated within an area of low economic-status. There were 7 GPs at the practice 
to manage the clinical needs of the 9,500 patient population that the practice was 
approximated to serve, holding an estimated MUS caseload of 300 people. The protocol 
for managing MUS at this practice was reported as being patient-centred, framing and 
managing the symptoms using either a biomedical route or psychological route 
dependant on patient related factors. Appointments were booked by patients on the day 
and got triaged by need.   
2.1. 1 Site Visit  
A visit was made to this practice during the planning stage which provided an opportunity 
to see the challenges that presented both for patient and GP in a consultation for 
symptoms with complex causes and also assess the logistics of introducing recording 
equipment in to the consultation, in line with one of the methods being discussed (see 
study design for details).   
I sat in on a total of six 10 minute consultations related to MUS, all with the same 
GP.  All cases gave verbal consent to the consulting Doctor for me to be present for the 




Consultation started by the patient sharing their symptoms and inquiry by the Doctor as 
to what their own understanding of the symptoms were.  It was noted that patients 
symptoms were often multiple and that there was already some shared idea between 
patient and GP - even if vague- of the potential causes for their symptoms.  
Options for management were varied and included delaying investigation-“shall 
we wait?”, doing a blood test but discussing the difficulties of diagnosis by exclusion, 
putting the patient’s request for a secondary care referral into context of the existing 
negative test results, and asking if the patient still wanted a referral to be made, and the 
suggestion that relaxation might help to ease the pain.  
Difficulties observed in the consultation were as follows: 
 The number of symptoms that the patients presented with and how to prioritise 
them in the consultation time.   
 Barriers to GP-patient communication for non-English speakers, with family 
members interpreting for their relatives.  
 The short amount of time in a consultation to complete physical health checks 
and psychosocial assessment of need, without prioritising one over the other.  
 The system pressures on appointment slots and people asking for medication 
‘just in case’ they cannot get an appointment or see the same doctor when they 
need to.   
In regards to having time to set up any potential study equipment, there was only 
a short gap between patients and this was used to quickly write an entry on the patient 
seen and check to see who their next patient was.  It was felt that introducing equipment 
would be placing too much demand on the already limited time constraints of the 
consultation and was not seen as a viable option at this practice.   
2.2 Study design  
The method of individual interviews to survey the experiences of both patients and GPs 
was considered to be the most suitable approach to take. Interviews would be completed 
at one time point and would include questions that facilitated the participant in wider 
reflections of their experiences, so as to capture the fluctuating experiences of MUS 




Several alternative approaches were considered. To explore the process of the 
consultation and reduce the potential of recall error in remembering events, there was 
discussion of recording MUS related consultations and using the method of interpersonal 
process recall (adapted by Elliot from Kagan,1980) with patients and GPs. This is an 
approach where both the GP and patient would be asked to comment separately on the 
recorded consultation by pausing the recording when they felt it important to comment. 
Although this had the benefit of being an approach directed by the participants as 
opposed to researcher led, on reflection this approach was not appropriate for the ad hoc 
nature of consultations and the extra demands this would place on the GP to obtain 
consent for recording and setting up the equipment.   
Keen to retain the study focus on understanding the process of communication 
between patient and GP, it was proposed that the study would interview patient and GP 
dyads separately but directly compare and contrast their experiences of a recent MUS 
consultation they had shared. It was thought that introducing a dyad aspect to the design 
would provide a novel approach that could further contribute to the field of research, by 
providing greater specificity on the process occurring between GPs and patients in the 
MUS consultation. As such, it was anticipated that recruitment of patients and GPs would 
come from the same practice.   
2.3 Sample Selection 
Patient eligibility was based on the following criteria: Aged between 18-65 years; 
identified by the general practitioner as having “medically unexplained symptoms”, had 
such symptoms for 3 months or more; have frequent attendance status based on clinical 
judgement of the identifying GPs; have sufficient spoken English and capacity to 
provided informed consent and take part in the interview.  Patients would not be 
approached if GPs identified them as having a comorbid diagnosis that might impact on 
their wellbeing and/or the study findings. This might include patients who experience 
significant difficulty recollecting past consultation experiences or patients who may 
experience distress being asked to share their experiences.  
GP participants would be nominated by the patients taking part in the study, who 
were asked to suggest a GP from the practice who had the most involvement with the 
care for their symptoms. A small sample of 3 GP's from an Academic Department of 
Primary Care in a school of medicine would also be interviewed to maximise variation in 





2.3.1 Sample Size  
For this methodology, the number of patients depends on the data elicited and the 
conceptual themes emerging from the study (Strauss & Corbin, 1990).  Although it would 
be desirable for the sample size to be determined by theoretical saturation, in practice 
this is seldom achieved and the pragmatic sample size set for this study was between 8-
10, which is the precedent established for a Doctorate in Clinical Psychology qualitative 
research project.  As such, the study aimed to get 5 patient-GP paired interviews and 3 
interviews with GPs in the Academic Department of Primary Care.  
2.3.2 Recruitment Framework 
It was anticipated that patients would be recruited purposefully in that the participating 
practice would be asked to identify patients with MUS who were deemed by their GP to 
have frequent attendance to the practice with unsatisfactory symptom management and 
those who have well managed symptoms. The guiding definition provided to GP’s as to 
what constitutes ‘MUS’ will be informed by Peveler et al. (1997) criteria of there being a 
presentation of physical symptoms and lack of explanation by a recognizable physical 
disease. This has been a definition used widely in MUS research, with it being viewed as 
a way to stay close to how GPs define MUS in their routine clinical practice. Identified 
cases would then be checked by the GP research lead at the practice to make sure they 
meet MUS clinical criteria.  
Confirmed patients with MUS would be mailed out by the practice, providing them 
with a practice covering letter that briefly introduced the study, a study information sheet 
and consent form, and a freepost return envelope.  Received expression of interests, as 
indicated by a returned consent form, would be followed up by the lead researcher by a 
phone call to introduce the study and agree a date for their interview.  
GP-patient dyads for the pairing of interviews were thought to be identified 
according to who the patient, at the point of expressing their interest, names as the GP 
they have seen the most frequently about their symptoms.  It was felt that this method of 
identifying GPs would enable patients to direct the studies recruitment of GPs and 
provide additional data to who the patient predominately identifies their MUS care with.  
In circumstances where the nominated GP declined study involvement, brief reasons for 
decline would be sought and the patients named GP would be approached. For any 
reason a patient could not be analysed as a dyad, this would be coded for and included 




in the study, then the GP could participate in one interview for each patient involved in 
the study. 
GPs from the Leeds University Academic school of Primary Care would be sent a 
study expression of interest email, providing study information details, consent form and 
evidence of ethical approval. They would be invited to express their interest in the study 
by contacting the lead researcher on the details provided. 
2.4 Interview Procedure  
Figure 1. shows the study procedure through to patient and GP interviews.  Participants 
that opt in to the study by returning the consent form would be contacted by phone by 
the lead researcher. This phone call would enable initial introductions and provide 
opportunity to address any questions, confirm their consent and arrange a telephone 
interview slot. To provide further context for the interview data collected, all patient 
participants would also be asked for permission to access their medical records following 
their interview. This would consist of using  a study proforma to record from the medical 
records the number of visits to the GP in the last year, type and duration of longest held 
MUS symptom and the other organizations or services that the patient has accessed for 
their symptoms over the 12 month period. 
 Questions from the GP and patient topic guide would be used to semi structure 
the interviews, which would last between 20-30 minutes for GPs and 30-60minutes for 
patients. General open ended questions would be asked initially to illicit rich descriptions 
of what the individual’s experience was of MUS, including how this is managed within the 
patient-GP relationship. All interviews would be carried out over the telephone and would 
be recorded. Although it has been said that telephone interviews are likely to produce 
shorter responses and with the absence of non-verbal data may lack the richness of face 
to face interviews (Breakwell, 2006), for reasons of being more convenient to the patient, 
it was believed to be the most appropriate method of data collection to use for this study.  
At the end of every interview, participants would be asked if they want to receive 
a summary of the results and given the opportunity to provide their feedback on the 
themes identified. They would also be asked to confirm if there was anything that they 
have shared that they would like removing at the write up,  and to contact myself within a 
week of the interview  if they do decide they would like to withdraw information.  If the 
patient revealed in the research interview that they were unhappy about the service they 




follow the practice’s usual complaints procedure that is detailed on the practice website, 
and that complaints are held in a separate folder and are not detailed in the patient 
record and therefore future care will not be affected.  
To maximise variation and contrast in professional experience, GPs from the 
University of Leeds Academic Department of Primary Care (𝑛 =3) were initially planned 
to be invited by email to participate to explore their views and experiences of managing 
adults with MUS at different practices in Yorkshire, UK. Following receipt of management 
permission from the Academic Department of Primary Care, it was anticipated that an 
email would be sent to academic GPs requesting that study expression of interest be 
indicated through replying to the email sent. The email would have attached a study 
information sheet, a consent form, and the confirmation of ethical approval. Interviews 
would follow the same procedure as outlined for GPs and patients above, however 
academic GPs would not be part of a patient-GP dyad and as such the semi structured 
interview focus would be on their experiences and practice of MUS management in 
general, rather than specific cases. 
Following the completion of an interview, all audio files would be uploaded to an 
encrypted password protected university networked drive.  Where a transcription service 
was used, this would be from the university approved list of transcribers who would have 
been asked to read and sign a transcriber confidentiality statement. All transcribed 
interviews from each group would be checked for accuracy, whereby I would listen to the 









2.5. Informed Consent  
All participants would be asked to read the study information provided and contact the 
lead researcher should they have any questions about taking part. Participants would be 
asked to opt in to the study by returning their consent form.   Consent would then be 
confirmed over the phone by the lead researcher at point of first contact and before 
interviews are scheduled. 
2.6 Anonymity and confidentiality 
All participants would be asked at point of consent to create their own unique identifier-a 
pseudonym- which could be used throughout the study.  Participants would be reminded 
that no data from within the dyad would be shared with either the participating GP or 
patient, unless there was a duty of care that needed to be followed with the patient 
reporting harm to self or others. Patients that had nominated their GP, would be informed 
that they would not be made aware of their GPs decision to take part as this would not 
affect their own involvement with the study. 
An email approach would be used to invite expression of interest in the study 
from GPs within the Academic School of primary care. Individual contact details would 
not be used, but a group email address (where by individual addresses are not visible) or 
an email sent out on behalf of the lead researcher by the department.  
All participants were informed in the study information and consent forms that a 
pseudonym would be used to support with anonymity of their responses, however that 
contextual information and direct quotes may be included in the write up. To maintain 
confidentiality, information perceived as potentially identifiable or sensitive, which had 
not been requested by the participant to be removed, will be analysed and referred to at 
the group level, rather than at the individual level.  
2.7 Harm to others 
All participants would be reminded throughout the interview of the option to pause or 
stop the recording if they feel distressed at any point.  If participants were to become 
upset by what they were sharing and want to continue with the interview, supportive 
counselling would be provided by myself (clinical psychologist in training).  Where it is 




explored with them and it was anticipated that I would need to assess in the moment with 
them the immediacy and form of support needed.  
All participants would be reminded that they do not have to talk for the full allotted 
time and a manageable length of time for the interviews would be agreed with the 
participant prior to being interviewed. This would consist of agreeing to complete the 
interview in two phone calls if necessary or reducing the interview duration. 
2.7.1 Discrepancies between practice identified MUS and patient reported MUS  
Recruitment was initially based on individual GPs assessment and referral of MUS 
patients. However, evidence suggests that patients may not identify with having a 
‘functional’ diagnosis when health professionals have referred them into a study 
(Fullwood et al., 2013), as such both patient and GP guidance was sought in developing 
the study documents, and careful consideration was made on the appropriate term for 
‘MUS’.  
2.8 Information governance and data protection 
Data would be accessed by people in the research team. Where transcribing services 
are used, a signed transcriber confidentiality statement would be requested and 
provided.  
Returned contact detail forms and consent forms would get stored in a locked 
filing cabinet at the University of Leeds, in the office of the doctorate programme 
research coordinator. Recording would be done using one password protected 
dictaphone and deleted after uploading to the secure university server, the M-Drive.  
All study documents would either be confidentiality shredded or deleted from the 
university secure server after 3 years from when the study ends, in line with the 
University of Leeds data protection policy.  
2.9 Data Analysis 
The framework approach was thought to be the most appropriate method for analysing 
the data, with patient and GP interview data being analysed separately, before being 
synthesised. The framework approach uses a thematic matrix to manage the data and 
provides a systematic and transparent approach to how data analysis moves from the 




(Ritchie and Lewis, 2003 p.212).  Originally a qualitative approach that was developed 
for systematically conducting social policy research (Ritchie & Spencer, 1994), the 
approach has been applied in healthcare research (Smith & Firth, 2011, Ali et al., 2017). 
This has included primary care research, for example using the framework approach to 
explore GPs views and local policy on managing multi-morbidity and areas concerned 
with patient participation, prescribing and clinical decision making (Smith et al., 2010; 
Bower et al., 2011; Solomon et al., 2012), and as such was felt to be a suitable method 
for this study to use in a primary care context. The analysis procedure followed in this 
study would be iterative, moving between the three phases outlined by Ritchie and Lewis 
(2003) and Smith and Frith (2011) of data management, descriptive accounts and 
explanatory accounts.  The end result of the analysis would be the production of a 
conceptual framework that captures what is found for patients and GPs; explaining the 
processes occurring at local level and generating recommendations. 
Details for each of the phases of analysis, along with examples, are provided in 
section 3.6 of the final study methodology.  
2.9. 1 Alternative approaches considered 
The framework method of analysis was considered most appropriate for understanding 
the context of the current local guidelines for managing MUS in primary care, as well as 
the effectiveness of this clinical approach for GPs and patients.   Unlike inductive 
methods of qualitative analysis, such as Interpretive Phenomenological Analysis (IPA; 
Smith 1996), and Grounded Theory (Corbin & Strauss, 1990), the framework approach 
focuses on the questions being asked of the data a priori, which are informed by the 
needs that have been identified and questions being asked at local level (Ritchie & 
Lewis, 2003). Although IPA would enable a detailed understanding of both GPs and 
patients lived experience of MUS,  the study was aiming to extend the detailed 
descriptions of the experience of MUS that already exist in the literature (Salmon, Peters 
& Stanley, 1999; Dwamena et al., 2009; Atkins et al., 2013; Nunes et al., 2013; Stone, 
2014; Houwen et al., 2017) into understanding the process involved in how symptoms 
are understood and managed between GP and patient.   
A Grounded Theory approach was also considered as this would enable the 
dynamic nature of how a person perceives their experience to be captured (Blumer, 
1969;  Strauss & Corbin, 1990). It was felt that developing a theory that was grounded in 
the research data, rather than fitting narratives to an existing theory, may provide greater 




chronic illness (Charmaz, 2008). Although there are various forms of Grounded theory, 
with different theoretical positions and epistemologies, common to them all is the 
procedure of theoretical sampling. For this, the number of patients would be determined 
by the data elicited and the conceptual themes emerging from the study (Strauss & 
Corbin, 1990). In this respect, sampling to develop an unfolding theory and explore 
ambiguities in the data may require more participants then would be advisable for a 
Doctorate in Clinical Psychology qualitative research project, which is between 8-10. As 
such, it was felt that the sample size may not be enough to capture the nuanced nature 
of MUS, which may limit the quality of the ‘theory’ developed (Charmaz, 2006 p.18).  
2.10 Data Validity  
Achieving trustworthiness of the data would be completed through the procedures 
recommended by Chiovitti & Piran (2003), which included: 
1. Letting participants guide the inquiry process- generating interview questions from 
previous interviews and consulting with GP and patient representatives on the interview 
topic guides.  
2. Checking the theoretical construction generated against participants meanings of the 
phenomenon- verify concepts generated by asking participants to review the conceptual 
framework generated and incorporating feedback in to further refinement of concepts 
and themes.  
3. Using participants actual words in the conceptual framework- consider the words in 
context and the different meanings they have for participants.   
4. Clarifying researcher bias- use a personal journal to support reflection and keep a 
clear audit trail of how themes were generated. 
Quality checks of the data collected would be verified through data triangulation between 
patient and GP interview.  Supervision would also be used to ensure quality of both the 
































2.11 Researcher Reflexivity  
As the interpretation that I bring to the research will invariably be 
shaped by past experiences, it is important that I consider where my own 
potential is for bias.  
My interest in the area of MUS has come from clinical training and the 
health related placements that I completed in secondary care. During these I 
sensed not only the patient’s anxiety about meeting with a psychologist for 
their symptoms and their concerns that this meant their symptoms were not 
real, but also the team’s concern with how best to manage symptoms with a 
“functional overlay” and whether current systems were unhelpfully reinforcing 
illness behaviours. In knowing this, my approach to patients in the study was 
to emphasise my role as a researcher rather than a psychologist, and to 
remind them of the study focus and how this was not part of their standard 
care for their symptoms.  I remained watchful of being pulled into advice 
giving, and remained neutral if the topic of system structures arose.  
In addition to having an interest in the area of MUS, the concept of 
power and how this gets acknowledged by health professionals and 
negotiated in the therapeutic relationship has also been an area that I have 
considered greatly, not only in my professional experience but also in my 
personal experience of communicating with health professionals. As such, I 
entered into this research from a position of interest in tools that could 
support with collaboration in patient care, whereby the person accessing a 
service would have the opportunity to be as actively involved in decisions 
about their care as they would want to be. This has lead me into the area of 
shared decision making- a framework of communication applied to areas of 
physical health management, and recently an emergence in the area of 
mental health- and whether such a framework could be a viable option in 
supporting MUS management in primary care. Acknowledging that my own 
disposition is for patient choice and advocacy, I tried to remain neutral to 
hearing the broad range of views on preferences in the patient-professional 
relationship, utilizing opportunities to reflect with my supervisors on the 
interviews, and also completing the majority of GP interviews once patient 





 2.12 Study Informants  
Patient and GP involvement was had throughout the initial development phase of the 
study protocol, to help develop a study that was reflective of the needs and views of both 
patients and GPs, with results that could be of clinical relevance. 
2.12.1 GP consultation  
An expression of interest email was sent to the Academic Department of Primary Care in 
the  University of Leeds, asking for GPs to express their interest in consulting on a study 
concerned with medically unexplained symptoms in primary care.  One GP replied, who 
also expressed a willingness to act as a field supervisor and for their practice to be 
involved in recruitment.   
Guidance was sought on the appropriate reference terms to use in the study materials in 
regards to ‘Medically Unexplained Symptoms’.  It was advised by the GP to make 
reference to the symptoms being ‘long term’ with ‘complex causes rather than the initial 
suggestion of ‘atypical’ or ‘unknown’ causes, and that any reference to medically 
unexplainable causes should be limited. Concern was shared that the term commonly 
used in research in this area -Medically Unexplained Symptoms -might undermine the 
work done by GPs to move the patient on from seeking a diagnosis to managing 
symptoms. It was also expressed that the term ‘MUS’ might imply that GPs had 
uncertainty about their patients diagnosis and management plan. The term ‘functional’ 
was also discussed and was considered by the GP to be less well understood by their 
patients and would be more vulnerable to misinterpretation in their view, as such it was 
agreed that neither MUS or Functional would be the main reference terms used for such 
symptoms.  
In addition to developing and reviewing study rationale, reference terms and interview 
protocol, this GP also provided a supporting statement to the ethics committee that 
outlined the need and practice support of this study (see Appendix 5).  The GP believed 
there to be a high proportion of patients who presented with medically unexplained 
physical symptoms at their practice and that this area represented a significant workload 
for GPs there.  This was in reference to the time spent on normalising symptoms in 
primary care, trying to understand the complex presentation of not one but multiple and 
extreme symptoms, as well as managing their own and their patient’s discomfort at 
thinking that inadequate care was being provided.  Additionally, it was shared that a 




patients, as a way to develop trust, build up symptom narrative and prevent unplanned 
A&E admissions. This GP felt that the important and relevant  questions to consider in 
this research would be to what extent continuity of care helps with this patient group and 
keeping the symptoms ‘contained’, as well as the extent to which they got the same 
response from everyone that they saw.  
2.12.2 Patient consultation  
Access to patient consultation was gained via the consulting GP, who was able to 
recommend a patient who had lived experience of long term symptoms with complex 
causes who was willing to consult on the study. Study materials were reviewed by the 
consulting patient, as well as feedback obtained on the relevancy of the research 
rationale and testing out the study explanation given at the initial approach to 
participants. In general they felt that the study was interesting and was relatable to their 
own experiences of finding it difficult to share their own understanding of their symptoms 
with their GP.  In addition it was reported that finding ways to make the consultation feel 
more patient centred would be of benefit.  
Initially it was proposed that the interview would be introduced to participants in the 
following way: 
 “…an interview to further understanding on how patients and 
their GP’s understand and manage  long term symptoms which 
cannot be medically explained or that have atypical causes.” 
Feedback from the consulting patient on this introduction was as follows: 
1.) The explanation was clear, however ‘atypical’ was recommended to be replaced 
by either the words unusual, uncommon, unknown causes. 
2.) The explanation is accessible and lay person friendly  
3.) The term ‘medically unexplainable symptoms’ should be avoided in any further 
elaboration, as might not mean much to people and if it is being used by GPs, 
then it might not be shared with the patient. 
When asked how they would feel talking in greater depth about their experiences, 
they shared that they thought it might help to give a person a “birds eye view” of their 
experiences, and that they already felt more positive and passionate after having spoken 
briefly about their experiences and that this came from a place of spending so long trying 
to “mask” the problems. They did not  report any concerns with the initial proposal of 




“useful”  feedback to the practice regarding the level of shared understanding found 
between patients and GPs. 
One further contact was had with the consulting patient Subsequent contact 
helped finalise the patient study documents and study protocol, which had been required 
to be amended  following the outcome of the initial Research Ethic Committee review.  
2.13 Ethics feedback 
The study’s initial submission for Research Ethic Committee (REC) review was on 
September 2017. This was reviewed a further three times before full approval was 
provided in January 2018 (Appendix 1). Table 1 provides the feedback obtained from the 
committees and how this influenced the method used in the study. Their main concern 
was that the dyad aspect of the study would risk the “breakdown” of the patient-GP 
relationship, as patients or GPs may be able to identify themselves in the publication of 
the results.  Despite the dyad aspect of the study being removed, concern remained that 
recruitment for patients and GPs would only be from one practice, increasing the risk of 
participants identifying themselves or each other.   
This concern was acknowledged, however it was felt that the risk of ‘breakdown’ 
between patient and GP had been reduced by the participants only being asked to share 
their general experiences of MUS management and not specific details about their 
experiences. Although participants may still share specific details or provide contextual 
identifiers, despite not being directly asked, it was felt that in adherence to the ethical 
principles described in the Belmont Report (1979) for respect for persons, the level of 
confidentiality should be the choice of the research participant as an autonomous agent. 
Participants should therefore be given the choice about how they want such data 
handled, enabling respondents to specify particular pieces of their data that should 
remain confidential at the end of their interview. In addition it was clarified that if the 
University perceived there to be potential risk for harm to individuals if the results were 
published, the University of Leeds policy for all Doctoral theses is that there is an option 
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 “Potential for a 
relationship 
breakdown to occur, it 
was considered that 
this could be quite 
significant, between 
both the patient, GP, 
and the practice.” 
 
“…concerned that the 
first time the 
comments might be 
seen could be through 
 
The patient and GP dyad 
group could still be used; 
however measures 
should be put in place to 
discuss any issues 
following the interview to 





The protocol was amended to outline the 
measures put in place to manage any issues 
following the interview. The measures included 
were: 
- Option of university embargoing sensitive data 
(up to 20 years), if publication of results are 
deemed to be detrimental to relationship between 
patient, GP, or practice. 
-Participants will all be provided with the option of 
a debrief telephone session to discuss any issues 
following the interview. Where patients have 
reported concerns regarding the management of 
their care by their GP, then as per new protocol, 




the published results 
of the study” 
“….too small and 
focussed, and the 
results too easily 
identifiable as only 
one GP practice was 
being used, this would 
make anonymity 
almost impossible and 
compromise 
confidentiality” 













dyad method could 
potentially destroy or 




“ethical concerns would 
not be raised if the GP 
was to be interviewed 
independently to gather 
generic opinion, rather  
than specifically 
matching them to their 
patient.” 
“ the Committee wished 
to strongly recommend 
The dyad aspect of the study was reconsidered.  
As such, the study proposed that it will no longer 
be looking at GP patient dyads, and patient and 
GPs will be interviewed separately about their 
general understanding and experience of MUS 






using GPs from a 
separate practice to 
patients to avoid the 









disruption to the 
relationship between 
the GP and the 






assurance that the 
relationship between 
GPs and patients would 
not be negatively 
affected and explain how 
this would be the case.” 
Letter from the GP leading on the study at the 
practice wrote a letter to assure REC that the 
number of patients potentially eligible for the 
study was sufficiently high enough to protect 
patient anonymity.  
It was acknowledged that the study could recruit 
patients with whom GP respondents have a 
working relationship and may be able to identify 
them from research output, however this would be 
addressed at multiple stages of the research 
process-data collection, data cleaning, and 




2.14 Protocol development work: The outcome 
2.14.1 Process Findings  
The process has highlighted the barriers and facilitators of developing and setting 
up a clinically relevant study in the ‘real’ world, which are detailed below.  
Barriers 
Qualitative research into the therapeutic relationship was highlighted as a concern 
when a dyad method was proposed for a therapeutic relationship that was current.  
From what has been reported regarding the local CCG priority for all patients in 
primary care - continuing care to build the illness narrative and prevent A&E 
admissions- it is possible that this view is widely held, with understandable 
concerns for anything that may potentially threaten the relationship.   For the 
research ethics committee, it would seem there was an implicit assumption that 
patients were able to routinely see the same GP for this relationship to take on this 
significance, as well as anticipating that difficulties would be disclosed from both GP 
and patients and that the first time the GP or patient would be aware of this would 
be from the results of the study. It was interesting to see how this view was in 
contrast to the patient representative and GP consulting on the study, both of whom 
perceived the study as providing a method of constructive feedback, with a hope 
that this could help improve the relationship, rather than “destroy” it.  It would seem 
that in addition to the method of dyads being used to explore the relationship in 
primary care being a barrier, there was a wider concern that it would be inviting 
blame.  
Facilitators  
An important factor that helped with the process of developing the study and getting 
it set up, was identifying a GP who would be involved throughout the process, 
which included leading on the study at the practice. Being able to provide ethics 
with the number of potential participant’s eligible was helpful in assessing potential 
anonymity of patient participants.  In addition to this, it was important to evidence 
how patients would be given the choice to say at what level they would be happy to 
have their data included in the write up, providing participants with the choice at the 




The site visit that was also made, helped to think about the structure of the 
consultation and the feasibility of certain study designs and procedures.  This 
provided an opportunity to also meet the GPs, as well as build an understanding of 
what was clinically relevant to the needs of the practice.   This helped to provide 
evidence of the feasibility of the approach being proposed.  
Lastly, accommodating some of the suggestions made by the research ethics 
committee did help to simplify and focus the study. However, it was also important 
that I persisted on other areas that were deemed important from the consultations 
had with both the patient and GP consulting on the study, and reiterating the 
rational for why certain aspects were deemed important to retain.  
2.14.2 Implications on final study methodology  
The aim of the study was to explore how patients and GPs understand MUS and its 
management. This was going to be achieved by addressing the following research 
questions:  
 How are medically unexplained symptoms understood and managed by 
patients and GPs? 
 What way does their understandings overlap and diverge? 
 How are differences in understandings negotiated?  
 How can this inform shared decision making interventions to manage 
medically unexplained symptoms more effectively in practice? 
The aim of the study did not change following patient, GP and ethics review. 
However,  changes were made to the study protocol and final study methodology. 
Table 2. summarizes the changes made to the study following the development 








Table 2: Summary of methodology changes following protocol development work   
DEVELOPMENT 
WORK 
FEEDBACK FINAL METHODOLOGY 
 
GP Consultation 
Difficulty in getting recent MUS rather than pre-existing as need a 
history and known to service for it to be classed as MUS.  
 
 
Frequent attendance is not getting at the real challenge of 
managing this patient group-may capture well managed MUS, or 





CCG priority- to what extent does continuity of care a.) happen at 




‘Long term symptoms with complex causes’, to be used in study 
material rather than ‘medically unexplained symptoms’.  
 
 
Patients to be directed back to their GP or given Samaritans 
number, if risk disclosed. If appropriate, direct them to  ask for a 
referral to the IAPT team via GP.  
Study focused on persistent MUS (unexplained 
symptoms >3 months). Inclusion criteria indicated 
duration of symptoms.  
 
Frequent attendance was initially removed following 
GP feedback. However, following REC 2 comments, 
this was negotiated to be frequent attendance based 
on the clinical judgement of the GP rather than 
arbitrary number of consults over a specified period. 
 
 
Initial protocol included a medical note review to help 
capture patient service use for symptom management. 
This was removed in the final methodology due to 
REC 2 feedback. 
 
Language in the study materials and in the aim and 
research questions for the study were altered to reflect 
the preferred terminology to use instead of  ‘MUS’.    
 
Risk information was added to the interview schedule 
to act as a prompt. 
Site Visit  
 
Adhoc consultations and time pressures in the consultation would 
make it difficult for the GP to introduce the study and set up any 
recording equipment needed to capture the consultation process.  
Individual interviews were completed to survey the 
experiences of both patients and GPs. The initial 




aspect to capture the relational processes occurring 
between patient and GP. This dyad aspect was 





Dyad aspect is a useful method of providing feedback to the 
practice about the process occurring between patient and GP in 




Change any reference to ‘atypical’ causes, for ‘unusual’, 
‘uncommon’, or ‘unknown’ causes. 
 
Avoid reference of MUS 
Although the dyad aspect of the study was removed 
following REC 2 feedback, the final methodology was 
approved that patient and GPs could be recruited from 
the same practice.  
 
Use of the word ‘atypical’ symptoms to refer to MUS 
was removed from protocol and in language used to 




REC Review 1 A recommendation that a method other than pseudonyms was 
used, e.g. ‘Participant A’ 
 
 
Potential for conflict to occur as there were no measures in place to 
resolve any issues which may be brought up following the interview 
 
The Committee was concerned that the first time the comments 
might be seen could be through the published results of the study. 
Participants anonymization was altered from 
pseudonyms to participant labels e.g. ‘Participant A’. 
Participant information sheets were updated to reflect 
this change.  
 
Potential conflict would be addressed by providing 
participants with the option of a debrief telephone 
session to discuss any issues following the interview. 
 
The university’s right to place an embargo on the 





REC Review 2 The current defined patent group would not give an idea of the 
severity/demand on the health service, the relationship with the 
health service, or the exact problem the patient themselves would 
be having. They stated that using patients who were frequent 
attenders with medically unexplained symptoms, for example, could 
give more meaningful results.  
 
 
Ethical concerns would not be raised if the GP was to be 
interviewed independently to gather generic opinion, rather than 
specifically matching them to their patient.  
 
 
Inclusion criteria altered to include frequent 
attendance  as determined by the clinical judgement 






Individual interviews were completed to survey the 
experiences of both patients and GPs. The focus of 
this was altered to generic experience, rather than 
shared experience within the dyad.  Changes made to 
the participant information sheets and interview 
schedules to reflect this. 
REC Review 3 Ongoing concerns for the disruption to the 
relationship between the GP and the patient with the current study 
design [individual interviews, not dyad, but at the same practice]. 
 
Committee noted that access to participants’ medical records would 
be required to verify information given by participants and queried 
why this was and that this would make the patient identifiable.   
Confidentiality process updated.  Participants were 
asked to specify the level of confidentiality of their 
interview post –interview.   
 
 





CHAPTER THREE: FINAL METHOD 
This chapter provides information on the final study that was developed with the 
feedback and guidance that came from the Research Ethic Committees, GP field 
supervisor and the patient study informant.  The focus of this chapter will be to 
provide the revised study design, the recruitment framework and further details on 
the method of data generation and analysis used. Details regarding the service, 
sample, the process of informed consent, the ethical considerations, information 
governance and data validity have remained unchanged and will not be repeated in 
full here.   
3.1 Study design  
A qualitative approach, using semi-structured interview was still believed to be the 
most appropriate approach to use in line with the aims of the study, for reasons 
previously stated. Due to the concerns raised regarding the dyad aspect in the 
study development work, the design was adjusted so that patient and GPs would be 
interviewed separately without a necessary association, about their general 
experiences of MUS.   
Recruitment of patients and GPs occurred at the same practice. This was 
considered to be an important part of the quality control framework for the study, 
supporting the overall trustworthiness of the qualitative results by increasing 
credibility of the conclusions made and helping to provide some control over 
contextual factors to increase the transferability and dependability of the results.  
3.2 Sample Selection 
The eligibility criteria for patient participants remained unchanged. However, GP 
participants were now eligible to participate if they were from the recruiting practice 
and had clinical experience of managing Medically Unexplained Symptoms.  GPs 
from the Academic Unit of Primary Care in a school of medicine were going to be 
approached to participate if GP recruitment needed to be opened up further.  
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3.2.1 Sample Size  
For reasons previously stated, the sample size aimed for between 8-10 participants, 
consisting of a minimum of 4 patient and 4 GPs interviewed. 
3.2.2 Recruitment Framework 
Patients were recruited purposefully, with the participating practice identifying 
patients with MUS who were deemed, based on clinical judgement, to have 
frequent attendance to the practice and had a presentation of physical symptoms 
with lack of explanation by a recognizable physical disease.  
Identified cases were then checked by the lead research GP to make sure 
they met MUS clinical criteria.  A study invitation letter, which was signed by the 
lead research GP and written on practice headed paper was then enclosed in the 
patient study packs provided (Appendix 2). The study packs that were sent by the 
practice contained a study information sheet, a consent form, a contact details form 
(Appendix 3 and 4) and a freepost envelope. Patients were only contacted by the 
study team once they had opted in by returning their signed consent form and 
contact details. GPs were recruited to the study via a presentation to practice staff, 
where they were invited to express their interest in the study by contacting the lead 
researcher on the details provided or returning their consent forms in the free post 
envelopes provided to the practice. 
Participants were identified and interviewed following the process outlined in 
Figure 2.  Where it was possible, GPs who had expressed an interest in taking part 
in the interviews were booked in for an interview once patient interviews were 
completed. This was done in an attempt to remain neutral when hearing the GPs 
































                             
                        










































































































































3.3 Participants  
As all participants had to be living in the catchment area of the recruiting surgery, 
the social deprivation score was calculated for the practice using 
http://dclgapps.communities.gov.uk/imd/idmap.html.  A score of 1 out of 32,844 
indicates the most deprived area in England to the largest number being the least 
deprived area. The score for the area was 2,389 out of 32, 844 within England. 
All GPs recruited to the study had spent the majority of their career in general 
practice at the same surgery. The sample consisted of GPs that were currently 
practicing at the surgery and GPs that had within the last two years retired.  
3.4 Interview Procedure  
Participants that had opted in to the study were contacted by phone by the lead 
researcher. The phone call was less than 20 minutes and provided opportunity to 
remind the participant of the study, address any questions, confirm their consent 
and arrange an interview slot. Participants were reminded that unless they had a 
particular preference for not completing the interview over the phone, then the next 
contact over the phone would be recorded, but that they could stop the recording at 
any time.  
Questions from the GP and patient topic guides, as shown in Figures 3 and 
4, were used to semi-structure the interviews. General open ended questions were 
asked initially to illicit rich descriptions of what the individual’s experience was of 
MUS. Subsequent questions were based on the literature reviewed in section one, 
and were  broadly concerned with the following concepts for both patient and GP: 
the symptom narrative of the complex symptom(s)- the effect and impact, the 
process of developing symptom understanding, symptom management, the patient-
GP relationship.  
Data collection and analysis were interrelated, whereby themes generated 
in initial interviews informed further questions and topics to be covered in 
subsequent interviews so that later interview questions became more focused. For 
example,  a question was introduced after the initial two GP interviews to explore 
how GPs decided what information got discussed with the patient. Similarly for 
patients, with a theme of patient involvement emerging from the initial interviews, 
the extent to which patients wanted to be involved in decisions made about their 
complex symptoms was included in subsequent interviews. Where GPs or patients 
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requested shorter interviews, the number and order of the questions on the 
interview schedules were adjusted to priorities gathering participants perceptions on 
their complex symptoms and management of them.  
 










At the end of every interview, participants were asked if they wanted to 
receive a summary of the results and informed that they would have the opportunity 
to provide their feedback on the themes identified. In addition, all participants were 
asked again at the end of their interview to confirm the level of confidentiality for 
what they had shared, and if there was anything they did not want including in the 
write up. This provided an opportunity for respondents to specify any particular 
pieces of their data that should remain confidential, as well as further opportunity to 
discuss with them any sensitive areas and answer any questions they may have 
regarding the research.   
Following the completion of an interview, the audio file was uploaded to an 
encrypted password protected university networked drive.  To support data 
familiarity, all the interviews from each group were transcribed by myself. All 
transcripts were checked for accuracy, whereby I listened to the audio recording 
against the transcript provided and made changes accordingly.  
3.5 Ethics 
Ethical approval for this study was granted by Full Research Ethic Committee 
Review by the Leeds East sub-committee in January 2018. Full HRA approval and 
local Research and Development approval was granted in February 2018 (see 
Appendix 1). Practice level agreement was provided subsequently, with the practice 
reviewing and signing the schedule of events form. Prior to external approvals the 
study was reviewed by two academic panels at the University of Leeds. 
3.5.1 Anonymity and confidentiality 
Patient participants were sampled from a list of 300 patients that met study criteria 
for Medically Unexplained Symptoms, which was considered high enough to reduce 
the risk of GPs being able to subsequently identify individual patients from outputs 
of the research. In addition, GPs were not informed which patients took part, nor 
were individual GPs aware of who from the 300 cases had been considered by the 
lead GP as meeting both inclusion/exclusion criteria, which includes meeting 
frequent attender status (𝑛= 72). A sample of GP participants was also taken from 
the expressions of interest received from the GPs at the practice and information 
about which GPs opted in were not provided to the practice or patients. All 
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participants were allocated a participant identification label at point of consent, for 
example ‘Patient A’ or ‘GP B’.  
It is recognised that the need to maintain participant confidentiality and 
anonymity in research, whilst also providing rich and detailed accounts of people’s 
unique experience, can pose an ethical dilemma in qualitative research (Kaiser, 
2009).  As it is important to treat research participants as ‘autonomous agents’ 
(Belmont Report, 1979), it was felt that a choice over the level of confidentiality 
should be provided to the research participant by informing them at the start of the 
interview of the option to pause recording at any time, or request that specific data 
be removed up to one week after the interview. Participants were again reminded of 
the option to remove sensitive data at the end of the interview.  
All participants were informed in the study information and consent forms 
that a pseudonym would be used to support anonymity of their responses, however 
that contextual information and direct quotes may be included in the write up.  
3.6 Data Analysis 
The framework approach was used in the analysis of the data, with patient and GP 
interview data being analysed separately, before being synthesised. The analysis 
was an iterative procedure that moved between the three phases outlined by 
Ritchie and Lewis (2003) and Smith and Frith (2011) of data management, 
descriptive accounts and explanatory accounts.  Further details of this analysis 
process is described below. 
3.6.1 Data management  
Initial codes and categories for the data were generated by going through each of 
the transcripts line by line, thinking about what the essence of the sentence was 
about. An excel spreadsheet was used to help create a coding matrix, which helped 
to break up the transcripts in to data chunks. Key phrases from the transcript that 
were felt to capture an initial code – a pocket of information that seemed to capture 
emotion, processes, the relationship between events- were then used to provide in 
vivo codes. Using in vivo codes is an essential part of Framework Analysis, as it 
has been reported to be a way of staying close to the data (Ritchie & Lewis, 2003).  
The essence or function of what is being captured in the descriptive code was then 
considered, with this appraisal then informing the development of a category. As 
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coding moved through the transcript, these categories became more abstract as 
similar codes were found and clustered together.  
 Figure 5. Provides an example of the coding matrix developed to support 
the process of moving from initial data sourced codes to categories from Patient B’s 
transcript. The coding matrix process was applied to both Patient A and Patient B’s 
transcripts, as well as a separate coding matrixes being developed for GP A and 
GP B’s transcripts. Rather than just have one example from each participant group, 
two examples were used as a way to get some variation in the initial categories 
developed.                                                  
Figure 5: Example of coding matrix used to analyse initial transcripts for both 
patients and GPs  
 
Following the initial construction of a list of categories for the two patient 
participants and two GP participants, the two participant groups were separately 
reviewed for areas of category overlap using post-it notes. As indicated in Figure 6, 
overlapping categories were amalgamated together into sub-categories (orange 
post-it notes). These sub-categories were then considered and clustered in to 
themes initially using the conceptual framework of clinical decision making: health 
beliefs and expectations, management options, values and preferences to order the 




This process formed the basis of a coding index, which would list by each theme 
the sub-categories that were associated with it, and was applied to subsequent 
interview data. Any new categories identified in the process were then incorporated 
into either existing themes and sub-categories or encouraged the creation of new 
ones (see appendix 6 for examples).   
Figure 6: The process of grouping the initial combined categories in to sub-
categories and themes  
3.6.2 Descriptive accounts and explanatory accounts 
Once all transcripts had been coded, the next phase of data analysis was to 
synthesize the variation within the data set. This was done through generating a 
series of maps for each of the individual themes. Figure 7 shows how a thematic 
map was created to highlight how issues related to each other within the sub-
categories identified and also how they related to other subcategories. This also 
enabled me to see any patterns occurring at the individual level, as well as group 
level. Meanings of the codes were constantly checked against the original 






 Figure 7: Thematic map of the GP theme “symptom beliefs and expectations” 
 
An overall thematic map was also created for both the patient and GP group of 
participants, as shown in Figure 8.  These were then compared and contrasted and 
more abstract concepts were generated to develop an explanatory account of how 
patients and GPs understood and managed medically unexplained symptoms. The 
end result of the analysis was the production of a conceptual framework and 
generating recommendations. Where participants had consented at interview to 
being sent a study summary sheet of the results, these were sent out via the email 
addresses the participants had provided at the initial contact. Participants were 
provided with a summary of the themes from their participant group (patient or GP) 
and a copy of the conceptual map. Participants were asked to reply to the email 
with any feedback that they had about the themes or map and that this would be 
included in the discussion. A summary of the themes for both participant groups 
and the conceptual map was provided to the GP field supervisor who was 
overseeing the study at the practice. They were also asked to review and provide 





Figure 8: Example of overall thematic map for patient’s experiences of 
understanding and managing their MUS 
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 CHAPTER FOUR: PATIENT RESULTS  
 This chapter will begin by providing context for the patient interview data collected 
and pen portraits for each of the patient participants.  The main and subthemes 
from the participant’s data will be presented in a table and supplemented further by 
rich description of the themes presented. Illustrative extracts will be provided 
throughout, with direct comparisons being made between participants reported 
experiences of managing MUS.  
4.1 Patient participants  
A total of 300 patients were deemed eligible on an initial screen for patients with 
MUS. Following the full application of the inclusion/exclusion criteria, a mail out was 
completed for 72 patients. Six patients opted in to the study, ranging between 44-
62years of age (see Table 3).   All patients had chronic symptoms, with duration of 
the longest held symptom varying from 2-20 years. All patients reported chronic 
pain and for most of the participants they had received a functional label for their 
symptoms of Fibromyalgia (𝑛 =4), whilst two patients had not.  
Table 3: Participants’ demographic and symptom information  




Patient  A 52 Male White-
British 




Patient B 52 Female White-
British 
Fibromyalgia  Long term 
Sick, worked in 
café  
Patient C 53 Female White-
British 
Persistent 
pain in legs, 
suspected 
restless leg 







Patient D 48 Female  White-
British 




Patient E 62 Female  White-
British  
Fibromyalgia  Medically 
retired Nurse  








prior to living in 
UK  
4.2 Patient pen portraits 
These pen portraits aim to contextualise the data collected and illustrate the 
uniqueness of people’s accounts. Although medical note review had originally been 
proposed to provide context to the participants interviews, ethical permission for 
notes review was not given due to concerns about potential threats to anonymity. 
As such, pen portraits were provided for each participant, with the rich descriptions 
provided for each enabling the reader with a holistic understanding of each 
individual,  which may not have been conveyed through the use of individual quotes 
alone (Hollway & Jefferson., 2013).  
4.2.1 Patient A 
Patient A had been living with pain for 7 years, which he was trying to manage 
through a combination of using the behavioural techniques learnt from pain 
management, making healthy lifestyle changes in terms of diet and exercise, and 
also taking prescribed medication that he was currently reducing.  He had a history 
of depression before the onset of his pain, which at times in the past has required 
secondary and tertiary care involvement.  He was particularly concerned that health 
professionals were attributing his physical health symptoms to being something that 
“was all in my head” and when the study was first introduced, questioned if this was 
my position too.  He did not identify with the label  given for his symptoms, and it 
was clear that he wanted greater understanding of both the mind and body and how 
they might interact.  
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He focused a lot in the interview about his suspicions that health 
professionals were withholding sharing their professional opinion about what they 
thought his symptoms were, or withholding further investigations. He felt that this 
might be occurring out of a professional fear of causing either him harm through 
triggering him to have a ‘breakdown’ or a system breakdown through spending 
money that the NHS did not have. Patient A seemed to manage this distrust by 
trying to “get on with it” without “bothering” his GP, and felt “lucky” to have the 
support of his wife, faith, friends and employer, all helping to provide him with a 
feeling of acceptance and stability that help to manage distressing thoughts that at 
times could be suicidal in nature.  
He was the only person who talked of having a variety of areas in his life 
that he felt supported in, and the role of his faith in coping.  He felt that the interview 
had helped him to realise the extent of support he had and how ‘good’ life was for 
him at the moment. At times in the interview it felt as though he had expected me to 
judge or reject what he had to say and my neutral and curious position was 
reiterated to him, to help encourage him to share what he felt comfortable to. 
4.2.2 Patient B 
Patient B had been living with pain and exhaustion for 5 years, and was currently 
caught in a cycle of feeling unable to engage in the areas of life that were important 
to her, becoming increasingly frustrated and low in mood, which appeared to be 
perpetuating the cycle further. This cycle was further exacerbated by co-existing 
COPD and the anxiety she experienced leaving the house. She was also grieving 
for the loss of her mum, whose death happened around the onset of multiple 
stressors including managing the pain.  
 She predominately managed the pain by taking prescribed medication, 
which she stated on many occasions during the interview that she did not want to 
take, particularly as she had taken a number of intentional overdoses in the past. 
Although she had attended pain management, she had found the experience 
frustrating and could not see how the techniques related to something she did not 
feel she could control. Similar to patient A, she did not identify with the label that 
had been suggested by her doctor for her symptoms.  Although she did not identify 
with the label, she welcomed the support of the online fibromyalgia group, and the 
immediate sense of not being on her own if she was having a difficult day.  
 She came across as someone who prides herself on working hard and 
being emotionally and physically “strong” for others, anticipating that others will only 
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push her away, rather than show care.  At times she would become tearful during 
the interview, which she would dismiss as just something that she did now, rather 
than her tears being justified for the experiences she was describing. Patient B was 
most focused on sharing her beliefs about the symptoms and the impact that the 
symptoms had on her. She was open to discussing accessing additional support for 
the depression she described as being secondary to her pain and was 
contemplating engaging with the mental health team at her surgery for further 
support.  She appeared to welcome the opportunity to talk freely, and thanked me 
for the time that I gave to speak with her.  
4.2.3 Patient C 
Patient C had been living with pain for the last ‘few years’, however was only 
affected when she was lying down or resting.  She had taken the doctors lack of 
follow up on her initial concern of what the pain could be as indication that it was 
not serious and could be something that she self-managed with painkillers if it got 
particularly bad. She had looked up on the internet what it could be and identified 
with the symptoms described for ‘restless leg syndrome’.  The pain did not impact 
on her daily activities, which she described as being very busy filled with working, 
volunteering, going to the gym and providing childcare for her son- her schedule 
being so busy, that we found it hard to find a time to do the interview. 
  She experienced tiredness with the pain, but was unsure if this was due to 
her co-existing difficulties with low mood and anxiety, which she had for the past 30 
years. She did not feel that the pain was associated with her low mood, stating that 
if it were that would mean the pain was psychological and she did not think it was.  
She had been diagnosed with cancer 5 years ago, which had initially been 
misattributed by her usual GP as lumps associated with aging.  However, patient C 
showed no concern that this could happen again, stating that now because of her 
medical history, she would be listened to if she raised concern with her GP that the 
pain maybe cancer related. 
She came across as someone who manages life’s challenges by keeping 
busy, but also finds it hard to assert her needs to others. She described herself as 
being a passive person in consultations, however following the cancer diagnosis the 
fear it could happen again now makes her speak up.  She was the only person who 
talked about pain not impacting on her usual routine, and was also one of the few 
people who did not mention suicide.  There was also little spontaneous reference to 
the support of others, although this was one of the shorter interviews conducted, 
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and may have come up if we had talked for longer. Patient C had the greatest focus 
on the health system and how the changes made it harder to consult her GP before 
she went ahead with changes to her care.  
4.2.4 Patient D 
Patient D was ‘diagnosed’ with fibromyalgia 4 years ago, after experiencing 
long standing difficulties with their thyroid, mouth ulcers and hip pain. She recalls 
‘always’ being in physical pain during her primary school years, which was 
attributed at the time as growing pains. She talked about the low mood being 
secondary to her pain, and that the thoughts of the constant pain being never 
ending, as well as trying to manage the pain alongside the additional family stress  
that co-existed. Patient D believed that these factors had all contributed to 
experiencing a “breakdown” and thoughts about ending her life with the pills she 
had available.  She feels that the suicidal thoughts were in part a side effect of the 
medication she was on, and continues to take the anti-depressants that were 
prescribed at the time.  
She described her symptoms as not only impacting on her but also her 
husband and their relationship, with her feeling no longer able to go out unless it 
was a special occasion that she had time to prepare herself for. Since her diagnosis 
she has felt able to share information about the condition with others, and is more 
able to cope with the symptoms. She credits the online fibromyalgia group as 
having “saved my life” after her breakdown, and manages the pain using alternative 
medicine suggested by the group. 
  She came across as a person who in most areas of her life has been, 
whether through choice or need, focused on the needs of others. At the Doctors 
she experienced someone who was focused on her needs and a shared search for 
the answer was sought. She valued the involvement, which she states brought with 
it feelings of being cared for and treated as a person. Out of all the patient 
interviews, patient D spoke the most about defining the problem, particularly the 
role of the label and reflecting on life events. She also talked the most about 
managing the symptoms through self-management, and compared to other patient 
participants, also had a greater focus on how the structures within the health 
system had supported her involvement in her care.  
4.2.5 Patient E 
Patient E had been living with severe back pain for nearly 20 years, although has 
experienced sciatica in her back since the age of 17, which she attributes to having 
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fallen badly as a child during sports activity. She also saw her earlier 
gynaecological problems as also being linked to her current symptoms.  She 
experienced soreness of skin, aching limbs and continuous pain, and identified with 
the label that her GP had given to her symptoms –fibromyalgia. 
 Since the diagnosis she had found a lot of helpful fibromyalgia information 
online, and had concluded that the reason for her pain was due to having too much 
factor-p, which made her hypersensitive to normal pain.   Prior to taking early 
retirement due to her health, she worked as a mental health nurse, but describes 
getting burnt out both by the distress she was witness too with little support,  and 
also physically by lifting and rolling people without proper resources in place.  She 
approached Occupational Health once she had her diagnosis and requested a 
change in her job to support her health needs. Since getting her diagnosis she felt it 
had provided her with a sense of control over the symptoms.  
She had the support of her husband at home, who would also share in 
reading up on fibromyalgia. In addition to taking analgesics to manage the pain, she 
also looked for alternative medicine that may help, as well as opportunities to 
participate in research in this area. She likened being approached with this study as 
taking two tramadol- she felt valued and appreciated that that her surgery had 
thought of her. 
  She came across as someone who has spent many years both in personal 
and professional roles being a carer of other people’s needs, and finding it hard to 
get space for her own to be seen and feel valued.  She has managed challenges in 
life through adopting a ‘what will be, will be’ attitude, which at times others would 
take advantage of and leave her feeling frustrated that her own needs would be 
pushed aside by theirs.  She was extremely  appreciative of the time spent listening 
to her narrative in the interview- not only reiterating her thanks at the end of the 
interview, but also in a follow up email after.  She had welcomed the opportunity the 
interview had given her to gently light up some of what she referred to as ‘my dark 
corners’ and felt that in doing so it had helped her appreciate her own value.  
4.2.6 Patient F 
Patient F had been living with back pain for 9 years, which he was trying to manage 
through prescribed medication that he could get in the UK and when he returned to 
visit his wider family in the Middle East.  He had also undergone physiotherapy in 
the UK, where he learnt that he also had weak muscles in his neck.  
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Patient F described the pain as “coming in waves” and would at times 
spread from his neck to his shoulder blades and back, where at times he has been 
unable to move his neck.  Dependant on the acute nature of the pain, he would try 
and manage the pain through taking hot baths and herbal medication, only taking 
stronger analgesics if the pain was acute.  He felt that the pain impacted on his 
mood due to his inability to do the things he thinks he should be doing socially, and 
the exhaustion of trying to provide for family and needing to just sleep rather than 
be with his children. He also felt that the pain was impacting on his memory of 
events.  
  At present he is unemployed and on long term sickness, however before 
leaving for the UK he worked in education and had involvement with a Refugee 
Project. He moved with his wife and children to the UK 10 years ago, and is 
supported by the Refugee Project in the UK.  Although he would make reference to 
his current living situation, he seemed more hesitant to speak when further inquiry 
was made.  Although participant F stated he understood the rationale for asking 
about psychosocial factors, he did not feel that this was relevant to his experience 
of pain.  He welcomed seeing different doctors to find different ways of looking at 
his symptoms, hoping to find something that could fix the pain and found it to be a 
problem when he had to see the same GP.  
The interview was conducted in English, with difficulties understanding each 
other on the phone being managed by either talking around the topic or giving 
examples to illustrate what we meant.  The focus of the interview was on the impact 
of his symptoms and how he was managing them.   This was one of the shorter 
interviews, however he was happy to be contacted again if further information was 
needed.  
Results from the patient interviews  
Data from all six patient interviews were included in the analysis. The five main 
themes were based broadly around the conceptual framework of clinical decision 
making, and consisted of:  symptom beliefs and expectations, defining the health 
problem, managing the symptoms, what’s important in my symptom management, 
and the experience of the system. The contribution of each participant to each 
theme and subtheme is indicated in Table 4. These frequencies are used 
‘qualitatively’, to illustrate the importance of each component for the patients. The 
 76 
 
main themes and the subthemes that were found to contribute to them will now be 
outlined.  
Table 4: Patient themes and subthemes and frequency of utterances by patient  












Frequency of Utterances 














When  ‘normal’ becomes  acute and 
chronic   
6 13 3 6 6 7 
The impact on self and others: ‘What if I 
can’t?’  
14 29 6 17 6 7 
It controls me or I control it 6 7 1 6 2 4 
DEFINING THE HEALTH PROBLEM 24 27 10 27 22 6 
Getting a label in the search for 
answers 
12 9 6 11 6 3 
The response of others 8 9 1 7 9 2 
Life before the symptoms 4 9 3 9 7 1 
MANAGING THE SYMPTOMS 22 32 16 38 14 13 
Deciding what is right for you and your 
symptoms 
15 5 9 18 12 6 
Going (back) to see the GP 2 10 3 6 1 4 
Feeling that I’m not on my own with 
‘strange symptoms’. 
5 7 0 9 6 1 
The tablets don’t work-what else is 
there? 
8 8 2 7 1 3 
WHAT’S IMPORTANT IN MY 
SYMPTOM MANAGEMENT 
24 13 21 11 24 ND 
Not being seen (as just a patient, a 
robot, or a number) 
4 3 8 3 8 ND 
The relationship 8 5 8 0 6 ND 
Becoming more involved in your care:  
‘Do I really want to be taking these?’ 
9 3 4 5 9 ND 
 ‘In house’ management  2 2 1 3 1 ND 
THE EXPERIENCE OF THE SYSTEM 6 9 9 16 3 1 
Your 10-minute slot 1 3 5 0 1 0 
(In)consistency 2 3 2 4 2 1 
When time is ‘made’ 3 3 2 12 0 0 
*ND- Not Discussed topic 
4.4 Theme 1: Symptom beliefs and expectations  
Theme 1 refers to the beliefs and expectations that people had about the symptoms 
they were experiencing. Patients described experiencing multiple symptoms, which 
either were perceived as originating from separate conditions that co-existed or 
made up from one condition that encompassed other existing symptoms. People 
described knowing what was normal for their own body, and expected that 
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deviations from this was a symptom of something needing to be followed up. This is 
described further in the sub-theme ‘When ‘normal’ becomes acute and chronic’  
which details how life experiences, both directly and indirectly, had contributed to 
the beliefs participants had about their physical symptoms and how the episodic 
nature of chronic symptoms brought an expectation that ‘good’ days would be 
followed by ‘bad’ days.  
The sub-theme ‘The impact on self and others:  ‘What if I can’t?’’ provides 
an overview of the various ways that people reported being affected physically, 
socially and psychologically by the painful sensations they all reported, whereby 
people spoke openly about the depths of this pain and how they had responded in 
their most despairing times. Participants also described a variety of factors that 
contributed to managing their distress, which included discussing the role of the 
family, their friends, their faith and past experiences of managing deviations from 
“the best laid plans”.   
The sub theme ‘It controls me or I control it’ outlines the various ways that 
patients set about taking back the control that the uncertainty of their symptoms had 
initially taken from them. A central issue was trying to do something that helped 
them to build an understanding of their symptoms. Further facilitators and barriers 
to establishing a sense of control over the symptoms are detailed within this sub-
theme.  
4.4.1 Sub-theme: When ‘normal’ becomes acute and chronic   
Participants spoke of knowing their own body and appeared to use this as a 
subjective measure of what was ‘normal’ for them.  Both Patient B and D spoke of 
initially putting their pain down to the usual aches and pains that everyone 
experiences, whilst patient F initially attributed his pain to sleeping awkwardly on his 
neck.  However with symptoms increasing or becoming stronger in intensity, 
explanations moved from pain and tiredness being normal experiences to ones 
indicative of something being ‘wrong’ and it became harder to ‘ignore’ as it 
impacted on their usual daily routine, or was no longer responsive to how they were 
trying to manage it. Patient B became concerned when she started to notice how 
more effort was needed to be able to get up and on with her day: 
 
“At first you think ‘oh everyone has pains’, but when you’re 
sat down and how hard it takes you to get up on certain 




All patients spoke of going to the doctors when their symptoms persisted. 
Patient A and E  had concerns that the symptoms would be confirmed as being 
related to mental health problems that either they themselves had a past history of 
or that ran in the family.  In contrast patient B had been with her friend when they 
received a terminal diagnosis of cancer and had known other people who had 
missed diagnoses of cancer. She was concerned that her symptoms were of cancer 
and that this would not be detected by a blood test. Patient D also initially thought 
that her mouth ulcers were possible symptoms of mouth cancer, and initially went to 
the dentist for a check-up. Patient F did not state what he thought the symptoms 
were initially only that “it is the worry that something is happening” that makes him 
go to the doctors with the pain. Patient C had experienced a past diagnosis of 
cancer, which initially had gone undetected by her GP. Despite this, patient C 
stated she did not suspect the pain in her leg to be anything to do with her past 
cancer diagnosis, and felt that if there was sufficient concern shown from the GP 
then she would be followed up due to her past history. In this respect, a past 
diagnosis of cancer was perceived as enhancing the level of attention and 
consideration given to physical symptoms reported, whereas a past diagnosis of 
mental health brought with it a concern that symptoms would be labelled as “being 
all in your head”.  
Symptoms were rarely on their own, with patients describing a constellation 
of symptoms which had been diagnosed at different points in time, and were largely 
viewed as being separate rather than interacting with their pain.  The exception to 
this were Patients D and E who both reported childhood memories of pain, and felt 
that their diagnosis of fibromyalgia had encapsulated the spectrum of problems they 
had experienced throughout life which included gynaecological related problems, 
thyroid, ulcers and IBS.   
 
All participants spoke about living with a variety of symptoms over a long 
period of time, making the narrative around the symptoms and their experiences 
harder for them to tell and for others to piece the complexity together at times.  
Although symptoms were long standing, patients spoke of experiencing an acute 
exacerbation in their symptoms, which for some happened at night time and when 
lying down and for others would fluctuate throughout the day or over a period of 
months.  Patient A was focused on embracing the good days he experienced with 




“You want to…it’s like my granddaughter is here today, and 
today is a good day so I can mess about with her and chuck 
her up and down, but you do have an effect afterwards, but 
it’s nice to be able to do that initially. On a bad day, you are 
not going to do that.” (58) 
 
Patient B also spoke of wanting to be the “fun nan” and on a “good day” felt 
that she was able to fulfil this role.  She spoke of not feeling like she could refer to 
herself as “disabled” or “ill” because her symptoms varied from being able to being 
unable to function and perceived herself as not necessarily looking ill.  In this 
respect fluctuating symptoms can be seen as impacting on the aspects of a 
person’s identity and what people feel they have permission to identify with.  This 
may hold greater implications for how such dynamic and fluctuating symptoms sit 
within the less flexible parts of the system, such as benefits.  
4.4.2 Sub-theme: The impact on self and others: ‘What if I can’t?’ 
Patients spoke of feeling ‘brittle’, unable to bend to accommodate social demands 
others would place on them and perceiving themselves as unable to take much 
conflict before ‘breaking’. There were also reports suggestive of some patients 
finding it hard to also trust their bodies to engage fully in family and social life, 
thinking “what if” the symptoms recur, and would need time to mentally ‘prepare’.  
All participants besides patient C, spoke of the emotional changes that came after 
the pain, which included feeling scared, frustrated and low by the symptoms. 
Patient F described his symptoms as making him feel “isolated from the world”, 
where he was unable to spend meaningful time with his family because he was in 
pain and tired, but that the difficulties he was experiencing with sleep meant that he 
also began dreading going to bed. Patient D highlighted that for her, the symptoms 
had gone from trying to manage a ‘tiredness’ that came with her other symptoms 
and had become ‘exhaustion’, which had cued her to go to her GP for help:  
 
“It was just the fact that I was getting really down with it-
feeling so rubbish, and there was stuff I couldn’t do and 
tired- no not tired- exhausted-I would do the house work and 
then would have to have a couple hours sleep after, as I 
was absolutely physically exhausted. I would have to sleep 
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when I come in from work-have a couple of hours sleep, and 
I thought I can’t carry on like this.” (6) 
 
In this example, Patient D also suggests the impact that managing such symptoms 
had on her mood, and describes a life that similar to patient F had become focused 
around completing priority tasks, such as work, rather than replenishing activities.  
For some even the priority tasks were no longer possible, with one patient sharing 
that the guilt she would feel at not being able to complete the house hold chores 
whilst  her husband was at work, would result in her spraying room spray to pretend 
that she had been doing something, concealing the true extent of the support that 
she needed.  
Patient E described withdrawing from her friends by unplugging the phone 
and getting her husband to open the door and pretending she was not in.  From 
what she described, it was not the pain that stopped her from going out, but more 
the thought she might let someone down by not giving as much as she used to in 
the relationship. Similarly, patient B would respond to her friend’s invitations to go 
out by saying she was busy and unable to go out with her friends or saying she was 
“fine” when people asked her if she was okay. Patient B’s response came from a 
belief that her friends would not understand the fluctuation in how she felt, and she 
reasoned that if the doctors were unable to understand her symptoms, then other 
people would also struggle. Instead she put her energy in to trying to keep her 
emotions down, which would then come tumbling out when someone showed 
concern, and heightened feelings of guilt about the lies she was saying to her 
friends, which she also recognised as preventing them from understanding what 
she was managing. The symptoms also impacted on patients’ partners, with time 
spent either going to appointments with them, reminding them of appointments or 
encouraging them to seek further help when they see the distress of their partner at 
home. With difficulties sleeping and going out socially, patients reported that 
activities shared together with their partner had decreased. The exception to this 
was patients A and E, who spoke with gratitude about the understanding and 
compassion that their partners held for them. This was in contrast to other patients 
who felt that their partners did not understand or believe in the diagnosis they had 
received for their symptoms.  
At the most extreme ends of the extent of impact that the symptoms had it 
varied from patient C reporting that she is able to “just get on with it” and manages 
by keeping busy and keeping moving, to patients A, B and D all sharing that the 
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depths of their despair at going through life with such symptoms, has meant that at 
times they could not see a way to carry on. Patient A describes: 
 
“I mean I do have days where I think I want to end it all, but I 
am never going to do that. I mean you might feel it, but there 
is a difference between feeling that I’ve had enough and 
actually doing something like jump off a roof. No, my life is 
too rich and so is the next day… and that is the sort of 
philosophy that doesn’t make me give up on today.” (30) 
 
Patient D states that it was not just the pain, but managing this alongside 
“other things going on” in her life at that point and thoughts that she had no quality 
of life.  Patient B stated she had taken three overdoses in the past, and now finds it 
hard to trust herself with the medication she is on for her pain and finds it 
frightening that Doctors continue to prescribe her medication for pain rather than 
suggest anything else.  Looking back now, patients wondered to what extent this 
was a side effect of the medication they had been taking, and credit changes made 
to pain medication, increased access to online support, getting a diagnosis, and 
reconnecting with their faith as factors helping to reduce the distress. 
4.4.3 Sub-theme: It controls me or I control it  
Participants spoke of living with the uncertainty of their symptoms. They had either 
been told by their GP that there was no cure for their symptoms and it was about 
trying to manage them, or patients had realised that pain relief was unable to “fix” 
the pain that persisted. Patient F shared that despite him believing that the pain 
cannot be treated with medication that will “work” for his pain, he feels it is important 
to try all treatment options available to him, which included going to have his weight 
and bloods checked if all else had been exhausted. It seemed that patient F took 
comfort in knowing he was doing something in response to his pain, and that 
regular monitoring of his health was still classed as a viable treatment option once 
all else had been tried, as this helped to manage the fear of ‘what if’ the symptoms 
are something new.  Participants C, D and E all spoke of increasing their control 
over the symptoms by gaining understanding about them through their diagnosis. 
Patient C was content with the understanding she had found online and felt a sense 
of control over her pain when she saw that the pain subsided with using a cushion 
under her legs and using pain killers when it was at its worse. Patient D stated that 
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before this point she felt like she was getting nowhere and likened it to “banging 
your head against a brick wall” with the frustration and hopelessness building at 
being told by her GP they were  not yet clear on how best to manage the 
symptoms.  Patient E stated it was the “fumbling about and not knowing” that was 
the hardest part of managing her condition , and that once she had this through a 
diagnosis she felt as though she had control over the condition.  She went on to say 
that she manages the anxiety about what could happen by not dwelling on it, which 
also included not thinking about “death”.  
Patient A and B were also unsure what the outcome would be of their 
symptoms, with patient A stating that he had found a suggestion online that 
symptoms might go into “remission” but he was unsure if it would for him. Patient B 
stated that living with the uncertainty of her condition meant she never knew if she 
was “dying or if you’re not”, because she was living with the belief that her 
symptoms could be signs of cancer. She felt frustrated that she could not find a way 
to exit a cycle she recognised she was in: 
 
“I feel like I’m  a hamster in a wheel- I get up, I think I’m 
going to have bath, put some make up and have a normal 
day, but my life is ‘I’m always going to do it’ [rather than do 
it]. I cannot get off this wheel.” (80) 
 
This extract also highlights the exhaustion that patient B felt from her symptoms 
and the powerlessness that she felt in being able to have control over them.  This 
was particularly evident in her description of having attended a pain management 
class, in which she stated she was being taught how to control the pain, which she 
did not feel ready for, thinking “I cannot help the pain”. 
4.5 Theme 2: Defining the health problem 
Theme 2 refers to the process of making the symptoms visible, starting with a 
search to answer the questions that arise with the experience of such symptoms. 
These are questions that not only the participants have about what is going on for 
them, but also the questions asked by friends, family and the wider system- health 
professionals, insurance companies and benefits assessments. Participant’s 
distress from the symptoms seemed to be heightened by the frustration that these 
were symptoms that are not visible to others and reliant on the subjective appraisal 
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of individuals. Some patients were okay with this, however others found it brought 
with it thoughts of not being believed or that other people were not truly able to 
understand the severity of their symptoms if they had not experienced anything like 
this themselves. There was concern that instead, in the absence of objective tests 
and a disease specific diagnosis, people would make their own assumptions about 
what was happening, which both patient A, B and E felt trivialised the extent of their 
pain.  
Participants spoke of  their sources of support coming from people who had 
lived experiences of the process they were on with managing their symptoms, as 
well as health professionals, other agencies and family members that showed 
active interest in understanding their situation by showing their support in reading 
material and sharing information with them.  This was in contrast to experiences 
prior to their symptoms whereby participants described life experiences that 
involved loss and social disconnection whilst managing increased responsibility for 
the care and needs of others.  
4.5.1 Sub-theme: Getting a label in the search for answers 
Participants spoke of going in to the consultation hoping it would fill the gaps in their 
own understanding. The function of getting this understanding was not only to help 
manage the symptoms, but to provide reassurance from their own fears of what the 
symptoms might be, as well as provide some justification to themselves as well as 
others, for how they were feeling and what they were or weren’t able to do.  Patient 
A showed the most concern that people were presuming his symptoms were “all in 
his mind”.  From what patient A had shared, he had been in hospital with mental 
health problems prior to the onset of his pain, and did not agree with the diagnosis 
he had got in relation to his distress then, which conveyed a wider perception that 
he held, of not expecting to be understood by health professionals.  Similarly, 
patient B was searching for justification and validation of how she felt.  She found it 
unhelpful when she would go to the doctors with new symptoms and be told it was 
her fibromyalgia, as she felt this did not give her an adequate reason for how she 
felt and did not feel that her pain was being understood. She states: 
 
“If someone told me tomorrow I had cancer and it was 
terminal, I would be quite happy with it, because I would 
know then that the illness that I have got, is a reason for 




Her desperation for having “a reason” for feeling can be detected in this extract, and 
that she felt that having a diagnosis for something that she feared would bring her 
some relief from the uncertainty she was living with.  In contrast the majority of the 
participants could identify with the functional label they had for their symptoms. 
Participants reported that having a label was a way to provide symptom coherence 
and visibility to the hidden problems they were managing and gave permission to 
be able to ask for help or decline requests put to them. Patient D explained that 
prior to the diagnosis she would just “get on with it” at work, using tablets to try and 
manage the pain. However since the diagnosis she has been able to provide 
people with information about the condition and speak up about what adaptations 
could be made to her shift to help manage the pain. Similar to this, patient E stated 
she did not feel she could approach occupational health with a “vague set of 
symptoms”, and needed confirmation from the GP before help could be accessed at 
work.  For patients C, D, E, and F, who could identify with the label either they or 
their GP gave to their symptoms, the label enabled them with what they had hoped 
for- validity and symptom coherence, without necessarily needing to know what 
caused the symptoms. This seemed to be where it differed for patient A and B, who 
both felt that the label given to their symptoms by their GP did not help them 
understand their symptoms, but actually prevented them from seeking further 
understanding. Patient A stated:  
 
“…is it fibromyalgia, because yes I have this joint pain, but 
have they just labelled me [with that] to give me tablets to 
shut me up- so that’s my thoughts on it…” (10) 
 
Both patient A and B wondered if the label was more about the GPs lack of 
understanding of their symptoms, with patient B questioning how they could 
diagnose her with having this condition through a blood test alone, stating “ they 
don’t really know its fibromyalgia. I’ve had no scans or anything…” In this respect, 
she firmly holds on to the belief that only a scan will be able to confirm the absence 
of disease.  However, despite not believing in the label, patient B states she has 
joined online forums for the condition. Similar to patient D, both spoke of belonging 
to an online group that they found supportive and meant they were not on their own.  
It would seem that although the label does not meet her needs for understanding, it 
does provide access to the support of others and a sense of connection.  
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4.5.2 Sub-theme: The responses of others 
Patients got various messages about their symptoms from the people around them, 
which at times could be confusing and frustrating. Patient A spoke of his insurance 
company needing to have the diagnosis of fibromyalgia ‘confirmed’ regarding a 
recent claim he put in for an accident. However, this approach was at odds with the 
health professionals that he encountered, which he states “[it] wasn’t about it being 
invisible and saying what it was and wasn’t”. In addition he spoke of his readiness 
to hear what people would say about his symptoms and that with time he had 
become more open to various ways his condition could be understood.  From 
describing his experiences with health professionals, he would initially hear their 
understanding as a judgement that he wanted to rebuff, but with time was able to 
view such professional opinion as an alternative position to consider.  For patient B 
this perception of judgement was heightened even further by the belief that most 
doctors did not believe in fibromyalgia and that they would not be interested in the 
symptoms she was approaching them with:  
 
“A lot of these doctors, without being rude, don’t want to 
know. You walk in and they look at you like ‘what can I do 
for you again’, and you think pardon-their lips didn’t move 
and they didn’t speak to me face. I think they think that 
because quite a few doctors don’t believe in fibromyalgia.”  
(40). 
 
Patient D and E also spoke of feeling judgement from friends and family, 
which came out of their loved ones lack of understanding for what they were trying 
to manage. Patient E spoke of the shame she felt at her colleagues seeing her take 
multiple tramadol at work, and what that may mean about how appropriate it was 
that she was at work caring for others.  Patient D shared that her husband 
commented that “you’re always at the doctors or hospital”, which left her wanting to 
show to him that this was not her fault and she was justified in her actions.  In 
contrast, patient F shared that his family encouraged him to see new doctors, as 
this brought with it opportunity to learn about different treatments that may help him 
with his pain. Such experiences highlight two sides of the same problem, which as 
patient E states occurs “when people around you can’t see what is going on, they 
can’t understand it either”, and instead people just “put on you” their understanding, 
which might not reflect what is actually happening.  
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4.5.3 Sub-theme: Life before the symptoms  
There was a strong sense from all patients that life pre- symptoms contained 
themes of either loss or isolation, and increased responsibility for the care of others. 
These losses were varied in nature consisting of loss of youth, loss of loved ones, 
and loss of social resources.  
 Patient A shared that he had not been able to go out much as he brought 
his daughter up on his own, and described himself as having been a “heavy drinker” 
and “heavy smoker”, suggesting that the priority at that time had not been his health 
and was more about doing what he needed to do to get by.  For patient B, the pain 
that she felt at the death of her mum after 5 years was still raw, and she 
acknowledged the profound change it had on her; “losing me mum was a big big 
impact on me life. I’ve never been the same person [cries]”.  She described herself 
as someone who “would do anything for anyone”, and alongside managing her 
health, supported her friend with terminal illness, as well as her mum.  Themes of 
abandonment and loss, which included her long term job were evident in the 
experiences she described. This was similar to patient E, who also described caring 
for her mum whilst trying to manage her own health needs, work and family life. 
She described having traditional segregated roles within the family and that being 
the only girl, she was expected to take on the caring role of others.  Even in her role 
at work she found she was unable to get the support needed to manage the high 
levels of distress she was encountering and found it preferable working in a lower 
paid job instead:  
 
“I went to work in Primark and it were the best job I’ve ever 
had. It were the poorest paid job I’d ever had but the team 
support-it were fabulous. Better then health professionals 
and things-it were all very back stabby [as a nurse]. It wasn’t 
a particular healthy environment…” (2) 
 
 She spoke of the losses she saw happening around in the environment she 
lived in, with loss of industry impacting on the resources in the area, which included 
the loss of the good reputation that the neighbourhood had. She described that 
people now had to “fight for what they needed”, which included healthcare.  Patient 
F did not directly speak of his experience moving to the UK, but as mentioned in the 
impact that his pain was having on him, he was left feeling “isolated” from the world. 
He had moved with his wife and 6 children and described living in accommodation 
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that he felt had added to his pain and decline in health.  That’s said, he felt 
supported by the refugee centre and felt settled starting a new life in the UK, 
despite having limited wider family around him.  
4.6 Theme 3: Managing the symptoms  
Theme 3 refers to the various ways that patients manage their symptoms. Patients 
spoke of not just responding to their physical symptoms but also responding to their 
perceptions of the GPs as being too busy or not believing the condition that their 
symptoms had been labelled with.  As such, patients described taking an active role 
in managing their symptoms, which was guided by the beliefs they held about them. 
Often management was also being done alongside managing other problems that 
co-existed, which also impacted on the extent to which the patient felt able to get 
involved in managing their symptoms.  Deciding to go to the doctors either with new 
symptoms or existing ones, was influenced by a number of factors that included 
following the advice of others to go to the doctor, the fear of new symptoms or 
increase in type or frequency of pain, as well as going in hope that any changes in 
symptoms would support with developing an understanding of what was happening.  
Patients had mixed views about the role of medication in managing their symptoms, 
with a common view being that the cost of the side-effects was not worth the small 
gains that were achieved in getting pain relief. Other treatments were also 
discussed and are outlined in the sub-theme ‘The tablets don’t work- what else is 
there?’  Common to all patients was a theme of not wanting to feel that they were 
on their own managing their symptoms. In addition to having support from health 
professionals, there were three key areas that were highlighted as important 
sources of support- family, friends and work- that are discussed in turn in the sub-
theme ‘Feeling that I am not on my own with ‘strange symptoms’’. 
4.6.1 Sub-theme: Deciding what is right for you and your symptoms  
All participants displayed a level of active involvement in how they decided what 
explanations for their symptoms was most applicable to their situation, as well as 
deciding  what was the best course of action for them in managing their symptoms.  
Participants spoke of trying to regain control over their symptoms by trying to make 
sense of what could not be medically explained. This was done through directly 
asking questions to health professionals or by looking up their symptoms on “Dr 
Google”, and appraising how applicable this was to their experiences.  Patient C felt 
that she did not need a diagnosis from her GP, as she was content with the 
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explanation and guidance she had found online for her symptoms and management 
of pain. She stated that the symptoms must be either physical or psychological and 
reasoned that as the pain did not appear to change according to how she felt, it was 
likely to be purely physical.  
 In contrast, Patient A had spoken a lot to health professionals about his 
symptoms and was curious about the suggestion from health professionals that 
mood could impact on his symptoms. He reflected that if this was so, then he too 
had also expected that his pain would get worse or better depending on how his 
mood was, which had not been the case. He was unsure how to integrate the two 
perspectives that he held, which was that pain felt like a “physical illness”, which 
might be occurring due to damaged tissue from manual work that he had done in 
his past, but also that his symptoms may also be a form of “mental illness” that 
consists of producing some form of “phantom pain”. He concluded that if some of 
his pain was to do with his mood, then it would need to be “deeper than 
depression”.   
This was similar to Patient B, who although initially stated that she thought 
her symptoms were to do with an undiagnosed cancer, she went on to wonder if her 
symptoms were to do with something “deep within”, as although she does not think 
she is “mental”, she stated “in life you shouldn’t be this sad”.  From what both 
patient A and B described, they entertain the thought that pain could also be 
existing outside of their conscious awareness. An alternative perspective on this 
came from Patient D, who accepted the diagnosis of fibromyalgia as an explanation 
for her symptoms.  Although she was aware of research and comments on forums 
for fibromyalgia that suggested links between childhood trauma and causing 
fibromyalgia, she was not sure how applicable this was to her and did not know if 
some of her childhood memories would be consider a “trauma”.  She believed that 
knowing what caused her to have fibromyalgia was not important, but how she 
managed the symptoms she has now.  It would seem that for some of the patients, 
particularly those who had not yet felt understood and heard, establishing a cause 
or symptom explanation that the person was able to identify with,  was the 
important aspect for their symptom management.   
 
From what patients described, how they perceived the GP and both the type and 
immediacy of the support they were able to provide, impacted to what extent they 
would consult their GP about management options or adhere to the advice given. 
Patient A shared his concern at being perceived as a “bother” by the GPs, viewing 
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them as busy and described himself as taking a “getting on with it yourself” attitude, 
which he applied to managing the pain relief medication he was on. He would 
evaluate to what extent the medication was ‘working’ and if it didn’t take the pain 
away then he would reduce or stop taking what was prescribed. 
 Patient B focused less on managing the medication and was more 
concerned with deciding how best to get the help that she needed for her pain. She 
stated that because she had perceived the GP as “not doing anything”, she had 
needed to go to the hospital. Patient B was concerned that she was not getting the 
scan that she strongly believed she needed for her symptoms to be diagnosed and 
searched to try and get what she believed she needed, regardless what the GP had 
said. 
 Similarly, patient C felt that nothing was “moving forward” with the concerns 
she had raised about her pain, and decided to look up the symptoms herself and 
work out what it could be and how to manage them. In relation to the prescribed 
medication she takes to manage how she feels, she adjusts this according to how 
she is feeling.  Although she recognises it would be advisable to do this under GP 
guidance, she cites finding it difficult to get a GP appointment and get access to the 
help she needs in the moment when she is making the decision. 
  Patient D used the immediate feedback she gained from the online forum 
to help make her decision about coming off of the pain relief she was taking. 
Although she felt well informed by her GP about the possible side effects of the 
medication, with the initial agreement being to monitor for side effects for them to 
review together necessary changes, patient D decided to replace her prescribed 
medication for cannabis seed oil and used it in the same quantity that she was 
taking the prescribed pain relief.   She described the approach she takes with 
symptom management as the following:  
 
“I think it is just a case of trial and error. Try and work out 
what works for you and if it doesn’t work it doesn’t work, and 
if it does it’s a bonus sort of thing.” (40) 
 
Patient E also described herself as a “self-manager” who would learn about 
what was effective management for her through trying out a range of management 
options she came across.  She reasoned that this was a necessary approach to 
take in the relative absence of evidence for the range of options available, and that 
getting actively involved in her management also came from her own 
 90 
 
“discontentment” that things were not happening as quickly as she would like, which 
would prompt her to “say it” when in the consultation with her GP, rather than go 
along with what was suggested by her GP.  
For patient F, the focus was on having access to prescribed pain relief and 
hearing about new treatments available for him to try. He explained that this would 
mean he would get medication both inside and outside of the UK, and would 
request to see different GPs as an opportunity to find out if there were more 
possible options for him to try.  
4.6.2 Sub-theme: Going (back) to see the doctor 
Participants described multiple reasons why they would continue to go to the 
doctors with their persistent symptoms, despite no treatment being available.  This 
included partners who were being affected by the symptoms at night (Patient A), 
new health professionals raising concerns following their initial assessment of the 
patient’s symptoms (patient C), dentist stating it was a problem more suitable for a 
GP to investigate (patient D) and wider family who advised going to different 
doctors to try and find new treatments (patient F).  For patient E, it was not 
necessarily about having encouragement from others to go the doctors, but more in 
the absence of feeling understood by others around her that she sought ‘kinship’ 
with talking to another health professional who she felt with their similar medical 
training would be able to “see through my eyes but not through my eyes” and be 
understood without having to put her pain in to words.  
Changes in the intensity of the pain or frequency were also causes of worry 
for participants and would motivate people to see their GP.  Both Patient B and F 
spoke of feeling “frightened” of experiencing a pain they weren’t ‘familiar’ with, with 
this new form of pain triggering worry about what it could be. It was not just fear that 
seemed to motivate patients to go to the GP, as patients also spoke of hope that 
the doctor would be able to understand them this time and suggest something that 
might make a difference.  When patient A’s symptoms persisted, he decided to go 
back and see the same GP but this time going in to the consultation prepared with 
his research about what it could be. Patient D also spoke of returning to the 
consultation with new evidence, hoping that it would make a difference:  
 
“I was going with different symptoms, like this is hurting 




Unlike patient A, the new symptoms she was experiencing were providing 
patient D with more evidence to support her position that something was going on 
with her health, and returned to the same GP until they reached an understanding 
about what was happening.  Since getting a diagnosis that she can now relate her 
symptoms too, Patient D states that she feels she is now able to manage the 
symptoms without going back to her GP, because ultimately she knows what works 
best for her body.  
4.6.3 Sub-theme: The tablets don’t work-what else is there? 
All patients spoke about the role that medication had in the management of their 
pain.  The type of medication being taken ranged from over the counter pain killers 
and anti-inflammatories that would be taken when pain was acute, to trying various 
prescribed medication such as Co-codamol, Gabapentin and Tramadol. Patients 
varied in their expectations of the medication being able to get rid of their pain. 
Patient A felt that the side effects that came with the prescribed medication 
outweighed the benefits he had seen with taking the medication. He had recently 
been experiencing problems with his stomach, which he attributed to making him 
consider the side effects of the medications he was taking and evaluating if it was 
worth continuing on them, stating “you can’t keep chucking everything in to your 
body and think that everything’s going to be okay”.  He felt that there was an 
expectation of cure from taking the medication, and that this came from the GP 
rather than the patient:  
 
“Don’t just accept the tablets that they give you, because if 
they aren’t working, then don’t take them, because the GPs 
will just chuck everything at you and expect that to cure you-
and that is not the case.” (68)   
 
This extract implies that there is also a perception of it being the GP who 
initiates or maintains the prescribing of medication, rather than it necessarily being 
a request or resistance that comes from the patient.  Patient B also held a similar 
view, that she had a preference not to take medication, which had been heightened 
after her last overdose, yet the response she felt she often received from health 
professionals was “its fibromyalgia and have pain killers”.  For patient B it was 
beginning to feel personal, that despite perceiving that her GP knows “quite a bit” 
about her, having shown the distress the symptoms were causing her, that the 
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response had been to offer her more tablets, which she had perceived as them 
doing “nowt” to help her.  It is likely that this perception is reflective of her wider 
beliefs that she is ‘unfixable’ and that no one can help her with her symptoms.  
In contrast to both these views, patient C described managing her pain 
using a combination of self-management techniques and pain relief when acute. 
She seemed to have accepted the position that she had read online that “nothing 
more could be done” and spoke of following the advice online, rather than 
questioning it further. A similar pattern of responding was also seen when she 
spoke of  the medication she took for managing how she felt, stating that although 
she sometimes wondered about side effects of long term usage, that her doctors 
would have brought it to her attention if there was anything that she needed to be 
concerned about.  This seems incongruent to her actual experience of having her 
symptoms of cancer that she had initially raised to her GP being misattributed to 
growing older, and nearly missed.  In this respect it seems likely that not thinking 
too much about what is happening helps to keep the anxiety low, and the requests 
for other treatment options to a minimum.  
Surgery was another treatment option that had been pursued by one 
patient, suggesting that for him it was still about treating, rather than managing the 
problem.  Patient F stated that he had been advised against this request by his GP:  
 
“The doctors have said that to treat it with surgery it would 
be difficult… and recommend that medication was better 
than the surgery, because surgery on the neck, is not 
100%….I am happy to do anything, just to get rid of the 
pain…”(5) 
 
This extract shows that although the argument is made that surgery does 
not guarantee pain relief, the alternative suggestion of medication is heard by 
patient F as having a higher guarantee of achieving his aim of being rid of the pain.  
This highlights how the suggestion of medication may be put forward to reduce the 
risk of harm and further exacerbation of pain from unnecessary procedures.  
However, the unintentional consequence of encouraging the patient to see other 
less invasive options as equally viable, possibly creates an expectation that the 
medication will be able to treat, rather than manage the pain.  
Having the opportunity to explore alternative medicine was raised by patient 
D and E.  Patient D stated her GP had suggested acupuncture to her, and although 
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this had been helpful she could only get three sessions on the NHS and could not 
afford to pay for it regularly. Patient D stated she felt there were limitations on what 
GPs were able to offer people who had conditions with a broad spectrum of 
symptoms, and had got further ideas on how to manage the pain from an online 
forum.  Both patients recognised that the evidence for alternative medicine was 
anecdotal, but in the absence of anything else having worked were open to trying.   
Although medication was the main management option discussed by 
patients, other management options had also been encouraged by their GP. Both 
patient A and B had been referred to pain management, with varying success. 
Patient A shared that he believed he was sent to pain management to “get some 
understanding” of his condition, but he was not sure.  He still used the exercises he 
had been shown there and shared that the level of validation and concern shown 
with his symptoms; “I believed that they believed”-made him ‘emotional’. Similarly, 
patient B also perceived her referral to pain management to be about furthering her 
own and her GPs understanding of what was happening. She had initially got 
“excited” by the referral thinking she was going to the hospital to see a neurologist, 
and was disappointed when she turned up at the sports centre for pain 
management.  
 
“What I’m trying to do is get some help for this pain-what is 
the point. What is that doing with my pain? The reason for it 
all was to manage your pain, to control your pain. But I can’t 
stand it, because I cannot help the pain.” (78-79) 
 
This referral did not fit within Patient B’s understanding of her pain and 
reinforced a message that she was not being taken seriously.  What did help was 
talking to the physiotherapist at the end, and feeling that she had been seen as “a 
lady who does need help” when she was asked if she was under a mental health 
team.  
4.6.4 Sub-theme: Feeling that I am not on my own with ‘strange’ symptoms 
In addition to feeling supported by health professionals, patients identified three key 
areas in their lives that helped them to not feel on their own with their symptoms. 
First it was having the support of their partners. Patient A stated that he did not 
have “a word to express” how much his wife’s support and understanding meant to 
him, and would not disturb him when he needed to rest. Patient B states that she 
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perceives her husband as not agreeing with the diagnosis she has and has said 
about “getting some money together” to go private for the scan she is requesting. 
Patient D spoke of how although she felt her husband did not understand her daily 
pain, it was him who helped her get the support she needed from her doctor when 
she felt she could no longer continue on, that in the moment of absolute despair he 
was there for her.  Similarly patient E described her husband as “a bit of a star” 
reading up on her condition and talking through things together, stating “If it weren’t 
for him then I would be a right mess”.  For these patients it would seem that 
although it differed to what extent support was felt from their partner, they had an 
ally in their corner in their most vulnerable times.   
The second area that contributed to not feeling on their own was support of 
friends. Patient A spoke of the acceptance he felt from his friends that when he said 
“even the doctors don’t know what causes it”, that they accepted and hadn’t asked 
further questions. In contrast, Patient B did not see the point in speaking to her 
friends about her symptoms, believing that they would not be able to understand it if 
the doctor were not able to.  She found it hard to receive the support that was 
shown to her, feeling guilty and ashamed when she would get upset in front of 
others. This left her in a dilemma of wanting the support of others to go to her 
appointments, but not feeling able to ask for the support.   For patient B she felt 
more at ease accessing support online, and although she did not necessarily 
identify with the diagnosis of her condition, she really valued the support she got 
from the forum, stating that “I’m not on my own-it’s not just me, like when I’m down , 
there’s lots of people”.  Similarly, patient D also spoke of the value she got from her 
online friends she had from the forum.  It would seem that the instant nature of 
being able to connect with others who may understand your pain and be able to 
provide suggesting on how to manage, was more appealing then attending a 
support group in person. She states:  
 
“…there’s thousands online, and so you put a message out 
to the group and you thousands responses back-me phone 
is pinging all the time!” (54) 
 
 For patient D, it was also important that the group was specifically for her 
condition, declining to attend the local fibromyalgia support group that was merging 
with the ME group, as she believed it to be not as relevant hearing about people’s 
experiences of ME. This seemed to strengthen her symptom identity as being one 
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aligned with the fibromyalgia group, rather than in a more general sense of relating 
to others living with long term health conditions.  
The third area mentioned was feeling supported by work. Both patient A and 
D spoke of how work had accommodated their symptoms by either being mindful of 
the shift patterns that were allocated, or being responsive to the requests for 
additional help to meet the demands of the job. For patient D having seen that other 
people are willing to help her at work when she was now asking for it means she 
did not have to push herself beyond what she felt able to do physically, stating that 
“I know me limitations and I don’t push myself in a ‘this is something I need to do 
and I can’t’.”  For patient E, even though she felt work got better “very quickly” after 
having occupational health involved, it was not enough to manage the demands 
she was continuing to experience in other areas of her life.  She spoke about the 
lack of support she had from her wider family, and how reducing the demand of 
work by retiring early was what was needed for her to be able to cope:  
 
“...there’s a lot of stress on me to be a nurse 24 hours a day 
and you’re not allowed to be supported…. It made it out of 
proportion [the stress on the pain]. The best thing I did was 
to stop working, as I couldn’t do all of that without breaking 
up.”  (27-28) 
4.7 Theme 4: What’s important to me in symptom management 
Theme 4 refers to the various aspects of their care that are important to them in the 
management of their symptoms.  Of central importance appeared to be the quality 
of the relationship held between patient and their GP, and the extent to which the 
patient perceived that the GP related to them as a person and that the 
understanding that was developed was just as unique as the individual themselves.   
In the sub-theme ‘Not being seen (as just a patient, a robot or a number)’, the 
barriers and facilitators to feeling heard are also outlined. Patients described the 
importance of building both trust and openness within the relationship and the 
extent to which these aspects are enhanced or compromised by past medical 
history. Dependant on whether this has been past physical or mental health 
problems, patients present two different perceptions on how GPs respond to 
hearing their medically unexplainable symptoms. With having increased access to 
information, patients also spoke of getting more involved in their care, using ‘Dr 
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Google’ to fill in gaps in their understanding. Details on the barriers and facilitators 
of, as one patient referred to it as being an “expert patient”, is outlined in sub-theme 
below and contrasted against more traditional views on the role of the patient and 
GP.  Lastly patients spoke of feeling that their care was being ‘held’ within the 
practice, as oppose to referring on. Patients presented a variety of views, which 
included feeling that more tests were needed to help reach an understanding, as 
well as the opposing position that a series of investigations delayed the process of 
getting on with managing the symptoms. These positions are outlined further in the 
sub-theme ‘‘In house’ management’. 
4.7.1 Sub-theme: Not being seen (as just a patient, a robot, or a number) 
When patients spoke about what was important to them in their symptom 
management, feeling believed was the dominating issue, with differences occurring 
in how patients felt this was being conveyed. Patient A spoke of GPs not seeming 
to “have time” and that sometimes he did not feel that he was believed in what he 
was saying.   Whilst his initial perception of GPs not having time could be consider 
in a literal sense of the time pressures on consultations, it would seem that what is 
being described is more of a feeling of being prematurely dismissed and not taken 
seriously. Such perceptions maybe particularly heightened with awareness of how 
busy GPs are and not wanting to be seen as a bother. This was a concern that 
patient C reported, that meant she found it hard to speak up and share her 
concerns in the consultation in case she was seen as “wasting time or feeling that 
you are being a bit silly”.  
 In contrast, on occasions where patient A has felt understood, he believes 
the difference was that he perceived the health professional to be showing genuine 
concern for him and his situation. That the personal approach taken was conveying 
to him that he was being seen as an individual, rather than a “robot” that has a 
standard way of functioning. Patient D echoed the importance of being treated as 
an individual, rather than feeling that a standard approach was being taken 
regardless of the presenting need. She credited the person centred approach as 
helping to build her own confidence in managing the symptoms:  
 
“It makes you feel a lot better and I would say cared for, and 
more capable of dealing with what you’ve got because you 
know that your opinion matters –you’re not just a patient or 




For patient B and C, feeling believed was about being able to see that the 
GP has a caring manner and is genuinely interested in what they are sharing. 
Patient C spoke of the difficulties she has getting this from the telephone 
consultations that she has for her medication reviews, stating: 
 
“Seeing the expressions, I feel as though I am being 
listened to a bit more when it’s face to face…” (18) 
 
For patient C, she cited telephone consultations as another barrier for her in 
not always consulting with her GP when making changes to her medication, as she 
did not always feel comfortable talking about how she felt on the phone and wanted 
to get a sense of the person she was speaking to before she did.   
Patient E spoke of the importance of having ‘kinship’ with the doctor that she 
sees, which she gets from talking to another health professional about her 
symptoms and builds further by speaking “woman to woman”. From what she 
describes, credibility of her symptoms is supported by the unspoken understanding 
that she perceives as existing between health professionals.  She particularly 
appreciated the gesture shown of her GP considering her for this study, explaining 
it provided her with a sense of feeling valued: 
 
“You know when I got that letter about this study that did as 
much good as two tramadol, because someone was 
interested in me- me as me, rather than a collection of 
strange symptoms…” (42) 
 
This is again similar to the need to be seen as an individual first, and the 
compassion shown for them with their symptoms is likened to a pain relief in itself. 
Collectively, participant’s comments also suggest a level of social pain that 
accompanies the symptoms and is seeking relief. 
4.7.2 Sub-theme: The relationship 
Patients identified two interlinking areas that were important to them in the patient-
doctor relationship.  The first area was feeling that you could trust in the doctor’s 
ability to help you.  Patient A spoke openly about his lack of trust in the medical 
profession in general to be able to “think outside the box” to understand symptoms, 
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which he felt had possibly been influenced by what he has seen in the media, but 
also further reinforced through past unsatisfactory consultations, which included a 
misdiagnosis- “…I just thought, well you don’t really care what you are doing do 
you.”  Patient B also shared a similar scepticism about health professionals in 
general, stating that she believed that “half the time their diagnoses are just so 
wrong”. Her past experiences of caring for her mum during her illness and the 
misinformation she got, as well as her current experiences of her own symptoms 
has contributed to her position of “I’ve got no faith in them”.  As such she finds it 
difficult to be reassured by doctors telling her not to worry about her current 
symptoms or the blood test results that come back to normal, anticipating that she 
will be one of the people that things go wrong for.  For patient B, the difficulties that 
she experiences with getting appointments and seeing a doctor is becoming 
personal, taking it as evidence that “they don’t want to see me no more”.   
Patient C in contrast did not have this perception, despite also having had 
an experience of feeling like her concerns were dismissed. She felt that since her 
diagnosis of cancer, she trusted that health professionals would now follow up her 
concerns if she had any.  This may also be touching on the area of ‘credibility’ and 
that patient C now feels able to speak up and be heard due to what happened 
previously with her symptoms of cancer being initially misattributed to the ageing 
process.  For patient C it was not just about trusting that the doctor would attend to 
her concerns, but also trusting in her own ability to speak up, stating “I now won’t let 
things pass”.  Patient C’s unsatisfactory experience did not seem to have been 
generalised to trusting other GPs, identifying factors that contributed to that 
situation happening- GP was nearing the end of their career, they had a good 
relationship and were a similar age, and she trusted the doctors more than she did 
her own opinion. It seemed that in thinking about the contextual factors that had 
contributed to that situation, she was able to feel a sense of control and 
reassurance that she could trust other GPs with her concerns.    
The other area overlapping with trust, is the need for there to be an 
‘openness’ in the relationship- a willingness to share.  Unlike patient C who felt that 
because of her past diagnosis of cancer her symptom concerns would be followed 
up, patient A talks of this feeling different when the condition is a mental health 
problem.  He felt that his history of depression was the only understanding that was 
being used to make sense of his current symptoms, but that this was not openly 




“Professional people, I think without telling you –they don’t 
want to tell you-it’s more of a mental problem then a 
physical problem....because they think we are going to have 
a breakdown!” (30) 
 
Not only did patient A think that GPs were withholding sharing with him, but 
this was also evident in his own responses to letting his GP know he had stopped 
some of his pain medication. This was about a fear that the approach would not be 
consistent if he had to see another GP, stating that “I’ll never get them [medication] 
back again” if he were to see someone else.  
 Both patient A and E spoke about ‘openness’ as being a personal quality 
that the GP has, rather than it being something that they can be taught in their 
training.  
 
“... The best thing is to have that in your relationship with 
your doctor and know how they view ‘expert patients’, 
because yeah every doctor will see ‘expert patient’ in a 
different light wont they- convenient sometimes, an asset at 
others, and a bloody nuisance- nobody likes a know all!” 
(38) 
 
In this extract patient E seems to hint that GPs might have a particular view of what 
their own role is within the relationship and may differ to what extent they are open 
to having two ‘experts’ in the room exploring the problem.  Patient A feels that one 
factor impacting on this openness is to do with generational differences between 
GPs, stating that it is harder for people to move with the time not necessarily on 
medical advances but on patient communication.  Patient B describes a 
consultation where she felt genuinely cared for by the GP she had seen, that the 
difference had been that this GP was not just there because it was her job, but 
because she genuinely cared and described this feeling as though the doctor was 
saying “I’m a doctor, but I am here for you.  I’m not here because I’m a doctor”. 
For patient E the personal qualities of the doctor were that important to her 
that if she could wait to see a doctor, she would try and ring on a day that she knew 
they were in.  It seems that although a symbiotic relationship is held between trust 
and openness within the relationship- that authenticity and a genuine interest in 
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what the patient is saying have been the crucial foundations for building openness 
and trust over time.  
4.7.3 Sub-theme: Becoming more involved in your care:  ‘Do I really want to 
be taking these?’ 
Ways in which patients got involved in their care was varied. The importance of 
seeking out further information to help build awareness, and increase confidence in 
questioning medical opinion was highlighted.  Patient A commented on the 
changing role of the patient with the increase access to information: 
 
“…It’s not like it was 30 years ago where we’ve not got that 
much available information to us. Now we can actually 
question people in this position where you couldn’t have 
done before.” (21)  
 
Patient B and E also spoke of the importance of reading up and questioning 
what was being suggested by the GP, rather than just taking it without 
consideration of what the side effects might be. Patient A, C and D and E spoke of 
using ‘Dr-Google’, with patient A acknowledging that he recognises you need to be 
careful when using it because the information won’t be “clear cut”.  Patient A and D 
both stated that they rarely bring in their own research to the consultation to discuss 
with their GP.  Patient A states he has done so when he has really needed to- when 
he felt he had not been listened to and to strengthen what he was saying to his GP, 
suggesting that bringing in research might be perceived by some patients as a way 
to increase credibility of what they are saying. In contrast patient C stated that 
although she has been taking medication for the last 30 years, she was not sure 
why and had not thought about the long-term effects of the medication either. She 
wondered if she had remained on them because she was “addicted to them”, but 
felt if this was so then her GP would have informed her and weaned her off.  For 
this patient, it would seem she has a more traditional view of what the role of the 
GP is, and although feels it is important to be involved in your care, stating “you’ve 
got to fight for what you really want” in relation to getting the care you need, she is 
also reliant on the GP to inform her of what she might want to consider. Patient E 
also acknowledges her wariness of being perceived as telling people how to do 
their job. She attributes this discomfort and awareness of who is the person asking 
for help, as being influenced by her past professional experiences where she did 
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not feel as a nurse she could challenge the psychiatrist and concludes “I suppose a 
bit of that settles on you doesn’t it-like dandruff!”. 
Patient D recognises that what the GP might advise as management options 
to consider are evidence-based management options for her pain, which are 
different to the ones she is currently trying.  Although she feels she could discuss it 
with her GP, she admits there is “no research in to it”. This might suggest that a 
barrier for some patients of sharing what they are considering as management 
options, might be the anticipation of it not being taken seriously with the lack of 
evidence base for it. Although this stops patients from sharing, it would seem that it 
does not stop patients from trying to see what works for them.   
Another way of getting themselves heard in their care seemed to be through 
resisting against what was being suggested, not just directly through questioning, 
but also indirectly through changing GPs and not adhering to advice that has been 
given. Patients also described seeing the effect that their word had in the 
consultation and how this influenced their subsequent response. Patient A 
described  a situation where he felt that the GP had not acted on the test result 
information he had given his GP, stating that when the GP had asked for another 
blood test and sample to be done, that he thought he was not going to rush to get 
this done due to how the GP had responded. In this situation it would seem that 
patient A did not know why he was having to repeat the blood test, and may have 
risked thoughts of not being believed. In a different example, patient D spoke of 
going back to her GP and discussing the side effects she was experiencing, and 
that because of the concerns she had raised about continuing, was tried on a new 
medication instead. When the side effects became too  much with that medication 
she went back again and asked what alternatives there were, whereby her GP 
advised her about a TENs machine. With patient D, she could begin to see how 
what she said could influence the consultation and increase her confidence that she 
would be heard. 
Patient E highlighted that there could also be a downside of continually 
being involved in your care and being regarded as an “expert patient”.  She felt that 
whilst she liked being involved, the level of involvement in her care would be 
dependent on the nature of what the consultation was about.  There were certain 
areas that she did not feel were meant for her and was happy to be guided by the 
GP.  She wondered if at times, because her professional background was known at 
the practice, that a “liberty” could be taken with putting the care back on to her, 
rather than assess and treat the problem with her being seen at the practice.  
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Patient E also made suggestions about what else would help her feel involved with 
her care. She requested that GPs provide more information on local groups 
relevant to her condition that she could attend, as well as continuing to be notified 
of any research opportunities. She stated that “being given an opportunity to 
participate in a professional study, you feel like you’ve got some value.”  
4.7.4 Sub-theme: ‘In house’ management  
Patients spoke about noticing how their care was ‘held’ by the practice, rather than 
referring outside primary care, with patient E stating she thought they were “shy” at 
referring on at times. The dominant view was that GPs would refer on when they 
did not know what to do, however there was contrasting views on whether the 
decision to refer on was delayed or appropriate. As mentioned previously, patient C 
felt that referring on would now happen due to her past history of cancer, so did not 
share the concerns reported by other participants.  
Patient A and B both spoke of not getting the necessary investigations they 
felt they had needed for their symptoms to be understood. For patient A this was 
about health professionals not checking with follow up investigations to see if the 
symptoms had been responsive to treatment, leaving him uncertain if the problem 
he was referring to had been treated.  Patient D in contrast spoke of the reverse 
problem, of feeling that time had been wasted going for X-rays and that the same 
diagnosis could have come from the blood test that confirmed it for the doctor: 
 
“She did this blood test and the results came back within a 
week –‘ah yes it’s this’, then a week later…in the space of 
two weeks it took to find out what it were, the pain had gone. 
Whereas it took 4 months going through the x-ray process.” 
(45) 
 
For patient D, she perceived it as the doctor being just as keen to find out 
what was happening and stated it was the Doctor who had “kept on sending me for 
X-rays to find out”. This difference in views might reflect the difference in perceived 
interest in understanding the symptoms and also patient D may not have held the 
same level of concern about the symptoms being indicative of cancer.  
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4.8 Theme 5: The experience of the system 
Theme 5 refers to the patient experience of the system that surrounds both 
themselves and their GP.  This was discussed at a local level, with the difficulties of 
getting an appointment, as well as the wider context of the practice being in a 
pressured and underfunded NHS.  Within this theme, the sub issues identified were 
to do with the duration of the appointment- your 10 minute slot and how both the 
process of getting an appointment as well as the actual 10 minute consultation was 
perceived as impacting not only on themselves and what they felt able to share but 
also the GP’s ability to explain.  Patients also spoke of the issue of the consistent 
inconstancies they saw in their symptom management. Sub-theme (In) consistency 
details the issues highlighted around not being able to see the same doctor, not 
knowing if you can see a doctor, being unable to continue with certain management 
options on the NHS.   Lastly, patients spoke of what contributed to their perception 
that time had been made for their symptoms in the consultation. Details are 
provided on the responses that patient’s valued receiving from their GP are 
provided in the sub theme when time is ‘made’. 
4.8.1 Sub-theme: Your 10-minute slot 
Patients expressed empathy at the pressures they could see that GPs were 
working under. Patient A stated that “It’s not them-bless them- I don’t blame them 
as a person, it’s just the situation that they are in”, recognising that the 10 minutes 
slot he describes being ‘put in’ was a symptom of the system around both him and 
his GP. Patient B comments on the changes she has observed over time, stating 
that GPs no longer have the time that they use to have to explain things.  For 
patient B, her particular concern was the difficulty of getting the 10 minute slot with 
the GP. She spoke of the dread she felt at waking up in pain and having to go 
through the “rigmarole” of getting an appointment, as well as being “frightened” that 
she would not be believed.   
Similarly, patient C also found the process of getting an appointment 
difficult. For her, the barrier was not feeling comfortable speaking to a receptionist 
about the nature of her symptoms to get an appointment. She also found it difficult 
to speak on the telephone consultations that would be done with a GP to review her 
medication.  She explains the impact that this has on her: 
 
“It’s just so difficult to get an appointment and getting to 




Whilst the appointment system may help to reduce the number of 
unnecessary appointments, it would seem for patient C that it colludes with her 
beliefs and concerns about being a bother and trying to manage it herself.  
Moreover, when she does get an appointment she finds it hard to “fit everything in” 
to the consultation, which increases the chances that symptoms don’t get attended 
to in the way that she hopes, for example with the pain she reported in her legs that 
did not get followed up as “it was mentioned alongside something else”.   Patient E  
shares similar concerns, however interestingly comes from the perspective of the 
health professional,  empathising with the GPs for needing to “cram everything in” 
to that window, recognising that the 10 minute consultation window was as much of 
a problem for the patient as it was for the health professional.  
4.8.2 Sub-theme: (In) consistency 
A shared theme among the patient’s interviews was the difficulties experienced and 
anticipated at getting an appointment with the same GP. Patient A stated that “you 
never see the same GP” and this had become the norm that he had just become 
“accepting of”.  He placed this in the wider context of the pressured system, aware 
that this was not just his experience but one felt by other people that he knew of 
also. Patient B and E spoke of the difficulties of calling up on the day for your 
appointment, which may mean you do not see your preferred GP. Patient B 
described seeing someone who was not her “proper Doctor” and that they had 
spoken to her about the possibility of her symptoms being Multiple Sclerosis, but 
states, “We never heard nothing else about that” in the consultations that followed 
with other GPs, leaving the uncertainty of the diagnosis with her.  In addition to the 
uncertainty of getting an appointment with a preferred GP, patient E also mentioned 
the uncertainty of being able to get an appointment when you called.  Overall she 
perceived the changes to the local appointment system at the practice as doing 
“damage” to the relationship with your doctor.  
Patient C spoke of the difficulties she had getting an appointment, citing that 
the practice’ move towards telephone consultations, as opposed to face to face 
consultations was not something she was used to, nor did she use it enough to get 
used to it. She stated “it was always a different one” that she would speak to and 
that her actual GP she hadn’t seen for a long time. As highlighted already in the 
sub-theme ‘Not being seen (as just a patient, a robot, or a number)’, patient C finds 
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it hard to share how she feels on telephone consultations and instead choses to 
manage her medication herself rather than speak to her GP on the phone.  
Patient D’s focus was on the need to be able to access a management 
option long enough to feel the benefit of it.  She had experienced three acupuncture 
sessions that had helped, but she could only have three sessions on the NHS 
before she would need to go back and be referred by her GP or go privately. She 
chose not to because it would take too long. She states:  
 
“Three sessions is not enough… if you’ve got to stop for a 
couple of months whilst the appointment comes through 
again all of the system, you think ‘well I’ve not really 
benefitted because we are starting again from the 
beginning’…You sort of get used to it and then it’s gone.”  
(35) 
 
In contrast to the dominant perspective that seeing a different GP was a 
barrier to getting the care you wanted, Patient F spoke of his concerns that seeing 
the same GP would limit his exposure to finding new treatments. He stated: 
 
“I’ve seen different doctors, that’s one problem is when I 
have to only see one doctor….I call the surgery in the 
morning they decide… I would like to see another GP to 
hear alternative…”  (14) 
 
It would seem that although this is an alternative position to those held by 
other patients interviewed, a similarity amongst all is about having the choice of 
who to see, whether that be the same or different GP- rather than have this 
allocated to you when making your appointment.  
4.8.3 Sub-theme: When time is ‘made’ 
The main issue that patients highlighted as important to their consultation, was 
having interest shown and that this could be conveyed in the exploratory questions 
asked or explanations given by the GP.  Patient A felt that there needed to be a 
difference in the consultation approach taken when the condition had “issues going 
on” rather than less complex conditions. He felt for the former, there needed to be 
more time to enable an explanation to be given, which would help to foster some 
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trust that the doctors were able to make sense of his symptoms.    At its most 
extreme, patient B describes an occasion where she  had gone to her GP extremely 
distressed, but not felt there was time for her to be able to talk “as there were other 
patients in the waiting room”, and made an attempt to take her life.  Although this is 
a rare response, it does highlight how  people’s perceptions of care fluctuate in 
response to not only the GPs actual response but also the person’s own level of 
distress and environmental influences that may heighten certain perceptions.  In 
contrast to this, patient B also spoke of the importance to her that one doctor had 
taken the time to hear her despite it having been a consultation for her step son, 
stating “They asked…they explained …they made time for me”. It would seem that 
patient B had not expected the GP to respond to her request, and that in doing so, 
all be it briefly, the GPs approach left patient B feeling cared for. 
Patient C found that being asked at the start of the consultation what she 
thought her symptoms might be or if she was worried about anything in particular, 
helped her to leave the consultation feeling reassured. She valued GPs talking her 
through what they thought it could be and reasons why they did not think it was 
anything “sinister”.  Patient D also talked about the importance of the questions that 
the GPs asked, and how this encouraged involvement: 
 
“The doctors have been really supportive.... They will ask 
you as well –we think you’ve got this, but what would you 
rather us do to help?” (47) 
 
Patient D spoke of seeing a change in the approach GPs take with their 
patients and that a “modern twist” has been brought in with new GPs –“…they are 
actually consulting me and seeing what I would like”. She contrasted this with the 
experience she has had of being told what she must and should not do by GPs, 
which she stated would result in her agreeing with things she did not really agree 
with just so as she could “get out as quick as I could”, but then would think “oh shit 
afterwards” at what she had agreed to.  In regards to her experiences now, she 
states:  
 
“I don’t get that ‘oh shit’ thought at all, because they involve 
you and don’t like dictate to you that you will have this done 
or you will have that done. They put you more at ease you 
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know…I was worried about this but I’m not now because 
they’ve explained this.” (50) 
 
How the explanation is presented is also important. Patient A stated that his 
experience of only being given a leaflet from the hospital about his condition, had 
left him with unanswered questions that he had not been able to discuss. He fears 
that this is what will happen more widely across services without more funding for 
the NHS.  This experience is in contrast to patient D who similarly was given 
information by her GP to consider at the point of her diagnosis, but that time was 
also given afterwards to discuss the information that she had read.   This might also 
be representing a difference between clinical approaches taken in primary and 








CHAPTER FIVE: GP RESULTS  
 This chapter will begin by providing context for the GP interview data collected and 
pen portraits for each of the GP participants.  The main and subthemes from the 
participant’s data will be presented in a table and supplemented further by rich 
description of the themes presented. Illustrative extracts will be provided 
throughout, with direct comparisons being made between participants reported 
experiences of working with and managing MUS.  
5.1 GP participants  
Four General Practitioners (GPs) were recruited from the 9 GPs that were 
approached with the study at the South Yorkshire practice.  As there was enough 
GP interest in the study to retain the study focus at that practice, recruitment was 
not opened up to the Academic GPs at the University of Leeds.  The recruited 
participants ranged between 35-65years of age. All had a variety of clinical interests 
and duration of clinical practice varied between 8-32 years, as indicated in Table 5.  
Table 5: GPs demographic and clinical interest information  















No 8 years   






No 28 years  




Yes 30 years  






Yes 32 years  
5.2 GP pen portraits 
Similar to the pen portraits completed for the patient sample,  these pen portraits 
aimed to put the individual accounts from the GPs into a wider context of their 
diverse range of experiences.  
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5.2.1 GP A 
GP A had been practicing for 8 years as a GP at the city practice. Similar to 
the other GPs interviewed, she saw that the biomedical model was a framework 
that did not meet the needs of all patients, and she incorporated approaches from 
other fields to inform a holistic, person centred approach.  She feels that her 
involvement with the university and medical student training has also had a focus 
on broadening her perspective on understanding illness, and has influenced her 
clinical practice.  A common thread throughout the interview was the value that this 
doctor placed on establishing collaborative working practice between her and the 
patient, and also between her and colleagues.  She found that this ‘partnership’ 
working, not only with patients but also staff took the pressure off of her to ‘have all 
the answers’, a pressure that came from the expectation of patients at times and 
also an internal pressure to be able to ‘cure’, which had lessened over her career. 
Despite this, there was an uncertainty to what extent patients saw ‘talking’  as a 
management option and would use the examination to help reaffirm what was being 
said. It was noticed that more management options were outlined in this interview, 
with the GP focusing more than any other interview on the issue of overprescribing 
of opiates and role of both prescribed and complimentary medication for this patient 
group.  
This GP seemed to carry the frustrations of her patients and showed a lot of 
empathy for her patients in how she spoke about her experiences.  She was 
instrumental in developing the current research project, and similar to the other GPs 
interviewed, welcomed any additional guidance that could be provided on ways to 
manage MUS at the practice.  It was noted that in comparisons to the other GP 
interviewed, this GP spoke less about the direct impact on herself as a GP in 
managing this patient group and less about the chronic nature of the symptoms.  
5.2.2 GP B 
GP B had been practicing for 28 years as a GP at the city practice. She perceived 
her general practice work as containing a large number of people with MUS- 
roughly 1/3 of the patients she would see in a surgery, and many of her ‘regular’ 
patients she would see would also be considered to have MUS. The interview 
focused a lot on the consultation techniques this GP used to convey to the patient 
that they were being heard, providing containment with a negotiated agenda at the 
start of the conversation and conveying to her patient that they had permission to 
come back and access care without symptoms.   
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 She recalled how the focus during her own medical training was to achieve 
a diagnosis by the end of the history taking, and although she recognised that 
training had changed, she felt it may heighten a doctors’ frustration when working 
with a group of patients that don’t lend themselves to this.  Other challenges of 
working with this patient group that were mentioned in this interview were the 
paradox of seeing the importance of developing the relationship with the patient and 
knowing what was ‘normal’ for them, but not working in a system that enables it, 
which left this GP at times feeling frustrated, exhausted and questioning what her 
function was with managing such symptoms.   
This interview was the only one which specifically talked about the cuts to 
social care and how although practical support was often the area that was 
perceived as making the biggest difference to her patients,  the unclear referrals 
pathways and variability in availability made it difficult for people to access or 
referrals to be made.   She came across as a GP that placed great emphasis on 
nurturing the relationships she had with her patients and had more traditional views 
and experience  of the GP being embedded within the community and being able to 
link patients in to relevant community projects. Similarly to GP A, there was a sense 
of not knowing if something was the right thing to do with understanding and 
managing such symptoms, but going with what felt right and what made sense in 
the context of the patient’s range of life experiences.   She spoke of the importance 
of learning about things through training and valuing learning, but also recognising 
that the pressures on clinical time made it hard to apply any thoughts about what 
might work in clinical practice.  
5.2.3 GP C 
GP C had been practicing for 30 years as a GP at the city practice, before retiring 
two years ago.  In addition to general medicine, he identified that he was also 
interested in social and psychiatric health, explaining that he started his career 
covering a list of patients with “classic psychiatric” problems, and over time moved 
into more “psychologically based problems”, which he felt medically unexplained 
symptoms came under. He reflected a lot on the changes that he had seen in the 
area and in turn the diverse patient population that the practice served, as well as 
the changes seen in the health care system from continuity of care to a split up 
system of care with many points that the patient could now enter. 
 Compared to the other GPs he spoke more about the challenges of 
diagnosis, particularly with seeing patients over a long duration and the increase 
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risk of disease pathology being missed or overshadowed by MUS. For him there 
was particular concern that missing something reinforced the existing distrust that 
he perceived the general public to have towards the medical profession, as well as 
the patient’s own beliefs that really they have got a serious problem that is not 
being attended to properly. In addition this interview also focused more on how 
system protocols perpetuate the problem, and the need but also difficulty of working 
to isolate the ‘problem’ with different levels of the system.  There was a clear 
interest in the local and wider system that operated around the patient and GP, 
providing reflection on how the move towards increasing service accessibility 
challenges the traditional model of care.  He came across as a GP that placed great 
emphasis on understanding how the system influenced the narrative that his 
patients came with about their symptoms, and spoke of the importance of working 
with the system- which included partnership working with colleagues across levels 
of the system and also where possible with the patient and their family.  
5.2.4 GP D 
GP D had been practicing for 32 years as a GP at the city practice, before retiring a 
year ago. His identified clinical interests were in medical education and also 
diabetes, but stated that he had also thought a lot about the difficulties of managing 
medically unexplained symptoms.  For GP D, the difficulty of general practice did 
not come from diagnosing, but holding the uncertainty around a patients symptoms 
and trying to maintain the patient-GP relationship.  He spoke of the ability to 
achieve both as fluctuating according to the backdrop of pressures GPs have to 
work under. He spoke openly about his curiosity declining with the repeat exposure 
to ‘self-limiting’ illnesses over a long career, which he believed had prompted his 
retirement. Unlike other GP interviewees he also raised the issue of general 
practice potentially being an isolating experience for a GP, with little contact with 
others, outside of seeing patients. For him it was important that time to connect with 
colleagues was built in to the day, and he spoke fondly of the daily coffee break that 
would happen, with colleagues supporting one another if they were running behind, 
to ensure there was an opportunity in the day for all to come together.  
This was one of the shorter interviews, which despite sharing the breadth of 
the themes that were raised in other interviews, may have lacked the depth and 
deeper exploration of the issues raised. He came across as a GP that held a lot of 
compassion not only for his patients but also the team he worked with and 
recognised the importance of staff connection with one and another.  
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5.3 Results from the GP Interviews:  
Data from all four GP interviews were included in the analysis. The five main 
themes were based broadly around the conceptual framework of clinical decision 
making, and consisted of:  symptom beliefs and expectations, diagnosing the health 
problem, managing the symptoms, professional preferences, and the experience of 
the system as a GP.  The conceptual framework used to analysis the GP data was 
the same as the conceptual framework applied to the patient data, so as to aid 
comparison and contrast between the participant groups. The contribution of each 
participant to each theme and subtheme is indicated in Table 6. The main themes 
and the subthemes that were found to contribute to them will now be outlined.  
Table 6:GP themes and subthemes and frequency of utterances by GP   










SYMPTOM BELIEFS AND EXPECTATIONS  14 34 33 14 
Symptoms will be complex and chronic  1 12 11 2 
Facing the brick wall and rolling a stone up hill forever 
after  
4 12 13 5 
It is real, but what I think is going to help is more with 
your mood 
6 5 5 5 
The uncertainty of getting through the barriers 3 5 4 2 
DIAGNOSING THE HEALTH PROBLEM 13 18 14 12 
Culturing Curiosity  2 8 3 4 
Negotiating different frameworks 6 8 10 5 
The weird and wonderful sounding [medical] names 5 2 1 3 
MANAGING THE SYMPTOMS 23 12 11 13 
Reducing additional risk  10 3 3 5 
Maintaining the relationship: knowing the person and 
giving permission to access care 
2 4 2 5 
Providing a credible alternative narrative 11 5 6 3 
PROFESSIONAL PREFERENCES 23 9 9 11 
Holding the uncertainty   6 2 2 4 
Openness, honesty and understanding 7 6 5 4 
Tackling the problem together  10 1 2 3 
THE EXPERIENCE OF THE SYSTEM AS A GP 18 14 18 13 
The priority of access over consistency 9 6 11 7 
Finding protection against the pressures 6 6 2 2 
Needing more time and resources  3 2 5 4 
5.4 Theme 1: Symptom beliefs and expectations 
Theme 1 refers to GPs general perceptions of the medically unexplained symptoms 
that their patients present with.  A dominant belief was that the physical symptoms 
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reported by the patient would be made up of psychosocial factors that patients 
would not necessarily connect with their symptoms.  GPs expected that the main 
focus of their work would be concerned with supporting patients to make and 
accept this connection.  However, the extent to which these could be thought of as 
the ‘cause’ for medically unexplained symptoms varied among the GPs interviewed 
and is detailed in the sub-theme ‘It is real, but what I think is going to help is more 
with your mood’. Also highlighted are GPs perceptions that the symptoms are often 
going to be complex both in understanding and how they are managed, and that 
these symptoms were likely to exist for the duration of their relationship with the 
patient.  Implications of such are discussed further in the sub theme ‘Symptoms will 
be chronic and complex’.  The impact of managing such complex and chronic 
symptoms are also discussed in relation to the pressures GPs reported as coming 
from the patient, their own internal pressure and the system around both patient 
and GP, and are outlined further in the sub theme ‘Facing the brick wall and rolling 
a stone uphill forever after’.  Numerous barriers that GPs were trying to find ways to 
overcome were identified in the sub theme ‘The uncertainty of getting through the 
barriers’, and details are provided on the different perceptions and approaches 
taken to managing such barriers in the consultation.  
5.4.1 Sub-theme: Symptoms will be complex and chronic 
GPs spoke of a number of factors that contributed to making medically 
unexplainable symptoms a clinically complex area to manage. Firstly, such 
symptoms were recognised as not fitting within the biomedical framework of having 
a symptom underpinned by a disease.  GP A talks about their own level of comfort 
with thinking outside of this framework to understand what the patient is presenting 
with.   Similarly GP B shows this level of comfort too, stating that she spends time 
“unravelling” the symptom to expose and address the psychosocial issues that she 
often finds are associated with the physical symptom.  GP C reflects on the difficulty 
of being able to do this, stating “…the difficulty is then that you have to sift out the 
different symptoms and where they fall”. For GP C, this appeared to be where they 
fell in relation to being either psychological or physical in nature, as well as 
distinguishing the medically unexplained symptoms that could also be co-existing 
with “real” physical symptoms.  
Patients with MUS, who the GP participants were able to recall readily in the 
interviews, appeared to be individuals who regularly attended with symptoms that 
were hard to objectively measure, and who would present for help but did not 
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enable GPs to give it.  In addition, GP B perceived there to be a difference in which 
patients were likely to give gifts to their GP stating “not many of our patients give 
gifts but, so it’s interesting that these patients do”.  For her the function of the gift 
buying was a complex range of factors that she hypothesised could be as simple as 
a thank you after having seen them for many years, but for others she feels  it could 
also be a “ ‘don’t let me go, carry on making sure you do everything you can for 
me’”. From what GP B describes, the gift buying itself then becomes a ‘symptom’ of 
the underlying issues for some of the individuals she sees.  
In contrast, GP D spoke of ‘clues’  in the physical symptoms patients 
reported that may suggest it is likely that initial test results will come back as 
normal: 
 
“Your common problems –chronic pain, recurring 
headaches, recurrent abdominal pain, [and] fatigue erm with 
people who have also got- I know from the life 
circumstances -that they have got other problems.” (2) 
 
Despite such clues, the area of MUS is further complicated by patients 
potentially presenting to health services with acute exacerbations of chronic 
problems. GP C explains that problems arise when the patient presents in different 
parts of the system and neither the patient nor treating clinician may make the 
connection that the current presentation is related to a chronic condition, which then 
triggers a further cycle of investigations.  Conversely, examples were also provided 
from GPs of the concerns that a long-term rapport could also reduce their ability to 
detect new symptoms. This rapport often came after many years of seeing patients 
as part of their management of their symptoms.   
GPs described working with their patients over a long period of time, and 
tried to develop a good rapport that at its best enabled the process of improvement 
to be seen in symptoms or functioning, and at its worst has brought increasing fear 
that a symptom will be overlooked.  GP B spoke of seeing one patient for nearly 20 
years and that it had become “quite hard to see her fresh each time”.  GP C also 
speaks of the difficulty of remaining open and alert to new symptoms, particularly 
when the patient’s initial symptoms have been considered as medically 
unexplained: 
 “You start wondering towards the end of your career which 
one of them is going to develop something else and you are 
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going to –in inverted comma’-‘ignore it’ because it’s part of 
their picture of their MUS.” (19) 
 
Overall, such accounts highlight the complex balance that GP’s are trying to 
establish in MUS management. GPs need to make sure that they do not disregard 
their core biomedical framework to treat new or existing disease pathology but also 
be open to exploring alternatives, and although a well-established rapport can have 
the benefit of knowing what is usual for your patient, caution is needed that an 
existing understanding of the symptoms does not over shadow new ones. 
5.4.2 Sub-theme: Facing the brick wall and rolling a stone uphill forever after 
GPs spoke of the exhaustion and often frustration that often went with managing 
complex patients with medically unexplained symptoms. One direction of frustration 
was at the system, which at times felt like disjointed care was being provided at the 
cost to both the NHS and the patient.   GP C spoke of the impact that unnecessary 
procedures had on the understanding he was trying to develop with his patient and 
had meant “going several stages back” in their understanding. GP D in contrast 
stated that his frustration was at the system not recognising and appreciating the 
work being done with the type of patients that “you are never going to get a physical 
answer for”- where you are unable to objectively measure symptom outcomes. That 
systems that are concerned with looking for certainty in this patient group only 
maintains the problem, which he compares to being “like rolling a stone up a hill 
forever after”.   
One area of frustration that was described by the GP participants was the 
feeling of being “stuck” and under pressure to move the conversations on in the 
consultation.  Both GP’s who were currently practicing (GP A and B) spoke of the 
frustrations that could come with not feeling able to move the conversation about 
the symptoms on for the patient. For GP A the obstacles to this were cultural and 
language barriers that made it hard for explanations to “land”, as well as the 
experience of a more extreme example whereby the patient continues to push 
against the time constraints of the appointment, which meant that this became the 
issue that was eventually attended to. GP B described a similar example of a 
patient who had become stuck in the search for an answer for his pain and was not 




“He was stuck with the fact that we were missing something 
still…therefore when we said there wasn’t any other 
management to offer apart from physiotherapy and 
analgesia, he couldn’t get pass the fact that he felt 
something was being missed.” (12) 
 
This extract suggests that part of the ‘stuckness’ that was arising may have 
been due to this patient wanting to find a treatment and fix from his pain, rather than 
management options that could improve functionality.  GP B found that this left her 
feeling “exhausted” after the consultation and questioning what her role was in his 
care, as she felt she had not been able to “give him anything” as he had not given 
her the opportunity to speak.  GP C suggests that where it has not been possible to 
match the patients’ health beliefs to his own, then one mutually agreed end point 
might be to stop seeing each other, stating “it’s time for both of you to move on, 
they [the patient] need a fresh start.”  
Both GP C and D referred to their being an internal pressure to get their 
symptom understanding ‘right’, which came from a place of concern that a 
misdiagnosis could undermine the trust, not only of themselves but the wider 
medical profession. For GP D, he outlined the pressure that he feels “comes both 
ways”, not only coming from the patient with their expectation that you will be able 
to label the symptoms and draw them together, but also the internal pressure felt as 
a GP to be able to do this and wondering ‘have I missed something?’.  
5.4.3 Sub-theme: It is real, but what I think is going to help is more with your 
mood 
Participants varied in the extent to which they would consider psychosocial 
variables to be the cause of medically unexplainable symptoms, but did appear to 
agree that psychosocial factors were involved and without question felt it was 
appropriate the person was seeking support.  GP D explains that regardless of a 
cause being identified it did not make a person any less justified in seeking help, 
stating that where symptoms were having a “big impact” on their lives and making a 
person “miserable” was enough justification to be seeking medical help.  
A key area that GPs felt to be important in the MUS consultation was 
supporting the patient to make the connection between their physical symptoms 
and the impact of past or current significant life events. Although GP B perceived 
that trauma was likely to be associated with such problems, she cautioned that she 
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would be “reluctant to suggest to them that this is the whole picture”, alluding to the 
inaccuracies of suggesting a linearity between the experience of trauma and 
physical symptoms as an inevitable response, without taking in to account other 
mediating and protective factors.  GP C echoes this in his view that complex 
problems such as MUS need to be put in to the “entire context” of the person’s 
situation as opposed to a very “brief context” for more simple problems.  
Patients were thought not to make connections between their physical 
symptoms and psychosocial context, which GP participants attributed to being 
either a protective psychological defence or that cultural factors did not permit 
people to talk openly about how they felt. GP C states:   
 
“…women in different cultures have different freedoms to 
express themselves… and frequently for both men and for 
women there are parts of the story that we are either 
unconsciously or consciously suppressing” (12) 
 
Similarly, GP D held the belief that generally speaking where a patient is 
using a non-European framework to make sense of their symptoms, it would not 
allow for physical symptoms to be due to psychosocial causes.  In general he 
perceived that even though many will come with terrible psychosocial trauma “they 
can’t make the link between that and the physical symptoms”, however did 
acknowledge that this may also be effected by the education levels of a person and 
that where people are more educated there may be a  more ‘sophisticated’ 
understanding of the mind and body.   
That said, GPs spoke of the importance of helping patients to accept the link 
between mind and body in the explanations they would provide to the patient. Both 
GP A and D made references to a model of reattribution, which GP D described as 
a process of “shifting the agenda from physical symptom to psychosocial context 
that the patient is in, and getting them to make the link between those things”.  
Rather then it be the GP providing the explanation, GP A and D explain that 
patients are encouraged to do this themselves, as GP A states “it always sticks 
much better than if you plant an explanation on their plate.”  This description of 
“planting the explanation on their plate” suggests an acknowledgement that 
although the GP may feel like they are giving the patient something, it will only be 
meaningful if the patient is ready to receive what is ‘put on their plate’ and can 
integrate it in to their existing beliefs about the symptoms.  Both GP A and C stated 
 118 
 
that only once this connection has been made by the patient would the option of 
psychological support be introduced. GP A reflects that learning how to approach 
the option of psychological support for the individual is something that has come 
over time and finding the language to use to reduce any inference made by the 
patient that she is saying they are making up their symptoms.   
5.4.4 Sub-theme: The uncertainty of getting through the barriers 
The GP participants spoke of the factors that contributed to their uncertainty of 
being able to overcome the barriers they encountered with some patients who had 
MUS, as well as what they have found helpful.  
GP A described a frustrating situation where she had been unable to 
develop a working partnership with a patient who was consistently turning up late 
for appointments. She had managed this by speaking honestly to the patient about 
the difficulty she was experiencing establishing a partnership, but instead of 
opening up the conversation as hoped and exploring the barriers together, the 
patient had responded negatively and the relationship broke down.  For GP A, 
although the approach had not gone as she had hoped, it was important for her to 
try and challenge the general perception that she felt was held by other GPs 
stating: 
“I am aware that some Doctors might [think] ‘nothing we do 
is going to make them better’ and can take a short shrift 
type of approach to them, and I do get a bit annoyed with 
that because it doesn’t help the patient and just moves the 
problem on to someone else.” (96) 
 
GP B also showed a similar determination to try and overcome the barriers 
that presented in her consultations. In the absence of not knowing what else to do 
with one patient who had not responded to her attempts to focus the consultation, 
she reflected on what she needed to feel more able to contain the patient. She 
spoke of using a double appointment to provide a 10-minute consultation, building 
in time for “self-protection” for herself. This GP wanted to make it clear that not 
telling the patient that they had a double appointment was “unusual”, and that she 
would “pick and choose” what she shares with the patient based on her 
understanding of them and their need.  It would seem that for this GP, she thought 
about what she needed to be able to maintain her energy and commitment of 
hearing the patient and finding other options to overcome the moments when her 
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“most effective ways of getting to the heart of the matter” were not working for the 
patient.  
Both GP C and D spoke of the difficulty of being able to help a patient once 
a cycle of investigations had begun. The help that was being referred to, was as GP 
D said being able to “produce a different narrative” for the patient, that could help 
position them away from referrals and investigations.  He spoke of this being 
particularly difficult when a patient’s illness framework varied considerably from the 
Westernized framework of illness that he held, stating that “it’s almost like a 
personality change that you’ve got to effect”. 
Overall there seems to be variation in the collective opinion of who is 
responsible for overcoming the barriers experienced in the consultation, from a joint 
approach whereby both GP and patient construct a way forward together, to one 
where the GP feels the weight of responsibility for finding a new way to overcome 
the challenges.   
5.5 Theme 2: Diagnosing the health problem 
Theme 2 refers to the process of building an understanding of the presenting issue, 
which is shared between the GP and their patient.  In the sub-theme ‘Culturing 
curiosity’,   GPs spoke of the various ways they tried to broaden their own 
understanding of symptoms that challenged conventional medicine, curious to find 
the context that may help explain the symptoms.  The effect of time and clinical 
exposure to similar symptom presentations is also considered in relation to what 
effect this might have on understanding the problem.   
The challenges that the GPs described of developing an understanding that 
was shared between both them and their patient is described in the sub-theme 
‘Negotiating different frameworks’.  The main presenting focus for GPs was wanting 
to make sure that their patient felt heard, and details are provided within this sub- 
theme on the various approaches that they used and the barriers and facilitators 
experienced.  In addition, GP’s spoke of the function of the labels that cluster 
together medically unexplained symptoms and how it could create understanding 
for some patients and not others.  Further details on the individual variation seen in 
patient receptiveness of functional labels is outlined in the sub-theme ‘The weird 
and wonderful sounding [medical] names…’, along with consideration of what role 
such labels have for the GP working in a medical system.  
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5.5.1 Sub-theme: Culturing curiosity  
Retaining curiosity about the symptoms that were being brought in to the 
consultation seemed to be an important factor for the GPs interviewed. GP A 
described seeing how on some occasions the medical model was “not serving the 
patients well”, which had encouraged her to explore other disciplines to see what 
other approaches could be taken.   
Similarly, GP B also spoke of “drawing on everything” to help build up an 
understanding of the presenting issue, but for her the “everything”  was in relation to 
exploring life circumstances of the patient to inform the approach taken.  For her, 
the indication that she needed to take this approach was when she felt she and the 
patient were getting “stuck”, she states:  
 
“I’m not going to unpick everyone’s past in a 10minute 
consultation when everything seems to be going alright, it’s 
when you feel like you are getting stuck and when you feel 
like they are presenting stuff that you are not explaining … 
your agenda is different from theirs and something needs to 
happen… “(52) 
 
From this extract, it would seem that she would open up the consultation focus 
more, when the focus began to feel too narrow for both her and the patient to move 
together.  
GP C also speaks of the importance of putting the issue in  the context of 
the person’s life story and belief system and that this can often give clues early on 
to “which direction the symptoms are heading in”. For him, he describes this as 
being “the single most important thing in any consultation”, yet that it can become 
overlooked in the pressure of work to get an “end result”.  Although this pressure for 
GP C is unclear where it is coming from for him, GP B perceives that there is a 
preference in the medical profession to be able to say what it is and be able to talk 
with greater certainty about what the patient might experience, which at worst could 
risk misdiagnosis.  
In addition to such pressure making it difficult to keep the person in context, 
GP D states that this becomes easier with time and experience, but that beyond a 





“Your skill improves over a period of time and then there is 
certainly the evidence that GPs in my age group get less 
good at it and are more likely to make mistakes-they get 
inured-they see so much minor self-limiting illness that they 
get complacent-that’s why I retired really.”(22) 
 
The extract illustrates how curiosity and confidence both increase with experience, 
but that familiarity of particular symptoms built up over many years may make it 
harder to retain the curiosity that contributes to being truly able to hear the  person 
as well as their symptoms.    
5.5.2 Sub-theme: Negotiating different frameworks 
GPs spoke of various ways they tried to manage the differences they perceived as 
occurring between their beliefs about the symptoms and their patients’. The main 
concern for the GPs appeared to be about making sure their patient felt heard. GP 
A stated that difficulties occur when patients get fixated on one type of framework or 
possibly feel “threatened” by a biomedical approach and decide to reject what is 
being suggested.  She suggests that maintaining the dialogue between herself and 
the patient is needed to be able to move things forward, and tries to be “open 
minded” to the way a patient maybe making sense of their symptoms, even if she 
does not necessarily agree, stating “if you dismiss them out of hand then you’re not 
giving the patient a good service.” However, she described being “stuck in a rut” if 
there was no willingness on the patient’s part to also keep the dialogue open.  For 
GP C, where differences were noted between his understanding and his patients, it 
was about trying to “tease out” what needed to happen to match his patient’s 
symptom beliefs against his, which did not always work for clients who did not 
share a European understanding of health and illness. He reflected for one patient 
that the explanation he had provided for her symptoms had not been that helpful, 
which he reasoned was because of her “deep seated beliefs” that meant she turned 
back to her own beliefs, rather than take on “a very European based belief set”.   
Both GP A and D spoke of using the model of reattribution to support 
patients to open up their focus of symptom understanding from the physical to 
psychosocial causes.  However, GP A states that one of the difficulties of doing so 




“…quite often it can be quite hard to find a reason for it and 
then that explanation just does not wash-‘well I don’t feel 
stressed’, and even to point out… you get ‘yes, but l I don’t 
feel stressed’, and then that tent will fall flat.”(71) 
 
Where patients had physical health symptoms that co-existed with medically 
unexplainable symptoms, this also added an extra layer of complexity. GP C spoke 
of trying to delineate these problems from each other where possible, and provide 
reassurance by building an explanation based on the physical health checks he 
would do in response to the patients’ concerns.  Remaining open to reviewing the 
current understanding of long term medically unexplained symptoms and displaying 
this to the patient was also perceived as important.  GP B describes the subtlety of 
the signs that cued her in to re-taking and listening again to one particular patient’s 
history: 
 
 “Normally she smiles at me and she pats my hand and says 
thank you doctor, and it was different this time…” (56) 
 
For this GP it had been important that her patient, who did not speak 
English, was able to convey her dissatisfaction and see that it would be heard and 
understood. In this instance the barrier of language was overcome by attending to 
the nonverbal communication occurring between this GP and her patient, and that 
an understanding of each other had been built over time.  
5.5.3 Sub-theme: The weird and wonderful sounding [medical] names… 
There were various views about the function of the terminology that gets used in 
reference to medically unexplained symptoms, and how the terms varied over time 
and context. Generally, the participants questioned the extent to which labels 
ascribed  to medically unexplainable symptoms were done so to support patient 
understanding of their symptoms or were reflective of the pressures felt in the 
health system to provide a diagnosis. Both GP A and C made references to this 
being a distinctive group of patients that has been recognised across different 
specialities, with many different ‘headings’. However, GP A questions the 
helpfulness of the language used to refer to such symptoms, not only questioning 




“I don’t think it serves the patient or us particularly well, 
because it is making something sound very medical, when 
what they are saying actually is there is nothing medical 
here.”(39) 
 
GP A felt that a decision had to be made about whether giving a label to 
otherwise medically unexplainable symptoms would help people to understand, or if 
this was going to reinforce already entrenched illness behaviour in the patient. For 
her, she perceived this to be a tension that also existed for the commonly used 
terms in primary care, such as ME or fibromyalgia, whereby it was helpful to some 
patients but by no means all.  Similarly, GP D also spoke of the individual variation 
seen with ‘fibromyalgia’ and how for some it had been an acceptable label that had 
been enough to help manage their symptoms, but for others, particularly where 
there was co-existing anxiety or depression,  it heightened their distress, perceiving 
the inference to be that it was ‘all in their head’.  
Not being able to provide a diagnosis went against the traditional medical 
model that most of the GPs participating in the study had experienced in their 
training. GP C states that the model she had been “brought up with” came with the 
expectation that diagnosis could be given at the end of taking a medical history, 
which medically unexplainable symptoms challenged.  This was similar view to GP 
D who also shared that he perceived the role of the GP to be about being able to 
“Label the symptoms, draw them together and label it”, and that if you couldn’t then 
this became difficult trying to create an explanation that could move the patient 
away from referrals and investigations.  
5.6 Theme 3: Managing the symptoms  
Theme 3 refers to how GPs respond to patients whose symptoms are medically 
unexplained. As there is no disease pathology to treat for these symptoms, GPs 
spoke in terms of how they supported patients to manage their symptoms.  Getting 
to a point of management, rather than treatment, came from GPs providing an 
explanation that the patient could identify with and was reassured by.   As detailed 
in the sub-theme reducing additional risk, a key issue was the duty of care to not 
harm patients, which GP’s identified as having for their patients and took steps to 
inform patient’s decisions about taking complimentary medicine, monitoring and 
intervening with opiate use, preventing unnecessary investigations, and seeking 
 124 
 
further support and opinion from colleagues to verify their own understanding of the 
complex symptoms.  Having a good working relationship with patients was deemed 
as one of the most important aspects for understanding and being able to manage 
the symptoms. In the sub theme ‘maintaining the relationship: knowing the person 
and giving permission to access care’, the barriers and facilitators to maintain the 
relationship are discussed in relation to the patient and the system of care that they 
are in.   GPs spoke of needing to provide an alternative explanation that could 
reassure patients about their symptoms and show that these symptoms were being 
taken seriously. The role of the examination, referring internally within the practice 
for second opinion and referring for psychological review are all detailed the sub-
theme ‘providing a credible alternative narrative’ . In addition, not only is this 
discussed from the position of the GP providing the credible explanation, but also 
the GPs response when this comes from the patient.  
5.6.1 Sub-theme: reducing additional risk 
The central issue was the duty of care that GPs held for their patients, with GPs 
reporting various stages in the management of medically unexplained symptoms for 
additional harm to occur.  One aspect was regarding complimentary medicine and 
the limited evidence base for the range of management options patients were 
seeking, as well as the lack of evidence base in general for treatments that help to 
manage MUS.  Although GP A could appreciate the value that complimentary 
medicine could have, particularly in encouraging a holistic approach to be taken, 
she also felt it could be “dangerous” if the patient pursued this at the exclusion of 
other areas, or without considering the risks.  
GP A describes managing this uncertainty by providing patients with the 
information she has, stating: 
 
“I will give you all the information and at the end of the day it 
is your choice...if they’ve got capacity then it’s their right to 
make what we may see as bad choices, and you just have 
to say well I’ve given you all the information and what you 
decide is up to you.” (12) 
 
It would seem that this was about supporting the patient to make an 
informed choice with the information available, and that in times of uncertainty it 
was important that the decision came from the patient.   
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Similarly, in addition to the risks of patients only pursuing an alternative 
therapy route, GP A also spoke of the risk of patients solely pursuing medication, 
particularly opiates and the associated risk of addiction. She described the position 
that she took with discussing management problems as consisting of “I don’t want 
to cause you more problems”.  GP A also recognised that it was not necessarily 
patients that were always asking for medication, rather it might also be GP’s 
responding to the pressure to “do something” to end the consultation. She states: 
 
“It is the easiest thing to do, to write a script. Much harder to 
just listen and avoid the temptation to write scripts out, 
because that’s erm [it] gets them out the door but doesn’t 
solve the problem.” (90) 
 
For GP B, C and D the concern was the risk of repeating an unhelpful cycle 
of investigations, and balancing this against the other risk of missing new disease 
pathology. GP D described that part of his job was to “protect the patient from really 
intrusive, painful, sometimes dangerous investigations”.  Both GP B and D spoke of 
trying to manage this in the explanation that was given about the symptoms, whilst 
also trying to listen for new symptoms that the patient might describe.  For GP D he 
spoke of incorporating the results from the preliminary tests that were done, and the 
medical history collected to build an argument that could position the symptoms 
within a psychosocial context and contain the problem within primary care.  He 
describes taking a direct approach with the patient about what he thinks the 
problem is related to: 
 
  “You know this is what I think is happening, we’ve done 
these investigations and they are all absolutely clear, I note 
that you’ve had this very difficult time recently…” (16)  
 
Reducing risk to patients was not the only consideration, but also reducing 
the risk of additional stress amongst GPs.  As detailed in the theme “the experience 
of the system”, GP D highlights his perception of general practice being an isolating 
experience at times, and that it was important to build in time to de-stress with 
colleagues. In reference to managing the complex nature of MUS, he states that he 
values  “sharing the load” with his colleagues, getting advice and second opinions 
from them, which helped to provide a “fresh look” at otherwise chronic symptoms, 
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and that doing so also was about “reassuring the doctor that their judgements are 
okay”.  
5.6.2 Sub-theme: maintaining the relationship: knowing the person and 
giving permission to access care 
The doctor-patient relationship was a key factor that GPs identified in enabling them 
to understand how best to help the patient manage their symptoms. Similar to what 
other GPs described as ‘having enough context’ for the symptoms, GP A also 
states that before you have a “deep understanding” of how the patient makes sense 
of their symptoms, then you are unlikely to get anywhere with discussing 
management options.   For GP A, this made it difficult for her to be able to say what 
management options she would be considering exploring with the patient, stating “I 
think it depends on the person I have in front of me”, with management options 
being guided by what the patient’s preferences are.  
For GP B, the familiarity that comes with seeing an individual over a long 
period of time, creates a sense of knowing what to expect from each other in the 
relationship. Being able to see patients regularly and agreeing to see them in a few 
weeks’ time to see how they were getting on, was commented on as being a helpful 
approach by both GP B and D.  For GP B this approach helped her to build an 
understanding with the patient over a long period of time, without the focus of the 
consultation having to be on new symptoms: 
 
 “…it’s quite useful to say that I will see you in whatever the 
time interval feels correct and then therefore they don’t have 
to actually present with a set of symptoms to get that 
appointment and you can build on –you’re not sort of trying 
to manage a new set of symptoms, but you can build on 
where you got to at the last appointment.” (69) 
 
This extract also begins to highlight the system challenges that the GPs are 
working against to manage the medically unexplained symptoms that patients have. 
That alongside an implicit message that the system may give of ‘you need 
symptoms to access care’, GPs are trying to give explicit messages that give 
people the permission to come back and develop the understanding needed for the 
management of their symptoms.  
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Challenges to developing the relationship and in turn understanding, are not 
just limited to system issues, but also the patient’s ability to take up the care 
offered.  All GPs spoke of the frustrations of having a patient who would continue to 
request further medical opinions or resist the support offered,  and how this could 
invite a rejecting or critical response from the GP.  For GP D , he acknowledges 
that  “it is so easy to reject these people”, and tries to counter this by conveying that 
he takes what they are saying seriously, and from a place of concern offers to see 
them regularly to build an understanding and monitor the symptoms.  
5.6.3 Sub-theme: Providing a credible alternative narrative  
One of the issues highlighted as being important to the consultation, was trying to 
build a credible alternative understanding of the symptoms, which showed that the 
patients symptoms were being taken seriously.  GPs described various ways they 
would try to develop this with their patient, without necessarily referring the patients 
for further investigations. For GP A the role of the physical examination was central 
in this and she perceived it as having other functions then just being away to gather 
information.  Her perception of the process of examining a patient was that this 
helped to show the patient they were being listened to and taken seriously, and that 
the tangible nature of the “laying on of hands” conveyed a feeling of being cared for.  
Similar to GP C and D, it was another way to help build the evidence to support 
their explanation. However, she goes on to say that it helps to demonstrate her 
skills as a doctor stating:  
 
“…I think a lot of patients don’t see talking as any sort of 
treatment, or don’t attribute the same weight of talking to a 
professional. Sometimes I have to elevate my status a bit by 
doing the examination thing…” (75) 
 
Here, there is an assumption that talking treatments are not perceived as an 
active form of management by patients, which contributed to this GP finding a way 
to “elevate” her status, being seen as doing something, so that she can be heard.  
Where she is struggling and getting resistance, then she will make the decision to 
refer to the pain clinic to access a psychological review of the symptoms by the 
psychiatrist there. She recognises that the patient may not take this option up, but 
for her it’s about trying all the options “before I give up”.  For GP D, although he 
would refer on if progress was not happening with developing a symptom 
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understanding the patient could identify with, he would refer to another colleague 
within the practice to review the patients symptoms.  He describes that the process 
of normalising the symptoms is much harder than diagnosing: 
 
“…the most difficult bit of general practice, it’s not making 
diagnosis, its actually convincing the patent that what they 
have got does not require investigation and it is in the 
normal range…somehow changing the narrative that the 
patient goes out with… that they’ve got a more positive 
narrative to explain the symptoms.” (20) 
 
Although the alternative explanation for the symptoms is predominately 
spoken about from the position of it coming from the GP, patients who experience 
new symptoms whilst receiving long term support for their medically unexplainable 
symptoms, may also present their GP with an alternative explanation for their new 
symptoms. GP B spoke of the importance of showing the patient that as a health 
professional you are prepared to change your own narrative around their 
symptoms, or will say if you are unsure of the cause of their symptoms.  She feels 
that this type of approach should be encouraged in junior doctors and that they get 
experience at taking the uncertain position in the consultation and doing so in a way 
that does not leave a patient feeling “completely vulnerable”.   That it is not just 
about the patient being prepared to change their narrative, but also the GP.  
5.7 Theme 4: Professional preferences  
Theme 4 refers to the values that GPs apply to their clinical practice. The need for 
approaching their work with acceptance of what they were and were not able to do 
or explain, is discussed in the sub-theme ‘holding the uncertainty’. Within this sub-
theme details are provided not only on the effects of time and experience on being 
able to establish this position in their work, but also the effect that patient’ 
expectation has on this.  
The importance of having openness, honesty and holding compassion for 
the patient and their symptoms were also important qualities that GPs tried to foster 
in their work.  All GPs were open to considering a mixture of frameworks help them 
and support the patient to understand their presenting problem.  The barriers and 
facilitators of taking an honest and open approach and how they sit alongside the 
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value of compassion are discussed in the sub-theme ‘honesty, openness and 
compassion’. Collaborating with others, which included both patients and other 
healthcare professionals, was also perceived as being important to the GPs 
interviewed. Issues of language ability, readiness for active involvement and 
academic ability were all factors that were discussed as barriers to patient 
collaboration. Further details of this, as well as the function of partnership working 
with other colleagues is discussed in the sub-theme ‘Tackling the problem together’.     
5.7.1 Sub-theme: Holding the uncertainty 
 One of the issues discussed as being important to the GPs in their professional 
practice centred on the process of developing acceptance that they will not be able 
to explain and cure every patient that they see, and that this was not reflective of 
their professional ability.   GP A describes this as being a ‘tough’ realisation stating: 
 
“I think you go into to medicine thinking naively that you are 
going to round curing lots of people and that’s not the case 
in general practice… I’m at peace with that and figured that 
at a while ago, that my role is not often about getting people 
better erm… so it is tough.” (53) 
 
This extract suggests the professional struggle and frustration of wanting to 
cure the problems people present with, but not being able to and questioning what 
your role is then about.   For GP A she states that “with a bit of maturity and 
experience” she now sees that she does not have to be the person who comes up 
with the answers all the time, and is happy to take a more advisory role for the 
patient.   
Similarly for GP B, she refers to being more at ease with saying when she is 
unable to explain something and instead has found it helpful to focus on improving 
functionality for the person.  She describes that since “getting better at not worrying 
about having a diagnosis”, she is more able to manage the patient’s anxiety and is 
in “a better place to explain” how she reached her understanding of the symptoms.  
There was also recognition amongst GPs that to hold on to this position of 
uncertainty also meant needing to manage the patient expectation that as a GP you 
will be all knowing and able to cure everything. GP C refers to the situation of 
having patients ask him ‘well how do you know it is not this?’, whereby he 
acknowledges that he cannot know for sure because “I am not God!”.  GP D 
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perceives that “holding that uncertainty is the essence of general practice”, and that 
patients with MUS are the most difficult part of being able to hold this. For him he 
feels that GPs have to have resilience to be able to cope with the pressures that 
this brings, which includes managing the “unspoken scenario” that if you have got it 
wrong as a doctor then the patient will sue.  
5.7.2 Sub-theme: Honesty, openness and compassion  
GPs identified three qualities that were important to uphold in the approach that 
they took with their patients- honesty, openness and compassion for the person’s 
symptoms were all described as being central to the approaches taken. All GPs 
described themselves as using a biopsychosocial approach to understand the 
symptoms, adapting how much they attributed the cause to biological, 
psychological or social factors as they got to know the patient and their symptoms. 
GP C states that it was important to come to the consultation with an open mind, 
reasoning that “0% to 100% of people’s symptoms might relate to social and 
psychological factors”.   GPs described various ways they displayed openness in 
their approach with the patient, ranging from being open about the discomfort they 
may have with certain management options and discussing with them their reasons 
for this, as well as being open to hearing the new symptoms patients bring or the 
patient’s own ideas for symptom management.  GP D also spoke of the factors that 
he perceived as compromising how open GPs could be in the consultation, 
particularly if this meant saying something that was not in agreement with the 
patient:  
“…everything gets in the way of the frank conversation- 
time, the discomfort of doing it, the skill needed to do it, the 
patients resistance, the patient getting angry-it’s 
everything!..” (17) 
 
This extract highlights the struggle of wanting to be open and honest, but 
being unsure how to do this in a compassionate and understanding way.  GP A also 
suggests this unease, describing how her approach of being honest and open with 
the patient about her discomfort at repeated prescribing of analgesics “might not be 
patient centred”, however she reasons “[if] I am doing a good thing for the patient 
then I don’t really mind”. In this respect GP A perceives that patient centeredness is 
not about agreeing with the patient, but acting with the patient’s best interests in 
mind and showing it is coming from a position of concern.  
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Being honest and self -reflective of your own practice was also highlighted 
by GP A and B. For GP A the cue for reflective practice was if patients kept on 
coming back and being curious as to what this might be indicating in regards to how 
well you’ve understood the problem. One perception was that health professionals 
may come across as dismissive in their approach due to not being transparent 
about their own uncertainty of how best to understand the problem. GP B states: 
 
“I don’t think professionals are always very good at being 
honest about our own thoughts about what is going on, so 
we sometimes use terms or seem dismissive because we 
have not explained something in our own minds fully, but 
we’ve done the tests that exclude the serious stuff…” (70) 
 
This extract might also be associated with the level of acceptance that GPs 
have of not having the answers, as detailed in the previous subtheme holding the 
uncertainty, whereby some GPs may feel that it is acceptable to say that they don’t 
fully understand, whilst some might assume they have to have it clear in their own 
minds before they can provide an explanation. Overall, considering the interviews 
collectively, GPs wanted the patient to leave the consultation feeling that their 
symptoms have been heard through the concern and interest shown and that they 
as health professionals could be trusted to act in their patients’ best interests 
through the openness and honesty they have shown in their clinical approach.  
5.7.3 Sub-theme: Tackling the problem together 
Partnership working was a factor perceived as being important for the GPs 
interviewed. However, GPs varied in the extent to which they spoke about this in 
relation to encouraging active involvement of the patient, or active involvement of 
other staff and clinical teams. GP A had a particular strong focus on promoting 
active engagement in the consultation.  She states that the importance of being 
“patient centred” was taught on training, however it was not until she realised later 
in her career that she did not have to have all the answers could she be “truly 
collaborative”. She states: 
 
“I’m more comfortable saying to patients that we don’t have 
all the answers and let’s try and figure this out together. I 
think what works quite well is the patient alongside you, and 
 132 
 
that ‘this is a complicated problem that needs tackling 
together really’…”(60-61) 
 
For this GP, it is about acknowledging the complexity of the issue and doing 
so in a way that not only empowers the patient to take on an active role, but also 
recognising the preferences that the patient may have.   
For other GPs the focus was more on trying to maintain the relationship in 
general and trying to create an explanation that patients could “take on board and 
understand”  (GP C).  The academic ability to understand levels and quality of 
evidence, the language and cultural barriers that limit communication and readiness 
to take on an active role in the relationship were all cited by the GPS as barriers 
that limited patient collaboration. GP D describes the impact of the language barrier 
on building a collaborative relationship 
 
“…all the tricks that one uses to build rapport and 
relationship- you’ve lost those, because communication is 
so poor. It’s like going to France and having a conversation 
with a French person there would be no humour, no 
literature illusions, no political illusions –it would be ‘can I 
have a cup of coffee’ –very transactional...” (25) 
 
GP A shares a similar experience of needing to be more “blunt” in her 
approach where there is a language barrier, and where she perceives people to be 
drug seeking.  
Working in collaboration with other colleagues was also highlighted as an 
important factor for GPs.  Firstly, this provide the function of establishing 
consistency with patients that “dot around” (GP A). GP D describes the importance 
of giving a “good background” in the referrals that he makes, to encourage 
receiving health professionals to “step back and talk to the patient” so that a unified 
narrative can be established.  A second function of working in partnership with other 
healthcare professionals, was the support that could be accessed to think about 
alternative ways to approach the problem.  For GP B, and in regards to accessing 
support for managing patients with MUS, she perceived that it was particularly 
helpful to talk to colleagues “who have a specific interest in mental health”.  
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5.8 Theme 5: The experience of the system  
Theme 5 refers to the views that GPs have on the healthcare system they work in 
and the way in which these impact on the management of patients with medically 
unexplained symptoms. GPs reported the system pressures to increase 
accessibility in healthcare, but that the challenge was to do so without 
compromising delivery of consistent care for patients in primary care. In the sub 
theme ‘The priority of access over consistency’ the issue of acute presentations 
‘overwhelming’ the daily case load of GPs was raised, with concern that this was 
impacting on them having time for the management of chronic symptoms. Despite 
this, GPs who were currently practicing at the surgery suggested ways in which a 
consistent approach for all patients was being kept in the approach of the practice. 
Difficulties maintaining consistency with other parts of the system were also raised, 
which included navigating around the different service protocols and risk thresholds 
of certain symptoms.  The issue of needing space to be able to withstand not only 
the system pressures, but also the pressures that come with managing complex 
symptoms was also raised by GPs and is outlined in the sub theme ‘Finding 
protection against the pressures’. Concerns were also raised that although the 
amount of resources that MUS patients require can vary, that it initially requires a 
significantly greater amount of time than what is readily available to GPs to be able 
to build the relationship and develop understanding. This is described further in the 
sub theme ‘Needing more time and resources’. 
5.8.1 Sub-theme: The priority of access over consistency 
Views on the delivery of healthcare were discussed in relation to both primary and 
secondary care, with the central issues being around the role of increased access 
and consistency in care.  
Primary care level  
The perception amongst the GPs interviewed was that the national push to 
increase accessibility of healthcare for patients, could compromise the need that 
their complex and chronic patients had for a consistent approach to be provided in 
primary care.  In regards to MUS management, GP C describes how traditional 
approaches of managing MUS by the same doctor seeing the patient and building 
an understanding of the symptoms had become increasingly difficult with the 
“outside pressures” placed on primary care. For him, he perceived this as a move 
towards seeing the GP role as providing “items of care rather than as personal 
care”.   GP D held a similar perception, stating that he felt the management of 
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chronic conditions was limited by what he describes as being “completely 
overwhelmed” with needing to be available to see acute problems in primary care. 
He also referred to the wider changes he had seen over time in the level of risk that 
was considered to be acceptable, stating that at the start of his career “many 
conditions would not be investigated as they are now”.  
 In contrast, although GP A and B also acknowledged the difficulties, there 
was also a pragmatism that accessibility did need to increase for patients at the 
practice and that the issue was how to make sure that this was done in a way that 
supported consistency.  GP B felt that increasing healthcare accessibility may help 
to manage some of the fear that may come with having symptoms that cannot be 
medically unexplained, stating:  
 
“I think also if you are scared by your symptoms, which is 
very understandable if you don’t know -nobody knows quite 
where they are coming from ….[then] lack of access to 
healthcare can be worrying.” (68) 
 
Here, for this GP there is concern that the difficulties that patients with MUS 
experience getting an appointment might heighten the fear that they have not only 
about their symptoms being serious but that they are also on their own managing 
them.   GP B also raised the importance of social care to provide the practical and 
social support that she felt patients with MUS needed, particularly where medically 
speaking nothing more could be done. For this GP her frustration was at the 
inconsistency of the services that she perceived as making a difference to her 
patients, stating that “it’s a forever changing picture”, in reference to which third 
sector services continue to be funded.  She describes it as a being a “big let-down” 
for both herself and the patient, after having reached a psychosocial understanding 
of the symptoms, but feeling unclear about how best to guide the patient towards 
the support that they’ve just identified as necessary.  Similar to GP C and D, she 
also talks about the importance of delivering personal care, and the need to find a 
way to keep the consistency for patients as they move between health and social 
care.  
 
Secondary care level  
Establishing good communication between primary and secondary care 
services was identified as an important factor that helped GPs to provide 
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consistency of care for their MUS patients.  GPs described taking active steps to 
support with the containing of the symptoms within primary care by placing notes 
that could quickly alert other parts of the system of the management approach 
currently being taken, or clearly stating their understanding of the problem in the 
background information for any referral letters they made. For some GPs, patient 
were not routinely copied in to the letters that would be written, however GP D 
states that patients could request to see a copy and that he wrote it “with the 
understanding that the patient may see it”.  GPs also described how the process of 
ensuring consistency when a patient is under the care of a specialist could create 
more work, particularly trying to negotiate the differences in healthcare protocols.  
GP A described an occasion where communication had not been 
satisfactory between primary and secondary care, which had resulted in her patient 
having unnecessary surgery. She describes:   
 
“I had rung A&E when I found out she had gone in and said 
she was well known to me and has MUS- I really don’t think 
this is appendicitis, and I was quite, I was dismissed really 
and by that point the decision had already been made…” 
(37) 
 
She felt that the difference in how this persons symptoms were understood 
may have reflected the greater extent to which the biomedical model gets used in 
specialist services compared to primary care.  This view was also shared by GP D, 
who perceived that secondary care was about finding “certainty” and that they 
would “investigate until they get an answer”.  
In contrast, GP C described an occasion where communication between 
different parts of the system had been effective. This was for a patient who was 
currently experiencing non cardiac chest pains, but whose past medical history of 
having an isolated cardiac event, would trigger a rapid response. He described the 
agreements needed to be established not only with the patient, but also the 
different parts of the system to be able to contain the problem.  
 
“They [ambulance team] were part of the problem, because 
with their protocol, with chest pain you have to immediately 
transport and that was one of the biggest barriers to try and 
come to negotiation and if they did take her to hospital, then 
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the next part of the agreement was –clear on the A&E 
records, that this was someone who was not needing 
medical investigations…” (34)   
 
This extract highlights that whilst this GP recognises that certain protocols are in 
place to protect the patient, that they also need to be considered in the context of 
the patient so that unintentional cost to patient and NHS are not incurred.  
5.8.2 Sub-theme: Finding protection against the pressures 
 Various views were put forwarded on how GPs withstood the pressure, not only of 
general practice but also of seeing patients with complex care needs. For GP A 
there was concern that under the time pressures, prescribing had become a 
method of quickly showing the patient that they have done something, which ends 
consultation.  She states that rather than have the time to be able to hear what the 
patient need actually is, the GP might act based on an inaccurate assumption of 
“what do we think the patient think is going on, [and] what do they want”. She made 
reference to the observed “cultural aspect” of opiate prescribing having increased 
within primary care, and her suspicions that this reflected in part the time pressures 
that GPs face. She states: 
 
 “…everyone that you speak to is having a tough time of it, 
that time pressure to be everything all the time is probably 
leading to that increase in prescribing and loss of continuity 
is harder now to keep continuity with our patients.” (91) 
 
This extract suggests that there is another concern, which is that prescribing 
is not only going up but that monitoring of such medication becomes harder with the 
loss of continuity.  GP A also suggested that another way GPs might try to manage 
the pressure of general practice might be to “give a short shrift” approach or refer 
patients on to other colleagues if they are perceived as “too burdensome” or 
“emotionally draining”.  
The GPs interview shared the view that space was needed to help 
themselves process challenging consultations. For GP A she stated that having the 
space to reflect on the “bad experiences” during the study interview had been 
cathartic, and enabled her to look at these experiences that “weigh in on the back of 
your mind” holding compassion for herself at having done her best even if it did not 
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have the outcome that she had hoped for.  For GP B she had started to build this 
time in to the appointment slots that she offered, providing extra time for patients 
where needed, but also recognising there were patients where she would need this 
“space to manage” for herself.  She had also experienced how useful it was to 
spend time going through patient notes, and spotting any patterns in repeated 
investigations, stating “you can sometimes stop an unhelpful cycle of assessments 
by just stepping back.”  For GP D, having space was about having time away from 
paperwork and patients to connect with colleagues at some point in the day. He 
comments on the importance of the practice coffee break:  
 
“I think building some time in to your day where you’ve got 
the opportunity to just discuss patients or de-stress is 
important…the coffee breaks got later and later but we all 
met up for that –a really key and crucial thing at our 
practice.” (23) 
5.8.3 Sub-theme: Needing more time and resources 
GPs gave various reasons for needing more time and resources for the work they 
were doing with patients with MUS. Firstly, it was recognised that building up the 
initial relationship and understanding was something that could only come with 
time. GP C makes the distinction between the “simple problem” needing a brief 
context for it to be understood, compared to the complexity of MUS that required a 
more holistic understanding being formed.  Instead, GP A describes the current 
approach as being “piecemeal”, where patients are seen recurrently to build up the 
understanding. She feels that if there was extra time then the consultation could 
take on more meaning to the patient. With GP A there seems to be a professional 
frustration at seeing what the patient needs, but not being able to provide it:  
 
“Just think, spend 30 minutes with them or an hour with 
them and [you would] probably would get to the bottom of 
it….but we don’t have that luxury unfortunately.” (84). 
 
However, it is also recognised that not all patients with MUS would require 
the extra time. GP B states that where she already has a well-established 
relationship with a patient with MUS, then they don’t always require the full amount 
of time, which differs from the initial appointments stating “often [they] take a lot 
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more than 10 minutes”.   Time can become further pressured with the language 
barriers that GP C describes, where time is needed to enable translation and 
navigate cultural differences.   From what GPs describe they are identifying that 
appointment times are having to be tailored more to the presenting needs of the 
patient, and that extra time is particularly needed in developing an initial 
understanding or where language barriers are present.  For GP D, there was a 
frustration and concern that although time was needed to be able to manage MUS 
patients and prevent costs to other parts the system, that without recompense for 
this type of work it was placing additional strain on an already pressured 
environment.  He states: 
 
“There is no credit for any preventative work... that sort of 
work is just not noted in the targets… there is no resource 
recognition… which basically means you are killing yourself 
because you don’t have an extra nurse, an extra doctor to 
do the work.” (14) 
 
Here, it would seem that GP D is describing an over stretched service that still 
continues to be pushed, without staff having the extra resource that they need to be 




CHAPTER SIX: THE CONCEPTUAL MAP  
A conceptual map was created, comparing, contrasting and combining the results 
from the patient and GP interviews, to build an overall understanding of the 
experience of managing medically unexplained symptoms more broadly.   Figure 9 
shows the conceptual map developed from the data, and shows how patients and 
GPs manage MUS separately outside of the consultation, as well as how they 
manage it within the consultation space. Three conceptual themes emerged from 
GP and patient interviews- understanding of the symptom(s), the emotion response, 
the validating relationship, with one further conceptual theme present for patient 
interviews- deciding what gets shared in the consultation.  
Similarity was seen in how patients and GPs both saw the symptoms as being part 
of a complex problem that had many possible layers to it. Divergence was found in 
whether psychosocial factors were considered to be secondary or primary to the 
pain symptoms patients reported.  Predominantly patients spoke of psychological 
factors being secondary to the pain, although over time some patients had begun to 
wonder if it was a symptom of something “deep” within.  In contrast, GPs perceived 
pain to be secondary to psychosocial factors, with the focus of the intervention 
being concerned with supporting people to develop a biopsychosocial 
understanding.  There was evidence of there being a shared frustration, which 
came about from the patients experience of trying to access help for their 
symptoms in a pressured service and the GPs frustration at trying to provide person 
centred care without the resources to meet the level of need and demand. Both 
tried to manage the uncertainty of the symptoms through seeking support within the 
healthcare system- GPs focusing more at eliciting this at primary care level 
amongst colleagues, whereas patients spoke more about accessing this both at 
primary and secondary care level.  In addition, patients also continued the search 
for understanding and management options outside of the consultation, which at 
times impacted on the level of adherence to the medical advice provided.    
Developing a validating relationship was important in the management of the 
medically unexplainable symptoms for both patient and GP. For patients this had 
the function of legitimising their level of suffering, and a space where their needs 
could be understood.  For GPs the relationship was central to developing an 
understanding of the symptoms, as well as enabling risk management not only of 




6.1 Patient and lead GP feedback  
All 6 patient participants were sent a summary of the themes and a copy of the 
conceptual map, to help assess the credibility of the results of the study. For the 
purpose of feedback and for respect for confidentiality, GP themes and concepts 
were removed from the conceptual diagram sent to the patient participant group. 
Only 1 patient replied to the email invitation of reviewing and replying with their 
feedback.  Patient A replied stating the following: 
“Thank you for the summary and I appreciate you took the 
time to get back to myself. I do not think I wish to add 
anything to what you have written, You have captured the 
situation well I feel from the notes I read. 
Kindest Regards …” 
Participants conveyed a strong sense of the importance of being understood in their 
interviews. Although not all felt comfortable in ‘speaking up’, the majority 
interviewed displayed a level of persistence in order to be understood. As such, I 
wondered if the lack of response to my approach for feedback was reflective of 
participants viewing the content as satisfactory, and that if there were enough 
concern then this would have motivated a response.   
The GP leading on the  study  at the practice was also sent a summary of the 
themes and a copy of the conceptual map.  The copy of the conceptual map 
contained both GP and patient  accounts, to provide feedback to the GP on the 
consultation experience of both patients and GPs at the practice.   The feedback  
from this GP was that this  also  “chimed” with their experience of clinical practice. 
In addition they also added their thoughts about how the results could inform 
changes to clinical practice, which was an additional source of data that was used 
to inform the discussion of the results.  
The next section will now discuss how the conceptual themes outlined and the 
participant feedback are situated within the wider literature, along with consideration 
of the possible structures to support with patient and GP collaboration in Medically 




Figure 9: Conceptual map of how GPs and Patients understand and manage MUS
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CHAPTER SEVEN: DISCUSSION 
The aim of the study was to explore how patients and GPs understand long term 
symptoms with complex causes and their management, by addressing the following 
research questions:  
 How are long term symptoms with complex causes understood and 
managed by patients and GPs? 
 What way does their understandings overlap and diverge? 
 How are differences in understandings negotiated?  
 How can this inform shared decision making interventions to manage long 
term symptoms with complex causes more effectively in practice? 
 
This chapter will provide a summary of the results in relation to the aim and study 
questions outlined, as well as consideration of the strength and limitations of the 
methodology, and what the clinical and research implications are of this study.  
7.1 Summary of findings  
 This study provides two perspectives-patient and GP, on one shared 
experience- the MUS consultation at a South Yorkshire practice . This study 
contributes to the existing literature on primary care management of MUS, by 
focusing on the process between patient and GP in the consultation and what 
factors challenge and facilitate the development of a shared symptom and 
management understanding.  The results suggest that both patients and GPs are 
trying to solve the problem of explaining and managing the medically unexplainable 
to the best of their ability, with the resources they have available. However, gaps 
are evident in both the management approaches used between patient and GP and 
the information that gets shared in the consultation. Both patients and GPs spoke of 
the importance of the relationship in the management of MUS symptoms, with 
patients valuing not feeling on their own managing their ‘strange’ symptoms, whilst 
GPs recognised the importance of being able to provide symptom validation and 
ongoing monitoring of the risk of new symptoms developing or changes in 
symptoms occurring.  The results from the study suggest that an important aspect 
to consider in the development of future interventions to manage MUS will be to 
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focus on increasing what information is brought in to the consultation space. The 
implications being that prior to utilizing interventions that facilitate patient symptom 
understanding, that alternative methods may need to be used to open up the 
shared space between patient and their GP in order to assess a patients symptom 
understanding and need. The facilitators and barriers to patient-GP communication 
will be discussed in relation to the research questions raised initially in the study, 
with discussion of how the results fit within the literature already considered in 
chapter one and other relevant areas that have not yet been discussed.   
 7.1.1 How are long term symptoms with complex causes understood and 
managed by patients? 
Understanding of the symptom(s)  
             All patients reported that chronic pain was the main symptom they 
experienced, with all but two diagnosed with a chronic pain syndrome that as yet 
has no identifiable cause-Fibromyalgia. Patients spoke of a process of trying to 
decide what normal pain for their own body was and initially wondered if this was 
reflective of age, or the cumulative effect of working in physically demanding jobs. 
Such normalisation of the problems would see patients try and self-manage the 
pain with over the counter pain relief, rather than see their GP.   These findings are 
similar to other studies that have considered how age affects a person’s cognitive 
appraisals of their pain, whereby attributions for mild and chronic pain differ 
between young adults who associate this as being a symptom and older adults (60 
years plus) who showed an increased likelihood to attribute this to the aging 
process (Prohaska & Leventhal et al., 1985; Hofland, 1992). That said, the age 
range of this study sample was between 44 -62 years of age, providing evidence 
contrary to Prohaska & Leventhal et al., that some middle aged people may also 
attribute their pain to growing older, all be it only when it is not severe and enduring 
pain. However, considering this study finding in regards to the self-regulation model 
of illness (Leventhal et al., 1984), it is possible that participants’ experience of pain 
may have been influenced by other social determinants. For example the 
environment around them and the conversations with family and friends who may 
talk about their own aches and pains of growing older, or suggest it as an 
explanation to the individual who mentions they are in pain.   
As predicted by the self-regulation model, when patients in this study initially 
attributed pain to the normal process of ageing, their coping response was to self-
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manage. However when the pain persisted despite attempts to soothe and the 
intensity increased, patient participants then reported perceiving the pain as a 
potential symptom of disease in need of investigating, where additional resources 
were needed to what they already had.  Appraising the pain as a symptom brought 
with it concern, which in addition to seeking help from their Doctor, for some it also 
brought with it a cognitive response of comparing themselves to other people that 
they knew with similar symptoms, and the beliefs that their symptoms might be a 
life limiting, or threatening disease such as cancer.  For others they went back 
through their family history to see if there was mental health or physical health 
problems that could account for the symptoms.  The process described by the 
patients interviewed seemed to followed a similar three stage process that has 
been outlined in how patients generally decide to access medical treatment- firstly 
noticing and labelling them as physical symptoms, secondly searching for causes 
and making symptom attributions based on past direct or indirect experiences of the 
symptoms, and thirdly deciding that the benefits of accepting treatment out way the 
cost (Safer et al., 1979). This suggests that the process of help seeking in medically 
unexplainable symptoms is similar to other medically explainable health conditions. 
The emotion response 
 This study found that some patients reported less frequent attendance once 
they had a functional diagnosis they could identify with and which provided them 
with an understanding of how to manage the symptoms, with one patient stating 
that she knew best what worked for her own body.  Excessive worry continued for 
patients who although had a functional diagnosis, were unable to identify with it in a 
meaningful way, and would repeatedly present at either the hospital or see different 
GPs at the practice.  The exception to this was one participant who despite not 
identifying with the functional label, had found an alternative active coping strategy 
to manage his worry- faith.  
The role of catastrophizing and its effects on pain severity, emotional and 
functional responses is well documented (Sullivan, Bishop, and Pivik, 1995; 
Campbell, Quartana and Buenover et al., 2010). What is less clear is to what extent 
catastrophic thoughts are primary or secondary to the pain experiences, and 
overlap with other pre-existing cognitive and emotional processes.  One participant 
shared that without having a scan to verify that she did not have cancer, it 
exacerbated her fear of “you never really know if you are dying or not”. Although 
she spoke of the depression as something that came after the pain, it was clear 
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from what she described that the onset of her pain coincided with the emotional 
pain from the loss of a significant relationship and that she had not been able to 
give herself the permission to grieve. It is likely that the catastrophic beliefs this 
participant held were a complex interaction of both her suspended grief, and the 
impact that the pain behaviours were having on her life.  In addition, there is some 
suggestion that catastrophizing could be a learnt way to communicate level of need 
and support from friends and family (Sullivan, Thorn, Haythornthwaite et al.,2001). 
For this participant, whose identity was built on being a “strong” person and not 
being upset, this had the effect of eliciting her partners support, who would take her 
to appointments and reassure her that they would  find the money to go get a 
private scan.   
The validating relationship 
Symptom fear was not the only motivator to see the GP, but also ‘kinship’ 
and hope were also factors.  For patients who described this as being a motivator 
for them seeking GP support, there was a hope that the consultation would be a 
space that they could feel heard and understood, in a way that they were unable to 
get outside the consultation space. One patient described how her professional role 
of being a nurse meant that everyone expected her to be ‘nursey nurse’ 24-hours a 
day. She felt that when she went to see her GP, that they could ‘see through my 
eyes’ the struggles she was experiencing. This seems to be in reference to a 
sharing of the caring professional identity, which could deepen the empathetic 
connection and sense of relatedness for the situation of being in the caring 
profession, but also not being immune from needing care for yourself.  The 
psychological need of relatedness, described as a “feeling of being respected, 
understood, and cared for by others” (Ng et al., 2012),  has been identified as one 
of the two social factors that contribute to personal wellbeing (Deci and Ryan, 
2000), as well as with reported patient satisfaction with healthcare services (Waters 
et al., 2016). It would seem that for this participant, the anticipated relatedness 
based on past experiences of healthcare contributed to her motivation to seek help 
from her doctor.  
Reasoning about what gets shared in the consultation  
Even when patients did go to their GP for management of their symptoms, 
there was also evidence of managing their symptoms outside the consultation via 
health forums, switching medication for alternative therapies and actively monitoring 
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what impact if any, their mood had on the amount of pain they were in.  Despite 
how involved patients were with their symptom management, none of the patients 
felt that in general they would bring such information in to the consultation.  One of 
the reasons cited for not approaching their doctor with the information they were 
reading, or decisions to alter medication, were due to the past experiences of 
paternalistic care- not necessarily by the GP, but recalling a care hierarchy growing 
up or from experience of working in health care settings, and being unsure to what 
extent their opinion would be welcomed “I am mindful that I am the one 
approaching them for help”. For others there was recognition that it was not an 
‘evidence-based’ management option they were trying, and did not want to bother a 
busy GP with it. Perceived difficulties in getting a face to face appointment was also 
preventing one participant from saying how she felt about taking medication, stating 
that the impersonal nature of the telephone consultation, meant she found it difficult 
to open up to the consulting GP on the phone, and similar to participants not 
wanting to be a ‘bother’, did not want to be perceived as ‘being silly’ if she were to 
share her concerns.  This suggests that for these patients there was an overall 
awareness of the pressures of the healthcare service, and that this, along with any 
internalized stigma regarding illness legitimacy in the absences of an identifiable 
cause,  may have exacerbated existing beliefs about their overall worthiness for 
care. This lends support to the findings reported in other studies that have explored 
MUS patients experiences of primary care,   whereby patients have  highlighted the 
importance of non-verbal communication, amount of GP transparency about the 
limits of their knowledge, and perceived empathy from the GP to challenge 
perceptions that they are being seen as an  ‘inconvenience’ by their GP (Houwen et 
al., 2017). In addition, where studies have suggested that patients may not feel 
comfortable talking to their GP about psychological health (Peters et al., 2009; 
Branch, 2000), this study would suggest that there may be a mutual colluding of not 
discussing co-existing  mental health problems between patient and GP, with one 
participant stating that he believed GPs don’t want to share what they are really 
thinking, as they are worried that patients will have a “breakdown”.  This perception 
reflects some of the findings of a study exploring patient and health professionals 
experience of discussing co-existing depression with management of long term 
physical health conditions, where concerns were expressed by GPs that making 
reference to someone’s “depression” might come across as “intrusive” and would 
be avoided if the patient was perceived to be at risk of disengaging or too 
overwhelmed in managing their physical health condition (Coventry et al., 2011). 
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7.1.2 How are long term symptoms with complex causes understood and 
managed by GPs? 
Understanding of the symptom(s)  
For GPs, how they understood medically unexplained symptoms was based 
on past clinical experience and drawing on practice based evidence of the clinical 
markers that over the years had become suggestive that the symptoms were likely 
to be medically unexplained. This process of using probability reasoning to quickly 
build an idea of the nature of the symptoms supports the finding that such ‘rules of 
thumb’ strategies are used by health professionals to help with quick decision 
making and risk assessing (Andre, Borgquist & Molstad, 2003).  Although this did 
not prevent tests from happening, it did seem to enable some GPs to make their 
rationale clear for why the routine tests were being done, and managing the patient 
concern and expectation that disease pathology would be found.  
  GPs expected that such symptoms would be complex in nature, and that it 
was important to keep the patient and their symptoms in a broad context. The 
amount of context that would be needed was dependant on the perceived 
complexity of the problem, with one GP stating that complex problems would need 
to be put into the “entire” context of the patient’s life story, compared to simple 
problems that need a “brief” context to be able to understand.   This position 
seemed to be influenced by the model of reattribution (Dorwick, Gask & Hughes et 
al., 2008), which both retired and current GPs made references to being a helpful 
model to ‘work to’, with one GP recalling that they had attended training a while ago 
at the practice on this model.  Despite it being considered a helpful approach to 
take, it was also acknowledged that the difficulty came when the explanation could 
not be hung on a psychosocial factor that the patient could identify with, and that 
then, as one GP described “the tent goes flat”.  There was a perception that whilst a 
biopsychosocial framework was held by themselves, that the patient often came in 
with a biomedical understanding and would require support to make the connection 
between the psychosocial context and the physical symptom, placing pressure on 
them to search for medical certainty.   
The emotion response  
The internal pressure to be able to  ‘fix’ was also identified by GPs in the 
study, and how tolerating uncertainty and not ‘buying into’ the public perception of 
the ‘all knowing’ expert,  came with the right amount of both personal and 
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professional experience.  GP’s commented on being comfortable and “at peace” 
with the uncertainty, and recognised that in being able to manage their own anxiety, 
they were in a better position to think about what was going on for the patient.  
Whilst there is evidence to suggest that tolerating the uncertainty of less 
‘concrete’ problems is a widely shared challenge amongst Trainee GPs (Stone, 
2013; Stone et al., 2014; Howman et al., 2016), there was evidence in this study 
that towards the later career stages there is also reduced confidence in the ability to 
assess symptoms due to a combination of the changes in the amount of risk 
tolerated in the healthcare system, as well as general over exposure to what one 
GP referred to as “self-limiting” symptoms. GPs then sought support from outside 
the consultation to reflect on the challenges of the consultation, doing so either on 
their own or with colleagues, or referring the patient on to other colleagues within 
primary care. 
The validating relationship  
Maintaining the therapeutic relationship was also identified by GPs as being 
a central part of MUS management. This enabled the gradual development of an 
understanding about the symptoms, which had to occur over many consultations 
due to demands on appointments, managing acute presentations, and the language 
and cultural barriers experienced with many of the patients with MUS.  Although 
GPs identified that the long relationships they held with their MUS patients helped 
to provide a firm level of understanding of the symptoms, it was also recognised 
that this came with the risk of missing something with not being able to see the 
patient’s symptoms “fresh” each time.  
This suggests a dilemma for continuity of care, which has also been shown 
to occur in another study exploring the value of personal continuity for GPs, with 
suggestions that this dilemma could be managed by moving towards providing 
continuity of care at practice level rather than individual (Ridd, Shaw & Salisbury, 
2006).  
7.1.3 What are the areas of divergence and convergence in patient and GP 
symptom understanding and management?  
In relation to how GP and patients both perceived symptom management, a 
similarity was seen in that both were searching for a way to make sense of the 
symptoms and fill in the gaps in their understanding.  However, both patients and 
GPs raised the issue of needing more time in the consultation to be able to develop 
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a meaningful understanding, with patients reporting that the quality of the 
explanation that the GP was able to provide was used to indicate the extent to 
which they had been heard by their GP and enabled subsequent trust to be built in 
the relationship.  Being able to provide and receive a range of options for managing 
the symptoms was also shared by GP and patients.  Both shared the frustrations of 
the management limitations through lack of evidence-base, as well as the vague 
direction that could be provided if the symptom understanding and management 
was for psychosocial support. One GP described how the fixed term contracts for 
third sector services made it difficult to establish a partnership and confidence in 
what she was ‘prescribing’. The lack of therapeutic direction with managing MUS 
has previously been cited as a shared concern by both patient and GP (Atkins et 
al., 2013), whereby patients interviewed about their experiences of MUS 
management reported that they felt “abandoned” by their GP, when diagnostic 
results came back clear and conversations began about potential co-existing 
stressors. Similarly, GPs in the Atkins et al. study also reported they at times felt 
unable to discuss ‘psychosomatic’ symptoms with patients anticipating this would 
be met with anger from their patients and would try and disguise their belief by 
using nonspecific phrases, such as ‘stress-related’ symptoms. The study suggested 
that GPs and MUS patients were silenced, stressed and working in their own silo to 
understand the symptoms.  
 To some extent this was evident in the current study. The study found a 
shared expectation between GP and patient, that the ‘other’ in the relationship 
would be using a different explanatory model to understand and manage the 
symptoms. For GPs this was the expectation that patients would predominately 
hold a biomedical understanding of their symptoms. Whilst for some patients this 
was evident, and the treatment goal was to fix, there were also patients who spoke 
of it being their GP on a search for answers and looking for a ‘cure’ for their 
symptoms.  Contrary to research having found that chronic pain patients and GPs 
held different frameworks for understanding, with patients using biomedical and 
GPs using biopsychosocial understandings (Allegretti et al., 2010), there was 
evidence in this study that there was much variation in how patients made sense of 
their symptoms, with both biomedical and biopsychosocial models being used. 
Contextual factors from both outside and inside the consultation are likely to 
contribute to the variation seen, for example three patients worked within the care 
profession and spoke in relation to symptoms being managed rather than cured. 
Also, the extent to which health professionals had spoken to them about their 
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symptoms from a biopsychosocial perspective may have varied in relation to GPs 
perceptions about which patients would be able and ready to enter in to this form of 
conversation. 
The findings from this study support existing research that have suggested 
that patients have a complex understanding of their MUS symptoms (Peters et al., 
2009; Liden, Bjork-Bramberg & Svensson, 2015). This lends support to the 
argument that although GPs report that patients are unlikely to make the link 
between bio-psycho-social factors themselves, that this might be reflecting not 
necessarily limitations in patients’ understanding, but their uncertainty about 
deciding what is relevant and how to talk about these issues with their GP. Factors 
such as the transient nature of internal and external experiences, cultural issues 
around talking about psychosocial issues (Coventry et al., 2011), as well as 
logistical barriers of appointment (Murray et al.,2016 ), have all been reported as 
barriers to good consultation communication.  
 The difference between the results in this study and Allegretti et al’s paired 
interview study between MUS patients and GPs, may also be highlighting another 
important factor that influences the extent to which patients pursue a biomedical 
explanation and treatment for unexplained symptoms- the role of privatised 
healthcare and the extent to which patients can afford to pursue it.   
7.1.4 How are differences in understandings negotiated?  
Patients varied in the extent to which they felt able to spontaneously say or 
question their GP if they were concerned or disagreed about something.  For some, 
they found it helpful when their GP began the consultation by asking them 
questions that helped them to share what concerns they had about the symptoms, 
giving them the permission to question. Signposting and providing of information 
was also welcomed by patients from their GPs, although it was important that there 
was enough time that this could be discussed together in the consultation.  
Where patients had not felt there had been a mutual exchange of 
information, there was evidence of resistance to medical opinion and seeking 
consultation with another GP or going to the hospital. GPs also commented on this 
stating that at times the dialogue between patient and GP would become ‘stuck’, 
with ‘both of us facing a brick wall’ - unable to move beyond a particular narrative in 
the consultation.   GPs spoke honestly about occasions when differences in 
understanding had not been possible to resolve and that the agreement reached 
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was to bring the relationship to a close.   One GP spoke of the importance of 
accessing the health beliefs of the patient and using this to work out what needed to 
occur to move the patient’s beliefs closer to their own.  Although there was also 
evidence that some GPs tried to co-construct an understanding with their patients 
about the symptoms and management options, there is also evidence to suggest 
some support for research that has previously found that where patients present 
with complex presentations, either the patient or GPs agenda gets prioritised, rather 
than shared (Sinnott and McHugh et al., 2013).   That said, it is important to 
recognise that a number of contextual factors will be impacting on how GP and 
patient approach patient involvement. This study found that although patients did 
favour the move towards patient involvement in their care,  it was also recognised 
that the amount of involvement they wanted in the consultation fluctuated and at 
times they felt it was more appropriate that the GP took the lead. This was 
attributed to the nature of the consult, and the acute nature of their symptoms.  This 
highlights the temporal nature of patient involvement and the dynamic assessments 
that GPs are having to make regarding the appropriate approach to take.  
7.1.5 How can this inform shared decision making interventions to manage 
MUS more effectively in practice? 
As outlined in chapter one, Shared Decision Making (SDM) has been 
described as a way to help promote patient involvement in decisions made about 
their health (Coulter & Collins, 2011), in a way that recognises both the 
preferences, values and knowledge that the patient brings, as well as the clinical 
expertise and knowledge regarding risk benefits of treatment or management 
options that the health professional brings (Ahmad et al., 2014).   Both patients and 
GPs in this study showed a similar anxiety regarding the risk of the medically 
unexplained symptoms either being, transforming or overshadowing something life 
threatening, and that both managed this anxiety outside of the consultation. 
Although this was helpful when GPs spoke to colleagues for their own support and 
suggestions, patients found it confusing if a referral was made that did not fit with 
their own understanding of their symptoms or style of coping, with one participant 
stating that she did not know how the exercises in the pain management 
programme applied to her when she did not believe she had any control over the 
pain.   Evidence suggests that where patients show low active coping response 
(taking active steps to make changes) and high passive coping response (look 
towards factors outside of them for control) there is an increased risk of non-
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compliance with referrals for exercise-based rehabilitation programmes (Ferrari and 
Louw, 2011), as well as reduced perception of being able to control the symptoms 
(Baastrup et al., 2016), and increased severity of depression (Mercado et al., 2000).   
This suggests that having space in the consultation to assess and discuss potential 
barriers to management options may support identifying patients in need of 
additional support before they are able to access self-management options for their 
symptoms.   
Use of Patient Reported Outcome Measures (PROMS) has been reported 
as one way of helping to open up the conversation between patient and health 
professionals and provide information that can be considered together to help 
inform decisions made about health care through use of generic or disease specific 
PROMS (Black, 2013).  Although use of PROMS in a primary care setting is not 
routine for chronic health conditions, a self-management screening tool has been 
developed and validated on a Netherlands sample of primary care patients with 
chronic health conditions, which measures self-efficacy, anxiety and depression, 
locus of control and social support, and assess preferences for mode of delivering 
support (groups, computer, willingness to self-monitor) (Eikelenboom et al., 2015). 
Whilst this screening tool did not include patients with MUS in the sample, it does 
provide an example of how the identification of barriers to management of long term 
conditions or symptoms could be a potential way of providing the permission that 
patients appeared to need to discuss different aspects of their health (mental and 
physical) with their GPs, and a way for GPs to safely approach the conversation of 
mental health and discuss risk issues.  This suggestion certainly fitted with the 
study feedback that was received From the GP, who suggested that introducing a 
triage system, whereby screening patients particularly for self-efficacy may help to 
determine the level of resource allocation needed. 
However, although use of PROMs in MUS management may have the 
additional benefit of evidencing need for resource to commissioners, the cultural 
diversity seen within a practice population would limit the extent to which 
standardised measures could be used, where validation of existing measures are 
unlikely to be representative of the cultural and clinical diversity seen with patients 
with MUS.  Other methods supporting generic shared decision making may be 
better suited to the unique needs of a practice, for example brief decision aids and 
option grids that could provide a visual representation of the risk and benefits of 
deciding between continuing with a focus on disease pathology whereby 
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investigations and treatments are pursue. Alternatively, a focus on quality of life and 
symptom management approach, as well as thinking about the congruency of their 
response to their symptoms with doing what is important to them in their lives 
(Ahmad et al., 2014). 
 7.2 Evaluation of method 
The overall credibility of the results, will now be outlined alongside the 
strengths and limitations of the design used. The trustworthiness of the results will 
be considered against the extent to which procedures recommended by Chiovitti & 
Piran (2003) were followed, which include  letting participants guide the inquiry 
process, checking the theoretical construction generated against participants 
meanings of the phenomenon, using participants actual words in the conceptual 
framework, and clarifying researcher bias. 
7.2.1 Quality  
Interview questions were developed with support both a  GP and patient 
consulting on the study.  In addition, the topic guides were used to provide a loose 
structure to the interviews, and enabled flexibility in how and in what order the 
topics were discussed.  Data from the interviews as they were completed also 
informed the gradual refining of the interview questions.  This was to add greater 
exploration of topics that had not necessarily been captured in the initial broader 
questions that had been asked.  
Pen portraits were also provided to help orientate the reader to the particular 
context of each of the participants. The process of developing the conceptual map 
was an iterative process of going back to the results and the transcripts to ensure 
that the words used were not being taken out of context. The lead study GP and 
patients were provided with a copy of the conceptual map and given the opportunity 
to verify the concepts generated. The feedback gained from both a GP and patient  
participant helped to confirm the representativeness of the results. In addition, the 
feedback from the GP on local developments primary care, helped to inform 
thinking about the clinical implications and recommendations from the study. 
Themes generated have remained close to the actual words used by 
participants. Although the conceptual map by its very nature moves towards more 
abstract concepts to support with the situating of results in to the broader context, 
participants own words have been used as much as possible, and extracts from the 
 154 
 
original data has been provided alongside the interpretations made for the readers 
to make their own assessment of credibility of the themes.   
The multiple process of going through ethics required providing clear detail 
and justification for the study procedures and methods of data collection. In addition 
the method used creates a transparent approach to how the process of moving 
from codes to categories was generated. The coding matrices used also had notes 
in red, to make it clear when interpretations moved away from the data and 
reflected researcher observations in patterns of meaning or assumptions regarding 
underlining themes in what the participant was reporting. All matrices used in the 
analysis are provided in the additional supplementary information provided. 
Reflection was encouraged in supervision, and areas for potential bias were clearly 
stated at the start of the study for the reader to make their own appraisal of the 
extent of researcher bias.  
Quality checks of the data collected was verified through data triangulation 
between patient and GP interviews.   Supervision was also used to ensure quality 
of both the categories and the constructs being generated. 
7.2.2 Strengths 
The study has contributed to the literature exploring medically unexplained 
symptoms from the perspective of GPs and patients, by placing a greater focus on 
the processes involved in managing the medical uncertainty between GP and 
patient in the consultation. Research that has highlighted the challenges of MUS 
management in primary care have predominately focused at the individual level of 
the GP and patient rather than the partnership and interaction between patient and 
the GP. Subsequent interventions have also been at the individual level, with it 
recognised that the variability seen in success may reflect the challenge being 
positioned with the GP rather than as a joint challenge that is shared and influenced 
by the patient and what they decided to share in the consultation (Peters et al., 
2009). The results from this study indicate how two perspectives of one shared 
experience – managing MUS in primary care- overlap and diverge between GPs 
and patients at one practice, and has enabled a closer focus on what’s important to 
GP and patient in a MUS consultation, the individual and system challenges that 
impact on this, and the possible areas to build on.  This may help to provide a 
broader context of the reported challenges of managing MUS in primary care and 
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the processes involved for GPs in developing a shared understanding of such 
symptoms and management options.    
Another strength of the study was the qualitative method used to collect and 
analyse the data. Use of a qualitative approach enabled the diversity to be seen in 
the views of the study participants, capturing the complex nature of MUS and 
consultation behaviours in a way that other quantitative approaches have been 
unable to capture (Van der Weijen et al., 2003; old Hartman et al., 2013). In 
addition, using framework analysis added to the transparency of the process of 
moving through the different levels of data abstraction. Although complete 
replication of the study results is not possible by the nature of qualitative methods 
(Seale, 1999), the use of coding matrices added to the explicit outlining of the 
procedures that led to the conclusions.  
 Lastly, the inclusion criteria used in the study was kept broad to limit the 
amount of researcher influence on how GPs were defining MUS in their practice, as 
well as  ‘frequent attender’ status within the practice. This provided face validity to 
the process of identifying eligible patients during the recruitment phase, and 
avoided imposing arbitrary criteria that GPs at the practice might not have identified 
with as being relevant to managing this patient group. GPs were reminded that 
‘frequent attender’ status could include people who have MUS symptoms 
satisfactorily controlled or otherwise. This enabled variation to be seen in the views 
collected from patient participants.    
7.2.3 Limitations 
The current study has several limitations. The context of the study was at 
one primary care practice; therefore caution should be taken generalising to other 
primary care sites, and further research would be needed to consider applicability to 
secondary care, where this  next tier in the healthcare system may come with 
different expectations and logistical challenges to the consultation. In general, the 
results did show some similarities in reported patient and GP experiences from 
other primary care studies that had occurred both within and outside of the UK, 
which would suggest that there are general challenges that are experienced in 
managing symptoms that do not have a medically explanation, regardless of the 
context. In addition, it was noted that the final sample consisted of mainly patients 
with a functional diagnosis of fibromyalgia, which may limit generalisability to 
nonspecific forms of MUS. That said, commonalities were seen in this study 
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between participants who had a diagnosis and those that did not, which may 
suggest that the shared feature between the participants was the important aspect- 
that they were all managing symptoms without an objective medical cause.  
The process of needing to opt in to the study, may have also introduce an 
under representation of views, with it reported that people who respond are more 
likely to be higher in literacy, education and motivation (Barker, Pistrang and Elliott, 
2002, p. 116). This may have meant that the views represented in this study are 
from participants who are motivated to be involved in their care and can create a 
more complex account of their symptoms. Interestingly, although the list of eligible 
patients was not shared with me, it was reported that the potential participants 
identified as eligible had a range of MUS labels, which predominately included 
‘medically unexplained symptoms’ and ‘unexplained symptoms continued’ rather 
than ‘fibromyalgia’.  One possible explanation for the increased response from 
patients with fibromyalgia, might be that all information sheets sent to participants 
included my name and that I was a trainee clinical psychologist. It is possible that 
people who were more willing to take part were more open to exploring the role of 
the mind on the body, which may also reflect that many of the patients who had a 
diagnosis of fibromyalgia were involved with the pain management clinic where this 
was being discussed.  However, the results of this current study did indicate 
diversity in how participants both made sense of their symptoms, as well as 
variation in the extent to which they thought they should be involved in their 
symptom management.  
Recruitment of GPs also included current and retired GPs at the practice, 
which may have introduced views that were not representative of current practice or 
memory recall bias. That said, GPs had spent the majority of their career at the 
practice and had retired within the last 2 years, with one GP commenting that this 
was a group of patients that you do not easily forget.   GPs that were no longer 
practicing shared that they did not mind speaking openly and frankly about the 
challenges they experienced, due to no longer working in the profession, which may 
have helped to reduce any potential effects of social desirability that limited what 
GPs felt able to share.  
Lastly the qualitative method used has the limitation of not being 
representative beyond the sample of participants in the study. In addition, the study 
results will invariably be affected by my own embeddedness within the research 
process, whereby the rapport I built with participants, how I posed questions and 
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which areas I decided to probe further in to, will contribute to the conclusions that 
have been made in this study. Although precautions were taken to add wider 
reflection, for example reviewing themes and constructs in supervision, as well as 
inviting feedback from participants, further research may want to use a 
questionnaire survey design to test how representative the themes are in the wider 
MUS population. This might enable comparisons to be made between primary and 
secondary care, as well as reducing the impact that the researcher might have on 
the data collected.  
7.3 Clinical implications and directions for future research 
One of the clinical implications for supporting the management of MUS in 
primary care, is to try and bring what is happening outside of the consultation for 
the patient, in to the consultation for shared discussion. Not only might this help to 
support with management consistency, but also is a way to monitor symptoms and 
manage risk of new symptoms and medication. The study highlighted the potential 
increased risk of patients altering medication or stopping without clinical guidance 
or awareness, whereby unused medication remained available, with some patients 
at their lowest points also reporting active thoughts of suicide. In addition there is 
the concern that patients are also substituting other medicines for ones they can 
access on line, which are not regulated and are being taken in combination with 
other medication. This comes with cost implications to the NHS, of prescribing 
medication that is not being used, as well as increased risk of unplanned 
admissions to hospital.   
The second clinical implication is to the importance of encouraging patients 
to see self-management as an active intervention that does not have to come at the 
end of a series of investigations where no treatment has been identified. Patients 
spoke of the frustrations that came with not having the knowledge to manage their 
symptoms without first getting a diagnosis. Although GPs spoke of the need to rule 
out serious disease pathology, and the importance of placing the symptoms in to 
the wider context of the person’s life, there could be an argument made that 
another important aspect is to provide an alternative narrative to the discourse that 
GPs acknowledge as having dominated medicine, and one that the patient has 
become to expect from their own past experiences, which is that intervention is only 
possible once a diagnoses is in place.  Patients have spoken about the importance 
of having access to information about their symptoms and being signposted to 
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credible sources that can provide this, as well as the value for some of self-
monitoring mood on symptoms, attending for regular physical health checks, and 
finding ways to increase access to social support. In this respect, it may be helpful 
to emphasise self-management as something that can start immediately, rather 
than something that comes at the end of trying everything else and only once a 
comprehensive understanding is in place. That self-management is not instead of 
investigations, but in addition to the preliminary investigations that would routinely 
be completed.  The clinical guidelines for the management of nonspecific pain 
conditions is currently under development, and may assist with how management 
options are discussed between patient and GP (NICE guideline: Chronic pain, 
2018).   
A third clinical implication is that although many patients could identify that 
psychosocial factors were associated with their symptoms, they were not sure that 
they were caused by them. Similarly, GPs recognised that although a model of 
attribution was helpful, it did not work for all patients that didn’t identify with the 
‘stressors’ being identified, leaving the dialogue feeling stuck.  An alternative 
approach was suggested in a pilot trial of a primary care ‘symptom clinic’ (Burton et 
al., 2012), which focused on developing explanations that were positioned within 
the medical framework that some patients were coming to the clinic with. The focus 
was on meeting the patient where they were in their understanding about the 
symptoms and opening the dialogue up enough for psychological factors to be 
discussed as factors that were likely to be associated with the physical symptoms, 
rather than the cause of the symptoms (Burton et al.,).  This was reported to be an 
acceptable approach to the majority of patients involved in the trial, with eight out of 
the eleven patients reporting that they felt helped by approach taken, and that the 
time and the explanations were particularly valued, however there were three 
patients who had remained sceptical about the approach and that this was still a 
method of attributing physical symptoms to psychological causes. Unfortunately no 
data was provided on any observed differences between patients that identified with 
the approach and those that didn’t.  Overall, it would seem that this approach would 
help to leave the direction of the relationship between mind and body open for the 
patient to decide on, which maybe in contrast to the Attribution model that positions 
the physical symptom with psychosocial causes.  
This study suggests that having an intervention that can support with the 
building of the shared part of the consultation between patient and GP may help to 
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reduce the risk that comes with management external to the consultation.  Patients 
reported that it was important to them to feel in control of their symptoms, and that 
having a tailored approach that could demonstrate they had been taken seriously 
and had been heard was an important aspect in the management of their MUS. 
 This also seemed congruent with what the GPs in the study reported of 
wanting to find ways to establish a partnership in how symptoms were understood 
and managed. Incorporating psychosocial measures in to routine clinical practice 
may also helped to supplement information in the consultation as well as facilitate a 
shared discussion about factors that are feared by GPs as being heard by MUS 
patients as “it’s all in your head”.  Feedback from a GP participant was that there 
may be potential to introduce a triaging system for patients, whereby screening 
patients for self-efficacy may help to determine the level of resource allocation 
needed. In addition, it was felt that using measures to triage may also help to 
reduce clinician ‘burnout’, by providing GPs with feedback about the additional 
needs that a patient may have.  It was suggested that initially this could be trialled 
using the local move in primary care to use the ‘Patient Activation Measure’ (PAM) 
in care planning,  as a measure of self-efficacy that is not disease specific and may 
hold relevance for patients with complex symptoms. Patients that scored low on 
self-efficacy would then alert the GP that a more bespoke approach was needed. 
7.3.1 Directions for future research 
Suggestions for future research in to this area may include increasing the 
representativeness of the results by using the results from both GP and patient 
interviews to develop a questionnaire that can be widely disseminated to other GPs 
at both urban and rural practices and patients with a wider range of MUS, which 
focuses on the illness (or symptom) perceptions that people have, the management 
options considered and the experience of shared decision making in MUS 
management. Collecting data on the type and number of MUS symptoms that 
patients have, for example using the Patient Health Questionnaire-15 (PHQ-15), 
and the intensity of their most prevalent symptom might also help to capture to what 
extent acute and chronic symptoms impact on considered management options and 
involvement.   That said, it may be that investigating the additional value and 
acceptability of introducing either PROMS or a general shared decision making aid 
could be trialled using a mixed methods approach in primary care MUS 
consultations. This could compare treatment as usual with consultations that have 
used explicit frameworks of SDM. The effect of using SDM on increasing perceived 
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symptom control and use of self-management options,  and reducing symptom fear 
and avoidance in patients managing MUS could be considered through measuring 
anxiety, self-efficacy, and including a measure of coping styles to explore the extent 
to which this  impacts on how people respond. In addition, interviews could be 
completed with a sub group of patients and GPs regarding their experience of using 
a SDM approach in the consultation and how this contrasted with times when they 
had not used this approach.  It is hypothesised that compared to consultations 
where SDM has not been used, that patients will report an increase on social 
factors that have been associated with personal wellbeing and patient satisfaction 
with services; increased feeling of competency to get involved in decisions made 
about their symptom management and an increased amount of felt relatedness 
between themselves and the GP (Deci and Ryan, 2000; Waters et al., 2016).   
This appeared to be the experience reported by one participant, who shared 
that participating in research was important to her and that having received an initial 
approach from her GP to take part in this study was likened to taking “two 
tramadol”.  In this respect, the participant was pleased that their GP had given them 
the opportunity to get involved in a project that they felt had relevance to their 
symptoms and was congruent with what they valued.  Despite the concerns raised 
in ethics about the possibility of damaging the patient-GP relationship, it would 
seem that for this participant, being approached by their GP with the study 
potentially strengthened rather than threatened the therapeutic alliance and was 
akin to pain relief.  As such further research about the patients experience of GPs 
approaching them with research and comparing this against patients with MUS 
experience of this, may help to assess if being given the option to take part in 
research has additional value for people with symptoms that are not medically 
explained. 
7.3.2 Plans for Dissemination 
Although the research findings have been shared with the GP consulting on the 
study, it is anticipated that the study results and recommendations will be presented 
to all staff at the South Yorkshire practice. The study will also be considered for 




The study explored patient and GP experiences of understanding and 
managing medically unexplained symptoms, comparing and contrasting interviews 
with patients (𝑛 = 6) and GPs at their practice (𝑛 =4). The study found that GPs 
viewed the patient-GP relationship as central to developing symptom understanding 
and providing support to patients that have symptoms that are medically 
unexplainable. The importance of being able to professionally tolerate the 
uncertainty that came with the symptoms was highlighted by GPs, both for their 
own wellbeing and that of their patients.  The role of the pressured working 
environment, the healthcare movement towards preventative intervention and fear 
of litigation, were identified factors that made this approach difficult to always 
maintain, but was buffered by the support of colleagues and the working alliance 
held with the patient.  Whilst patients also reported anxiety around their medically 
unexplainable symptoms, they showed evidence of having built an incomplete but 
multi-layered understanding of their symptoms through actively seeking 
understanding and management options both within and outside of the consultation.  
However, patients recognised this information was not always shared in the 
consultation, due to lack of time during the consultation as well as concerns about 
how their contribution would be perceived by the GP. The results highlight a 
potential gap between patient and GP approaches to symptom management, as 
well as identifying a shared belief that the relationship between patient and GP is 
valued in the management of MUS. The clinical implications outlined provide 
potential ways to open up the shared dialogue between patient and GP, so that a 
balance can be established between the patient’s understanding and preferences 
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